US5639402A - Method for fabricating artificial bone implant green parts - Google Patents

Method for fabricating artificial bone implant green parts Download PDF

Info

Publication number
US5639402A
US5639402A US08/288,120 US28812094A US5639402A US 5639402 A US5639402 A US 5639402A US 28812094 A US28812094 A US 28812094A US 5639402 A US5639402 A US 5639402A
Authority
US
United States
Prior art keywords
calcium phosphate
calcium
polymer
implant
polymer binder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US08/288,120
Inventor
Joel W. Barlow
Goonhee Lee
Richard H. Crawford
Joseph J. Beaman
Harris L. Marcus
Richard J. Lagow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US08/288,120 priority Critical patent/US5639402A/en
Application filed by University of Texas System filed Critical University of Texas System
Assigned to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM reassignment BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BARLOW, JOEL W., BEAMAN, JOSEPH J., CRAWFORD, RICHARD H., LAGOW, RICHARD J., LEE, GOONHEE, MARCUS, HARRIS L.
Priority to AU33614/95A priority patent/AU702229B2/en
Priority to JP8507436A priority patent/JPH10508324A/en
Priority to PCT/US1995/010017 priority patent/WO1996005038A1/en
Priority to EP95930121A priority patent/EP0775046A4/en
Priority to US08/832,882 priority patent/US6183515B1/en
Application granted granted Critical
Publication of US5639402A publication Critical patent/US5639402A/en
Assigned to NAVY, SECRETARY OF THE, UNITED STATES OF AMERICA reassignment NAVY, SECRETARY OF THE, UNITED STATES OF AMERICA CONFIRMATORY INSTRUMENT Assignors: TEXAS, UNIVERSITY OF, AT AUSTIN
Priority to US09/765,801 priority patent/US6540784B2/en
Priority to US10/255,336 priority patent/US20030069638A1/en
Assigned to CROSS ATLANTIC PARTNERS IV, K/S, AS ADMINISTRATIVE AGENT reassignment CROSS ATLANTIC PARTNERS IV, K/S, AS ADMINISTRATIVE AGENT SECURITY AGREEMENT Assignors: BIOMEDICAL ENTERPRISES, INC.
Assigned to CROSS ATLANTIC PARTNERS IV, K/S AS ADMINISTRATIVE AGENT reassignment CROSS ATLANTIC PARTNERS IV, K/S AS ADMINISTRATIVE AGENT RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: BIOMEDICAL ENTERPRISES, INC.
Assigned to BIOMEDICAL ENTERPRISES, INC. reassignment BIOMEDICAL ENTERPRISES, INC. CORRECTIVE ASSIGNMENT TO CORRECT THE IDENTITY OF THE ASSIGNOR AND THE ASSIGNEE. PREVIOUSLY RECORDED ON REEL 022764 FRAME 0679. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE OF SECURITY INTEREST. Assignors: CROSS ATLANTIC PARTNERS IV, K/S
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/622Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/626Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
    • C04B35/628Coating the powders or the macroscopic reinforcing agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2/30942Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C64/00Additive manufacturing, i.e. manufacturing of three-dimensional [3D] objects by additive deposition, additive agglomeration or additive layering, e.g. by 3D printing, stereolithography or selective laser sintering
    • B29C64/10Processes of additive manufacturing
    • B29C64/141Processes of additive manufacturing using only solid materials
    • B29C64/153Processes of additive manufacturing using only solid materials using layers of powder being selectively joined, e.g. by selective laser sintering or melting
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C64/00Additive manufacturing, i.e. manufacturing of three-dimensional [3D] objects by additive deposition, additive agglomeration or additive layering, e.g. by 3D printing, stereolithography or selective laser sintering
    • B29C64/10Processes of additive manufacturing
    • B29C64/165Processes of additive manufacturing using a combination of solid and fluid materials, e.g. a powder selectively bound by a liquid binder, catalyst, inhibitor or energy absorber
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y70/00Materials specially adapted for additive manufacturing
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y80/00Products made by additive manufacturing
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/01Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on oxide ceramics
    • C04B35/447Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on oxide ceramics based on phosphates, e.g. hydroxyapatite
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/622Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/626Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
    • C04B35/63Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
    • C04B35/632Organic additives
    • C04B35/634Polymers
    • C04B35/63404Polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C04B35/63424Polyacrylates; Polymethacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • A61F2/2875Skull or cranium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/30199Three-dimensional shapes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2002/30929Special external or bone-contacting surface, e.g. coating for improving bone ingrowth having at least two superposed coatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2/30942Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques
    • A61F2002/30952Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques using CAD-CAM techniques or NC-techniques
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2002/30968Sintering
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00179Ceramics or ceramic-like structures
    • A61F2310/00293Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29LINDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00Other particular articles
    • B29L2031/753Medical equipment; Accessories therefor
    • B29L2031/7532Artificial members, protheses
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y10/00Processes of additive manufacturing
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30Constituents and secondary phases not being of a fibrous nature
    • C04B2235/32Metal oxides, mixed metal oxides, or oxide-forming salts thereof, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
    • C04B2235/3201Alkali metal oxides or oxide-forming salts thereof
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30Constituents and secondary phases not being of a fibrous nature
    • C04B2235/32Metal oxides, mixed metal oxides, or oxide-forming salts thereof, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
    • C04B2235/3205Alkaline earth oxides or oxide forming salts thereof, e.g. beryllium oxide
    • C04B2235/3208Calcium oxide or oxide-forming salts thereof, e.g. lime
    • C04B2235/3212Calcium phosphates, e.g. hydroxyapatite
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30Constituents and secondary phases not being of a fibrous nature
    • C04B2235/36Glass starting materials for making ceramics, e.g. silica glass
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/50Constituents or additives of the starting mixture chosen for their shape or used because of their shape or their physical appearance
    • C04B2235/54Particle size related information
    • C04B2235/5409Particle size related information expressed by specific surface values
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/50Constituents or additives of the starting mixture chosen for their shape or used because of their shape or their physical appearance
    • C04B2235/54Particle size related information
    • C04B2235/5418Particle size related information expressed by the size of the particles or aggregates thereof
    • C04B2235/5436Particle size related information expressed by the size of the particles or aggregates thereof micrometer sized, i.e. from 1 to 100 micron
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/60Aspects relating to the preparation, properties or mechanical treatment of green bodies or pre-forms
    • C04B2235/602Making the green bodies or pre-forms by moulding
    • C04B2235/6026Computer aided shaping, e.g. rapid prototyping
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/60Aspects relating to the preparation, properties or mechanical treatment of green bodies or pre-forms
    • C04B2235/608Green bodies or pre-forms with well-defined density
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/60Aspects relating to the preparation, properties or mechanical treatment of green bodies or pre-forms
    • C04B2235/61Mechanical properties, e.g. fracture toughness, hardness, Young's modulus or strength
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/60Aspects relating to the preparation, properties or mechanical treatment of green bodies or pre-forms
    • C04B2235/616Liquid infiltration of green bodies or pre-forms
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/65Aspects relating to heat treatments of ceramic bodies such as green ceramics or pre-sintered ceramics, e.g. burning, sintering or melting processes
    • C04B2235/658Atmosphere during thermal treatment
    • C04B2235/6583Oxygen containing atmosphere, e.g. with changing oxygen pressures
    • C04B2235/6584Oxygen containing atmosphere, e.g. with changing oxygen pressures at an oxygen percentage below that of air
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/65Aspects relating to heat treatments of ceramic bodies such as green ceramics or pre-sintered ceramics, e.g. burning, sintering or melting processes
    • C04B2235/66Specific sintering techniques, e.g. centrifugal sintering
    • C04B2235/665Local sintering, e.g. laser sintering
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/70Aspects relating to sintered or melt-casted ceramic products
    • C04B2235/74Physical characteristics
    • C04B2235/77Density
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/70Aspects relating to sintered or melt-casted ceramic products
    • C04B2235/80Phases present in the sintered or melt-cast ceramic products other than the main phase
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/70Aspects relating to sintered or melt-casted ceramic products
    • C04B2235/96Properties of ceramic products, e.g. mechanical properties such as strength, toughness, wear resistance
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/70Aspects relating to sintered or melt-casted ceramic products
    • C04B2235/96Properties of ceramic products, e.g. mechanical properties such as strength, toughness, wear resistance
    • C04B2235/9607Thermal properties, e.g. thermal expansion coefficient
    • C04B2235/9615Linear firing shrinkage

Definitions

  • the present invention relates generally to manufacturing methods and systems (collectively referred to as "processes") for the freeform shaping of calcium-containing powders.
  • This invention more specifically relates to processes for shaping bone implants from various calcium phosphate powders and polymer-emulsion binders.
  • Certain embodiments of these processes focus on the use of a Selective Laser SinteringTM (“SLSTM”) device to automatically and selectively fuse the polymer binder.
  • SLSTM Selective Laser SinteringTM
  • complex three-dimensional objects may be built by selectively fusing successive thin layers of the powdered material.
  • TCP implants are known to be readily resorbable.
  • sintered TCP plugs with pore sizes between 100-200 microns have been implanted in rats (Bhashar et al., 1971).
  • Very rapid bone formation was reportedly observed at three days after implantation, and highly cellular tissue, consisting of osteoblastic and fibroblastic proliferation, was found within the pores.
  • the size of the implant was reduced, and new bone formation was extensive.
  • connective tissue had infiltrated throughout the ceramic.
  • the boney material within the ceramic continued to mature. Electron micrographs indicated that within clastlike cells, ceramic could be depicted in membrane-bound vesicles.
  • Koster et al. (1976) reported the testing of the calcium phosphate formulations monocalcium phosphate, dicalcium phosphate, tricalcium phosphate, tetracalcium phosphate, and combinations consisting of 20% monocalcium phosphate and 80% of either di-, tri- or tetracalcium phosphate as implant materials in dog tibiae. These investigators tested both dense ceramics and porous ceramics with pore sizes between 800-1000 microns. They reported that tissue compatibility is dependent on the CaO/P 2 O 5 ratio. All materials with ratios between 2/1 and 4/1 are compatible with the optimum ratio being about 3/1 for TOP. After 10 months, Koster et al.
  • Jarcho et al. (1976, 1977) reported the development of a process for preparing dense, polycrystalline, calcium hydroxyapatite (CHA), with the empirical formula 2(Ca 5 (PO 4 ) 3 OH) or (3Ca 3 (PO 4 ) 2 )Ca(OH) 2 .
  • plugs were fabricated at 100% density and implanted in dogs. No evidence of tissue inflammation occurred, and in contrast to the porous TCP implants described above, little resorption or biodegradation was observed after six months.
  • Ca/P ratios in the range 0.1 to 2.0 probably show satisfactory biocompatibility.
  • CMP calcium metaphosphate
  • Patents in this area include: U.S. Pat. Nos. 4,046,858; 4,274,879; 4,330,514; 4,324,772; 4,048,300; 4,097,935; 4,207,306; and U.S. Pat. No. 3,379,541.
  • any calcium and phosphate source can be used to prepare materials of interest.
  • An important issue is the ratio of Ca to P or, as it is usually expressed, CaO to P 2 O 5 , molar ratio in the reactant mixture.
  • monocalcium orthophosphate monohydrate from the reaction of CaO with orthophosphoric acid, H 3 PO 4 , as shown in equation 1: ##STR1##
  • Heating the orthophosphate hydrate can lead to a variety of known products, depending on the firing temperature used, as shown in equations 3-8: ##STR3##
  • Tricalcium phosphates can be easily obtained from CHA by simply lowering the Ca/P ratio, as shown in equation 9: ##STR4##
  • Thermally dehydrated calcium phosphates are known to form a CaO and P 2 O 5 binary system.
  • the chain phosphates appear between the orthophosphate (mole ratio of CaO/P 2 O 5 of about 3) and metaphosphate (mole ratio of CaO/P 2 O 5 of about 1) or ultraphosphate (mole ratio of CaO/P 2 O 5 of less than 1).
  • the metaphosphates in particular, generally exhibit very high degrees of polymerization and good mechanical properties.
  • this binary system with a mole ratio of CaO/P 2 O 5 less than 55/45, a glass-like structure forms from the melt which has mechanical properties similar to those of natural teeth (Yoshihiro, 1975).
  • Ceramic composites made by this approach are relatively large, 10-50 microns, agglomerates of polymer-coated inorganic particles. These agglomerate powders may spread easily into uniform layers and fuse readily in the SLSTM machine to yield porous "green" parts that have relative densities near 50%, excellent connected internal porosity, and sufficient strengths to be easily handled and shipped. Interconnected pores in bioceramics are often difficult to achieve and are very important in fostering bone growth and for preparing metal matrix/ceramic parts, artificial hips.
  • PMMA Polymethyl methacrylate
  • alumina has also been used to form green composites with alumina and with silica/zircon (U.S. Pat. No. 5,284,695).
  • an appropriate ceramic silicate colloid is used to infiltrate the connected pores of the polymer-bound green part, the colloid is solidified below the fusion temperature of the binder to maintain part geometry, the binder is then thermally removed and the part fired at typically 1000° C. to form porous, all ceramic parts that are suitable for use as cores and molds for metal castings.
  • Such parts typically have only a 1% linear shrinkage, relative to the green state. Their strengths and porosities can be adjusted by additional infiltration and firing treatments.
  • CPB powder is a pure calcium phosphate material with condensed phosphate chains (as shown below) with degrees of polymerization often greater than 120.
  • Lagow CHA materials produce sintered materials that have compressive strengths greater than 200,000 psi and flexural strengths in excess of 20,000 psi. These strengths are about twice that of porcelain used to make dental crowns.
  • Lagow CHA material Lagow and Friedman have recently completed the first successful, year duration, mandible implant in a canine. Work with CPB implants has demonstrated by electron microscopy backscattering that new bone growth occupied nearly 55% of the volume of a CPB implant in the alveolar (tooth bearing) ridge of a dog, after only four months (Nelson et al., 1993). This rate of resorption and replacement by living bone in CPB is about twice as fast as that in CHA.
  • Bone banks currently provide gamma radiation-treated cadaver bones for various orthopedic and reconstructive purposes in a world-wide business. Appropriate geometries are not always available from these sources, and there is some concern about the transmission of HIV and other diseases.
  • wedge materials that can provide support and promote the deposition of additional bone.
  • Facial and cranial reconstructive surgery is an area where the need for individual implant geometries is especially critical. At present, such reconstructions tend to be very difficult surgical procedures, typically involving highly skilled grafting with allogenic bone.
  • the method and system of the present invention can be utilized to accurately construct a complete facsimile bone structure, suitable for implantation, employing geometric information that is obtained from either CT data or a Computer Aided Design ("CAD") software package.
  • CAD Computer Aided Design
  • the present invention addresses the foregoing and other problems experienced in the art by providing processes for automatically shaping bone implants from various calcium phosphate powders.
  • This invention employs polymeric binder compositions particularly adapted for the formulation of free flowing calcium phosphate/binder composite powders.
  • the powders are suitable for production of bioceramic computer-modeled geometrical implants. Green parts produced in this manner may be post processed to be substantially free of the binder.
  • This invention also allows bioceramic parts to be produced by the low power lasers used in the laser sintering process.
  • the processes may utilize a process called Selective Laser SinteringTM in which complex three-dimensional objects can be built automatically by selectively fusing successive thin layers of powdered material.
  • One embodiment of the present invention provides a method for making an implant by forming a mixture of a calcium phosphate and a polymer binder, and selectively fusing the polymer binder to form an implant. These steps can be repeated to prepare a multiple-layered implant by successively forming layers of the calcium phosphate and polymer binder mixture, and selectively fusing the polymer binder in that layer and to other adjacent layers to form a plurality of connected layers.
  • implant refers to a device that is fabricated for the purpose of embedding, or placing, within a body.
  • the types of implants encompassed by the present invention include implants suitable for the replacement, repair, or modification of bones, teeth, and the like. However, under certain circumstances it may be conceivable that implants of the present invention may serve other useful purposes.
  • the term “selectively fusing” refers to the process of selectively coalescing, or combining, particles such that the formed structure has sufficient strength to be handled and further processed, as desired.
  • the term “selectively” is used to denote the controlled and discriminating fashion with which the fusing process occurs.
  • “fusing” refers to the viscous sintering of polymer binder particles that are coating, or otherwise associating with, calcium phosphate particles. This results in a linking of the calcium phosphate particles into a part, which can be further processed by thermally decomposing and removing the polymer binder or by infiltration and subsequent thermal dehydration and the like.
  • This fusing can generally be accomplished selectively by controlling the spatial arrangement of the interconnected particles, for example, with laser sintering processes and the like.
  • the selective fusing could be accomplished using a thermal mask system or by the selective spraying of liquid binders and solvents.
  • the thickness of the layers formed in this method is preferably from about 3 to about 12 thousandths of an inch. In cases where CT data is employed to shape the implant, the thickness of the layers may be determined by the CT data.
  • the calcium phosphate is preferably prepared by reacting a mixture of hydroxyapatite and phosphoric acid, although other calcium phosphates can be used.
  • Preferred calcium phosphates include calcium metaphosphate, calcium pyrophosphate, calcium phosphate with from about 25 to about 45 percent by weight calcium oxide, and calcium phosphate with from about 0.5 to about 2 percent by weight sodium oxide, with calcium metaphosphate being particularly preferred.
  • the calcium phosphate preferably has a mean particle size of from about 5 to 100 microns, with the range of from about 30 to 50 microns being most preferred. Smaller particles tend to produce weaker green parts whereas larger particles can affect the layer thickness and forming.
  • Certain embodiments of this invention involve coating the calcium phosphate particles with polymeric binders to provide free-flowing powders with advantageous properties for processing into shapes by sintering with a laser beam.
  • the polymeric binder compositions may be employed to mix with, or to coat, ceramic particles to produce free-flowing powders with flow characteristics substantially independent of relative humidity.
  • the polymer binder may be selectively fused to replicate or form a desired geometrical shape, such as a bone or an enhancement of a bone feature.
  • This desired geometrical shape may be obtained from CT data or CAD software data and communicated to a laser beam by a computer.
  • the calcium phosphate powder may be mixed with water and a polymer-emulsion binder to form a slurry.
  • this slurry is rapidly dried by momentarily suspending drops of it in a stream of hot air at a temperature above the fusion temperature of the binder, such as exists in a spray drier or fluidized bed coater.
  • the binder and powder preferably agglomerate and adhere together to form a free flowing composite powder with preferred dimensions in the range of 5-75 ⁇ m.
  • the mixture be in the form of agglomerated polymer-coated calcium phosphate particles
  • mixtures of uncoated calcium phosphate powder and spray dried polymer binder can also be used. Coating the calcium phosphate with the binder is preferred as the polymer binder is used more efficiently in this embodiment, and the coating reduces segregation by density during storing or transporting.
  • agglomerated polymer-coated calcium phosphate particles refers to an indiscriminately formed cluster of particles consisting of calcium phosphate powders that have been coated with a polymer binder. These clusters may be free-flowing substantially independent of the relative humidity.
  • the implant may be thermally sintered. This can effectively remove the polymer binder, and sinter, or fuse, the calcium phosphate powder.
  • the terms "sinter” and “sintering” refer to the forming of a coherent bonded mass by heating without melting.
  • the calcium phosphate particles may be combined into a coherent mass with heating, whereas in sintering by laser the polymer binders may be selectively fused by the low energy of the laser beam employed.
  • the implant may be infiltrated with a calcium phosphate solution or the like. This may decrease shrinkage in the implant and also modify the relative density, porosity, and other properties of the implant.
  • the term "infiltrating” refers to a process in which a porous implant is placed in an aqueous solution of an inorganic material. This allows the solution to fill the interconnected pores of the implant, and thus upon drying deposit the inorganic material inside the implant. A further thermal sintering step may be undertaken to fuse or coalesce the calcium phosphate.
  • Preferred polymeric binders include those formed from 1,1-disubstituted vinyl monomers such as esters and amides of methacrylic acid and its derivatives.
  • 1,1-disubstituted vinyl monomers include methacrylic acid, dimethylamino ethylmethacrylate and methacrylamide, methyl methacrylate and butyl methacrylate.
  • the polymers formed from these monomers are particularly preferred because the major thermal decomposition route is depolymerization to gaseous products in both oxidizing and reducing atmospheres, largely eliminating problems with residual ash.
  • homopolymer, copolymer, or terpolymer of methyl methacrylate refers to polymers that are formed by polymerizing methyl methacrylate. These polymers may be formed by the homopolymerization of methyl methacrylate or by polymerizing methyl methacrylate with one or more other monomers.
  • Another embodiment of the present invention encompasses the implants produced by the previously described methods. These implants preferably have a mean pore size of from about 50 to about 300 microns and a percent relative density of from about 50 to about 80%. As used herein the term “percent relative density” refers to the ratio of the implant density to the calcium phosphate density multiplied by one hundred. As defined, the percent relative density can be used to obtain the percent porosity by subtracting the percent relative density from one hundred.
  • Another embodiment of the present invention provides a system for making an implant, comprising a mixture of a calcium phosphate and a polymer binder, and means for selectively fusing the polymer binder to form an implant.
  • the fusing means may comprise a laser sintering machine.
  • the system may additionally comprise means for controlling the fusing means in order to form an implant having a desired geometrical shape.
  • This controlling means may be a computer that obtains information about the desired geometrical shape from patient computed tomographic data or Computer Aided Design software.
  • FIG. 1 is a diagram showing a typical apparatus used in the Selective Laser SinteringTM process employed by certain embodiments of this invention.
  • H is a computer control for a laser source A, focused by mirrors B. Heating is provided by a radiant heater C.
  • D is a leveling mechanism for a powder bed F.
  • G is a new layer being added to the part E being produced.
  • FIG. 2 is a scanning electron micrograph of calcium hydroxyapatite at 1000 times magnification.
  • FIG. 3A is an x-ray diffraction pattern for calcium phosphate with 35% by weight of calcium oxide powder. This pattern closely matches that of tromelite, Ca 4 P 6 O 19 (upper small box).
  • FIG. 3B is an x-ray diffraction pattern for CMP powder (1) as directly prepared and (2) as prepared from a fired 35CaP part that was infiltrated with a calcium phosphate solution and fired again.
  • FIG. 4 is a photograph of an SLSTM processed craniofacial implant fabricated from CMP powder.
  • FIG. 5 is a graph demonstrating the effect of the density of a fired and a infiltrated part on the modulus of rupture (three point bending strength).
  • FIG. 6A is a scanning electron micrograph of a porous surface after firing, shown at 200 times magnification.
  • FIG. 6B is a scanning electron micrograph of a porous surface after firing and infiltration, shown at 200 times magnification.
  • FIG. 7 is a scanning electron micrograph of calcium hydroxyapatite which has been reacted with orthophosphoric acid, shown at 1000 times magnification.
  • FIG. 8 is a scanning electron micrograph of a polymer coated powder, shown at 800 times magnification.
  • FIG. 9 is a scanning electron micrograph of a sintered surface at 800 times magnification.
  • Certain embodiments of the present invention provide processes capable of fabricating complex three-dimensional implants made of calcium phosphates.
  • a preferred source of calcium phosphate is from the reaction of hydroxyapatite and orthophosphoric acid.
  • CHA powders are generally very cohesive and consist of very porous agglomerates with mean particle size of 1 to 2 ⁇ m and bulk density of less than 0.4 g/cm 3 (Hattori et al., 1990). The surface area of such powders determined by Mercury intrusion analysis is about 60 m 2 /g, suggesting very small particles.
  • Stoichiometric CHA contains constitutional water in the form of OH - ions. This water can be driven off at 1200° C.
  • CHA is somewhat hygroscopic and will adsorb water from the atmosphere. This physically bound water forms steam when the powder is heated above 100° C. This interferes with the SLSTM process.
  • FIG. 2 shows the microstructure of finely divided CHA powders.
  • These powders generally require high sintering temperatures, and therefore typically are not suitable substrates for SLSTM processing. However, coating these powders with polymer binders that can fuse under much milder conditions may alleviate this problem.
  • Such coated particles are shown in FIG. 8 as compared to non-coated particles of CHA which are shown in FIG. 7. As used in this invention, these coated particles may provide excellent substrates for producing bioceramic implants in laser sintering processes.
  • the binder coated calcium phosphate powders may be readily handled, conveniently shipped and may be stored for long periods of time without the separation of components sometimes encountered when using mixed powders. In addition, one may readily produce green parts that can be post-processed to be free of polymer binder.
  • the polymer be distributed so as to cover as much of the surface of the particulate as possible. In principle, this could be accomplished by dissolving the polymer in a suitable organic solvent to achieve a low concentration of the polymer, depositing the solution on the surface of the particulate, then evaporating the solvent.
  • this process has the disadvantage of solvent recovery costs as well as potential environmental harm associated with use of organic solvents.
  • the amorphous polymeric binders preferably are prepared by emulsion polymerization as described in the literature (U.S. patent application Ser. No. 08/279,235 filed on Jul. 22, 1994, which is commonly owned with this application; Vail et al., 1994).
  • Emulsion polymerization is generally known to produce high molecular weight products at high polymerization rates and is the method of choice for preparing the polymer binder commonly used in water-based acrylic paint systems.
  • the polymer binder should soften and flow at temperatures between 40° C. and 100° C. Additionally, the polymer coating should be rigid and non-tacky at room temperature. This reduces "blocking” or premature fusing of the polymer-coated powder during storage and provides some structural permanence (low creep rates and low flexibility at ambient temperature) to composite parts made from this powder.
  • the polymer's fusion temperature is a function of its molecular constituents. This temperature is characterized by the polymer's glass transition temperature, T g , if the polymer is amorphous, or by its melting temperature, T m , if it is semi-crystalline.
  • T g polymer's glass transition temperature
  • T m melting temperature
  • the compositions employed in the present invention may be prepared from water based emulsions. This places a limit on the number of molecular constituents that are useful to give an amorphous polymer with a T g in the desired range. An upper limit of 100° C. for the softening temperature is set by the normal boiling point of the water vehicle in the emulsion.
  • the surface temperature of the particle will be limited to 100° C. as long as a water film is present.
  • the lower limit of the softening temperature may be set to about 40° C. to prevent blocking and creeping at ambient temperatures.
  • the green strength and agglomerate morphology are related to the binder's ability to rapidly wet the inorganic particle during the coating process.
  • These polymeric binders can be synthesized in emulsion form at controlled viscosity (Vail et al., 1994). The viscosity and the related melt flow index are held in the desired range by the addition of chain transfer agents to the polymerization reactions. The lower viscosity material will have an increased melt flow index, near 30 g/10 min at 200° C. and 75 psi, to optimize the coating characteristics of the polymer binder and the subsequent strength of the green part.
  • FIG. 1 illustrates an apparatus employed in Selective Laser SinteringTM apparatus.
  • the apparatus includes laser source A, mirrors B, radiant heater C, leveling mechanism D, green part being produced E, powder bed F, new layer G of polymer coated powder, and computer control H.
  • the polymer binder in part E is selectively fused by the action of a low power, rastered, modulated, infrared laser beam A.
  • the preferred type of laser used is dependent on many factors, and in particular the type of powder that is to be sintered.
  • a 25 wattage CO 2 laser typically used to sinter waxes and plastics, generally may be used to sinter the powders of the present invention.
  • the laser beam output of the laser A has a wavelength of 10.60 microns, which is near infrared.
  • the laser A can be modulated on or off to selectively produce a laser beam which travels along a specified path.
  • the directed laser beam A selectively sinters the powder in the target area to produce the desired sintered layer with the defined boundaries of the desired cross sectional region. This process is repeated layer-by-layer with the individual layers G sintered together to form the green part as shown. It is important to note that in connection with this embodiment the laser beam A fuses only the binder and does not substantially alter or fuse the bioceramic E.
  • the selective fusing is governed by geometric information that is generated by a compatible device at computer control H, such as the CT converter program disclosed with this invention or CAD software.
  • a compatible device at computer control H such as the CT converter program disclosed with this invention or CAD software.
  • CT scan information permits faithful geometric replication of complex bones to be rapidly and easily prepared by this additive process.
  • naturally complex bone geometries can be prepared from biocompatible materials that could not be prepared by conventional molding or other fabrication processes. It is also possible to design bones or to modify data from CT scans as might be useful for plastic surgery.
  • the polymer-bound "green" part E may be post-processed to thermally remove the polymer binder and to sinter and fuse the calcium phosphate powder to prepare bone replicas with a controlled, interconnected porosity.
  • the polymer binder is preferably designed to provide adequate strength to permit handling of the green part, and to debond cleanly without residue. Debonding and sintering can be carried out in a conventional oven that has sufficient capacity to reach the high temperatures required for sintering the ceramic components. Porosity in the final part is a function of SLSTM processing conditions, of oven sintering times and temperatures, and of the original polymer and calcium phosphate type and content in the composite powder.
  • Post-processing may also encompass infiltrating the implant and then thermally dehydrating the implant.
  • water-borne ceramic cementing agents are infiltrated into a polymer bound part previously shaped by laser sintering.
  • the cementing agent is dried and set and the polymer burned out to produce an all-calcium phosphate part.
  • This method of post SLSTM processing has been used to produce other ceramic parts and is described in U.S. Pat. No. 5,284,695. This is generally accomplished at much lower temperatures than post-processing without infiltration. Infiltration can generally accomplished with any inorganic compound or cement generally useful for this purpose. However, where biocompatible implants are desired, it is preferable to infiltrate with calcium phosphate.
  • the polymer binder materials used in the present invention have been developed as thermoplastic binders for ceramic particles, as described in U.S. patent application Ser. No. 08/279,235.
  • the polymeric binders are readily removed from the calcium phosphate compositions by thermal decomposition in oxidizing atmospheres to produce parts that contain only ceramic.
  • the binders are amorphous and polymeric. They are polymers, copolymers or terpolymers having glass transition temperatures above 40° C., and having a melt flow index between about 1 to about 50 g/10 min. at 200° C. and 75 psi extrusion pressure, using the instrument geometry and testing protocols described in ASTM #D1238.
  • Preferred polymer binder compositions include methyl methacrylate and butyl methacrylate. The copolymer of methyl methacrylate and n-butyl methacrylate is particularly preferred as a polymeric binder.
  • the binders employed in this embodiment of the present invention are different from water soluble binders and slip aids used in conventional ceramics processes in which the binder coated powder is compressed to a shape prior to furnace treatment to remove the polymer and thermally consolidate the ceramic (German, 1990). Such compression is not used in Selective Laser SinteringTM processing; therefore, it is important that coated powders for SLSTM and similar type processing be free flowing at processing conditions.
  • water immiscibility of the polymer binder is important. If the binder is too hygroscopic, excess water may create steam during the SLSTM process. This may interfere with or prevent fusion of the binder and substrate into a useful green part. Furthermore, water insoluble polymer binders may permit retention of green shape when infiltrating with water-borne inorganic materials.
  • Certain binder and binder coating systems may produce a coated particulate that is optimal in size for best performance in the SLSTM process. Particles with diameters from 5 ⁇ m to 25 ⁇ m have been found to spread, level, and sinter well. Depending on the thickness of the powder layer employed, particles as large as 200 ⁇ m (and perhaps larger) can be processed. Lowered bed densities and powder spreading and shear problems may result when particles with diameters smaller than 2 ⁇ m are attempted.
  • the disclosed emulsion polymer binders (typically containing 40% by weight of polymer solids in water) are mixed with calcium phosphate particles to produce a slurry that contains 5-40 vol % polymer when dried.
  • a small amount, typically ⁇ 1%, of the emulsion of high molecular weight, water-soluble polymer may be added as a suspension aid to help suspend the inorganic particles that are typically 2-150 ⁇ m.
  • Typical viscosity of the slurry is kept low, approximately 10-100 poise at room temperature, to facilitate spraying of the slurry.
  • the slurry of polymer binder emulsion and particulate is spray-dried in a standard NIRO spray drier equipped with a centrifugal atomizer wheel (Vail et al., 1991).
  • the wheel is usually operated at 35,000 rpm causing a fine mist of the slurry mixture to be slung out into a hot air stream.
  • the water in the mist rapidly evaporates to produce solid particles.
  • Particle size in the range of about 25-50 ⁇ m in diameter is preferred.
  • the conditions of the spray drying for example, temperature, feed compositions and atomizer wheel speeds, one can adjust the particle size in either direction (Lefebvre, 1989).
  • the particles obtained are agglomerates of polymer and particulate, as can be seen in FIG. 8.
  • An improperly processed slurry e.g., where the exit air temperature of the dryer is too low relative to the polymer fusion temperature or where the binder viscosity is too high at the processing temperature employed, may produce a large quantity of smaller, non-agglomerated particles. Such particles do not spread and level as well as the larger agglomerates in the laser sintering processes.
  • the T g or T m of the polymer binder should be at least 10° C., preferably 15° C. or more, below the exit air temperature of the dryer. Many dryers are operated so that the exit air temperature is near 100°-110° C., and for such dryers and drying operations a T g or T m below 80°-90° C. is preferred.
  • Another preferred coating technique utilizes a fluidized bed dryer that coats the particulate by fluidizing it in a heated gas stream, then spraying the polymer emulsion into the fluidized bed of particles.
  • This coating technique also works well with the disclosed emulsion polymer binders to give uniformly coated particles.
  • the disclosed binder system may be used in a variety of coating applications so long as such applications incorporate evaporation of the water vehicle near the normal boiling point of water.
  • Decomposition of the polymeric binder material may be important because in processes used to produce implants, it is desirable to remove the binder material so all-calcium phosphate parts are obtained.
  • most organic polymeric binders may be oxidized to carbon dioxide and water in the high temperature furnaces normally used to "fire" or sinter ceramics.
  • binder compositions Small amounts of other substances may be added to the binder compositions.
  • chemically similar compounds that do not have the requisite structure for depolymerization may be included to enhance adhesion and other desirable properties.
  • these monomers make up less than about 10 mole percent of the copolymer composition. Typically, this will amount to only a few percent, e.g., 3-5%, depending on the particular polymer and the desired purpose.
  • CHA was obtained as TCP from Monsanto Inc. and phosphoric acid was purchased from Fischer Scientific in 85% concentration.
  • Poly(methyl methacrylate-co-n-butyl methacrylate) copolymer with a Melt Index of 30.9 g/10 min at 75 psi and 200° C. was synthesized as described in the literature (Vail et al., 1994), and used as a polymer binder in Example 2.
  • UCAR 430 Acrylic Polymer Latex (obtained from Union Carbide Corporation) and PMMA emulsion copolymer (Vail et al., 1994) were investigated as polymer binders in Example 3.
  • Inorganic ceramic cement, Cerama BindTM 542 was obtained from Aremco Products Inc. This inorganic cement, employed in Example 3, is an alumino-phosphate material that can react to form phosphate bonded CHA material.
  • the calcium phosphate powders were ground by a Szegvary attritor system, type 1HSA, prior to being mixed with polymer for SLSTM processing. Acceptable ranges in particle size were from 20 to 100 microns in diameter with 30 to 50 microns being preferred.
  • the mercury porosimeter, Poresizer 9320 from Micromeretics was used to determine the surface area of the powder.
  • the powder samples were heated to expel the absorbed moisture and then stored in a desiccator until analyzed.
  • the sample in a penetrometer was initially evacuated to 25 ⁇ Hg.
  • Mercury was then admitted and pressure was increased up to 30,000 psi which is capable of measuring pore size of 0.006 ⁇ m.
  • a contact angle of 130° was assumed in the calculation of pore size.
  • the particle size distributions of powders were measured by a Coulter Multisizer.
  • Samples of polymer coated substrates were prepared by spray drying a slurry of emulsion copolymer and calcium phosphate powder according to the following equations that determine the amount of each ingredient: ##EQU1## where m E is the required amount of emulsion, m s the amount of powder to be coated, m w the amount of water to be added, x p is the mass fraction of polymer in the resulting sample, x E the solids mass fraction of the emulsion polymer, x s the total solids mass fraction of the final slurry, ⁇ p is the mass fraction of the copolymer, ⁇ p is the density of the polymer, and ⁇ s is the substrate density.
  • Polymer binders were deposited on the calcium phosphate powders by spray drying a slurry of the calcium phosphate powder and the polymer emulsion employing either a bench scale Pulvis Mini Spray Dryer or a pilot plant scale NIRO Spray Dryer, equipped with a centrifugal atomic wheel. Operating conditions for the NIRO Spray Dryer were 30,000 rpm and an exit gas temperature of 110° C. Alternatively, mixtures were formed by physically mixing polymer binders, which had been spray dried, with the dried calcium phosphate powder.
  • the SLSTM machine used for this work was a Model #125 (DTM Corp., Austin, Tex.). Polymer coated powders produced by the spray coating method were processed by SLSTM to fabricate the desired green shapes according to the following method.
  • the free-flowing polymer coated powder was loaded into the SLSTM machine for processing.
  • the operating environment temperature was biased to heat the powder bed to just below the glass transition temperature, T g , of the binder, ⁇ 90° C. This corresponds to a setting of 104° C. on the temperature controller.
  • thermocouple At equilibrium conditions this thermocouple indicated a temperature of ⁇ 119° C. These readings were machine dependent as well as material dependent. The powder bed temperature and the operating environment were allowed to equilibrate for at least 1 hr. The environmental atmosphere was maintained semi-inert (O 2 ⁇ 8%) by N 2 purge.
  • the CT data image of human temporal bones was received from a GE 9800 CT scanner as a series of slices, nominally 1.5 mm thick. Each slice consisted of a raster image of the temporal bone; the resolution of each image was 256 ⁇ 256 volume elements, or voxels. Each voxel was 2.5 mm 2 and was represented as a floating point number indicating the average density of the tissue at that voxel location. The density is measured in Hounsfeld units, representing the ratio of the tissue density to the density of water. Density values ranged from -1000 to 3095. The SLSTM process required boundary information rather than interior density data; therefore, a conversion process was necessary.
  • a computer program was written to convert the raster images to contour images of the temporal bone slice in each plane by specifying a minimum threshold density below which the data could be ignored.
  • a source code listing of this program is appended at the end of this specification.
  • the threshold value was selected manually by a CT technician and provided as input.
  • the program then scanned each row in the raster image to locate changes in density that crossed the threshold value provided. These changes represent the bone contour outline.
  • Each voxel at which the threshold crossing is detected is converted to a laser toggle point location by simple translation and scaling transformations. The parameters for this conversion are based on the known size of the sample.
  • the toggle point information was then written in a file in the correct format for direct processing by the SLSTM machine.
  • the SLSTM control compensated for this by either skipping layers (for thinner layers) or replicating layers (for thicker layers).
  • the thresholding software was implemented in the C programming language on a Sun Microsystems SparcStation 2 workstation with the UNIX operating system. The implementation is independent of the hardware and could be ported to other stations.
  • This experiment illustrates the fabrication of complex and delicate bone shape parts from CT data using a Selective Laser SinteringTM process.
  • calcium metaphosphate powder that has been mixed with polymer binder and SLSTM processed was either heated at high temperatures for long periods of time, a procedure that increased shrinkage and geometric inaccuracies, or heated at lower temperatures for shorter periods of time to lightly sinter the part followed by infiltration with a calcium phosphate solution, drying, and refiring at a lower temperature to produce a calcium ultraphosphate glass-bound calcium metaphosphate structure.
  • a part made from a calcium phosphate powder that contained a higher Ca/P ratio than CMP e.g., tromelite (referred to herein as "35CAP")
  • 35CAP tromelite
  • CPP was prepared from reacting CHA (251 g) with 85% phosphoric acid (196 g) in a manner analogous to that described for the preparation of CMP. ##STR9## (3) Calcium phosphate with 35 wt % of CaO (“35CaP”)
  • the prepared CPP powder was mixed with 1 weight percent of Na 2 O (by addition of 1.7% by weight of Na2CO 3 ) to depress the melting temperature in order to study the influence of surface area of the powder on green strength.
  • 1NaCPP was thermally coalesced at 1020° C. and then ground in the attritor. The ball milling time was controlled to have different particle size and consequently surface area. Three samples of pore surface area, 1.8, 1.4, and 1.1 m 2 /g, were measured by mercury porosity.
  • 1NaCPP powder with a surface area of 1.8 m 2 /g exhibited poor green strength, while the powder with a surface area of 1.4 m 2 /g showed very good strength. Both powders were mixed with 15% polymer binder by weight.
  • the appropriate powder was physically mixed with 15% by weight (30% by volume) of spray dried polymer, poly(methyl methacrylate-co-n-butyl methacrylate) copolymer, and SLSTM processed with the conditions shown in Table 1.
  • the SLSTM processed CMP green parts had a density of about 0.91 ⁇ 0.03 g/cm 3 , 33% of the theoretical density, with the fracture strength of 130 ⁇ 20 psi. This was sufficient to permit rough handling of complex bone shapes, such as that shown in FIG. 4.
  • 35CaP green parts had a density of 0.83 g/cm 3 with a fracture strength of 40 ⁇ 10 psi. This relatively low strength of the latter parts was attributed to smaller particle size and, consequently, higher surface area of this powder than that of the CMP powder.
  • the first method involved firing the implant for several hours at sintering temperatures, roughly 800°-1600° C., depending on the calcium phosphate composition used. This approach produced the highest strength materials.
  • the firing step caused the part to shrink, which may not be desirable for construction of an accurate facsimile bone structure from geometric information obtained from patient CT data.
  • the shrinkage was not isotropic. Linear shrinkage in thickness was much larger than that in width or length, due to the nature of layer-wise construction of parts in SLSTM process.
  • the second approach was accomplished either by sintering the implant for a reduced period of time, and then infiltrating and dehydrating the implant and heating to the melting point of the infiltrant to sinter the part.
  • This approach allowed the implant's density and strength to be increased relative to an implant with the same sintering conditions but no infiltrant.
  • the implant also shrank much less than in the direct thermal sintering approach.
  • the implant exhibited less green strength as a function of density, as shown in FIG. 5.
  • the third approach to reduce shrinkage is to infiltrate the implant and then thermally dehydrate and sinter it without a previous firing step (U.S. Pat. No. 5,284,695). This may decrease the amount of shrinkage and green strength even more.
  • the resorbability of implant desired is a function of the density. Therefore, by adjusting density, perhaps by filling the pores with calcium phosphate, the resorbability of the implant can also be adjusted.
  • the green parts were fired up to sintering temperature to remove the polymer and subsequently sinter the calcium phosphate.
  • the temperature was raised at an average rate of 16° C./min up to 500° C. and then raised slowly to 880° C.
  • the parts were held at 880° C. for 2 hours and cooled down slowly.
  • the parts were kept in lightly packed CHA powder to help maintain the shape and provide even heat distribution to reduce curling.
  • CHA was chosen as the packing material due to its low bulk density, less than 0.5 g/cm 3 , and high melting temperature.
  • CMP green parts were fired at 880° C. for 2 hours.
  • the fired CMP parts showed a 3 point bending strength of about 400 psi and a density of about 0.97 g/cm 3 , corresponding to a 17% volume shrinkage.
  • a strength of about 2700 psi was obtained by firing a CMP part at 940° C. for 1 hour with a density of about 1.4 g/cm 3 .
  • Calcium phosphate paste was prepared by mixing CHA and phosphoric acid which was then diluted with water to form a slurry. The prepared slurry was dissolved in boiling water. It was found that 15g of CHA with 60g of 85% phosphoric acid was a good composition when dissolved in boiling water to make about 120 ml of solution.
  • Infiltration was performed mainly by capillary action by placing the implant in the solution. After the pores were saturated with infiltrant, the parts were taken out of the solution and allowed to dry at 50° C. and then fired at the appropriate temperature according to the expected final Ca/P ratio. It was found that when the pores were saturated upon infiltration, the resulting weight gain was inversely proportional to the initial density.
  • the polymer free parts with a density of about 0.97 g/cm 3 were infiltrated as described earlier.
  • CMP parts a first infiltration resulted in 31 ⁇ 2% weight gain after firing 725° C. and strength of 1100 psi and subsequent infiltration increased the density about 50% and strength about 1500 psi.
  • Strength vs. density data are shown in FIG. 5. Further infiltration caused the parts to melt and deform inhomogeneously at 725° C., which could indicate existence of a Ca/P concentration gradient through the part. This also lowered the strength of the part.
  • the fractured surface of this part showed randomly distributed vitrified parts. It is believed that infiltrant filled up the pore and formed a phosphate glass.
  • phosphate glass was verified in a separate experiment.
  • the calcium phosphate solution was heated to 600° C. where it formed a nonporous transparent glass that contained 15.7% CaO.
  • the infiltrated part was ground to a powder for x-ray diffraction analysis. There was no significant difference in x-ray patterns before and after infiltration. This indicates that no new crystalline phase had been formed.
  • a 35CaP green part was fired for 2.5 hours at 880° C. to achieve a lightly sintered structure.
  • the structure showed a 40% weight gain upon first infiltration with a calcium phosphate solution due to its lower density.
  • This part was dried and then heated to 725° for longer than 6 hours. Further infiltration increased the strength to about 4200 psi and a relative density of 57%, density of 1.6 g/cm 3 .
  • FIG. 3B shows this phase transformation.
  • the morphology of the fired and infiltrated fracture surface are shown in FIGS. 6A and 6B. Infiltration caused more necking between the grains. The pores were well interconnected and the pore size was approximately larger than 50 ⁇ m.
  • the coated powder was heated in air to 150° C. to fuse the polymer. Afterwards, the powder was cooled and qualitatively examined. More than 20% (45 vol. %) of UCAR 430 was required to produce a cake that barely permitted handling. While polymethyl methacrylate copolymer coated materials showed better properties at 20% coating, cakes were still easily crumbled. These problems were attributed to the high surface area of the finely divided CHA powder.
  • CHA 50 g
  • orthophosphoric acid H 3 PO 4
  • the cake was then ground back to a finely divided powder.
  • the morphology of the reacted CHA powder is shown in FIG. 7.
  • the powder was spray dried with 14% by weight (30% by volume) of polymethyl methacrylate polymer and examined.
  • the oven sintered cake showed significantly improved strengths, enough to permit rough handling.
  • FIG. 8 shows the scanning electron micrograph of a polymer coated powder. Spray dried powders were SLSTM processed employing the operating conditions presented in Table 2.
  • SLSTM processed parts were infiltrated with a phosphoric acid based inorganic cement. High surface tension was observed upon infiltration which prevented effective penetration by the cement, Cerama BindTM. Methanol and Witcolate D51-51 surfactant (Witco Corporation) were used to reduce the surface tension. Infiltrated green parts were dried for 5 days under ambient conditions. Upon drying, the parts were cured in the oven, at 200° C., raised from ambient temperatures at a rate of 50° C./hr. As a final step, green parts were fired up to 700° C. in the furnace for 2 hours to burn off the polymer.
  • CHA in its pure form has a bulk density of less than 0.4 g/cm 3
  • CHA reacted with 5M phosphoric acid shows increased density to over 0.7 g/cm 3
  • SLSTM processed parts made of reacted CHA had sufficient strengths for rough handling as oven tests of the sintered cakes predicted. The strengths of post-processed bioceramic parts were even higher.
  • FIG. 9 shows a fractured surface of a part that was post processed and fired.

Abstract

Bone implants are made from calcium phosphate powders by selectively fusing layers of calcium powders that have been coated or mixed with polymer binders. The calcium powder mixture may be formed into layers and the polymer fused with a laser. Complex three-dimensional geometrical shapes can be automatically replicated or modified using this approach.

Description

The U.S. government owns rights in the present invention as relevant developmental work was supported by DARPA/ONR (Grant No. N000014-92-J-1394).
BACKGROUND OF THE INVENTION
A portion of the disclosure of this patent document contains material which is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure, as it appears in the Patent and Trademark Office patent file or records, but otherwise reserves all copyright rights whatsoever.
A bibliography of references cited herein is included at the end of this specification. The references listed in the bibliography, to the extent that they provide exemplary procedural or other details supplementary to those set forth herein, are specifically incorporated herein by reference.
1. Field of the Invention
The present invention relates generally to manufacturing methods and systems (collectively referred to as "processes") for the freeform shaping of calcium-containing powders. This invention more specifically relates to processes for shaping bone implants from various calcium phosphate powders and polymer-emulsion binders. Certain embodiments of these processes focus on the use of a Selective Laser Sintering™ ("SLS™") device to automatically and selectively fuse the polymer binder. In such processes, complex three-dimensional objects may be built by selectively fusing successive thin layers of the powdered material.
2. Description of the Related Art
Much attention has been given in the art to the development of materials to assist in the regeneration of bone defects and injuries. In 1926, DeJong observed the similarities between the powder X-ray diffraction pattern of the in vivo mineral and the hydroxyapatite (Ca5 B(OH)(PO4)3, "CHA"). Calcium compounds, including calcium sulfate (Nielson, 1944), calcium hydroxide (Peltier, 1957), and tricalcium phosphate ("TCP") (Albee et al., 1920), have been observed to stimulate new bone growth when implanted or injected into bone cavities (Hulbert et al., 1983). These materials also exhibit good biocompatibility and compositional similarities to human bone and tooth and can serve as resorbable or non-resorbable implants depending on their degree of microporosity.
Some TCP implants are known to be readily resorbable. For example, sintered TCP plugs with pore sizes between 100-200 microns have been implanted in rats (Bhashar et al., 1971). Very rapid bone formation was reportedly observed at three days after implantation, and highly cellular tissue, consisting of osteoblastic and fibroblastic proliferation, was found within the pores. At one week, the size of the implant was reduced, and new bone formation was extensive. After two weeks, connective tissue had infiltrated throughout the ceramic. During the next four weeks, the boney material within the ceramic continued to mature. Electron micrographs indicated that within clastlike cells, ceramic could be depicted in membrane-bound vesicles. The authors concluded that TCP implants were biodegradable, via phagocytosis, the ceramic did not elicit a marked inflammatory response, and connective tissue grew rapidly within the pores.
Similar results have also been reported by Cutright et al. (1972) who also implanted TCP in rat tibiae. In this study, the ceramic cavities were filled with osteoid and bone after 21 days and the TCP implant was no longer detectable after 48 days.
Larger implants in dogs are reported to elicit slower responses. Cameron et al. (1977) found that TCP implants in dog femurs were completely infiltrated with new bone by four weeks. However, after six weeks, the rate of new bone growth had slowed as the TCP was resorbed. Additionally, only 15% of a 2 cm×2 cm iliac TCP implant in dogs was resorbed after 18 months (Ferraro et al., 1979).
Koster et al. (1976) reported the testing of the calcium phosphate formulations monocalcium phosphate, dicalcium phosphate, tricalcium phosphate, tetracalcium phosphate, and combinations consisting of 20% monocalcium phosphate and 80% of either di-, tri- or tetracalcium phosphate as implant materials in dog tibiae. These investigators tested both dense ceramics and porous ceramics with pore sizes between 800-1000 microns. They reported that tissue compatibility is dependent on the CaO/P2 O5 ratio. All materials with ratios between 2/1 and 4/1 are compatible with the optimum ratio being about 3/1 for TOP. After 10 months, Koster et al. (1977) found that tetracalcium phosphate was resorbed only to a minor extent, but that TCP demonstrated lamellar bone growth throughout its pores. Both were found to be tissue compatible. The authors stated that the 3/1 material was not as strong as the 4/1 material and suggested that TCP should be used only in low stress areas while tetracalcium phosphate could be used in high stress environments.
Jarcho et al. (1976, 1977) reported the development of a process for preparing dense, polycrystalline, calcium hydroxyapatite (CHA), with the empirical formula 2(Ca5 (PO4)3 OH) or (3Ca3 (PO4)2)Ca(OH)2. In this study, plugs were fabricated at 100% density and implanted in dogs. No evidence of tissue inflammation occurred, and in contrast to the porous TCP implants described above, little resorption or biodegradation was observed after six months.
Holmes (1979) reported that resorption did occur in porous CHA structures. These results led deGroot (1980) to suggest that all calcium phosphates are degradable (resorbable), but the rate is determined by the degree of microporosity. A dense calcium phosphate with negligible porosity would thus degrade only nominally. These results seem to be verified by Farris et al. (U.S. Pat. No. 4,673,355), who claim biocompatible materials with good properties over the range of Ca/P atomic, or molar, ratios from 0.1 to 1.34. (All patents and patent applications cited herein are incorporated by reference.) These ratios convert to CaO/P2 O5 ratios between 0.2 and 2.68, lower than the 3.0 ratio suggested above. They suggest that the Ca/P or CaO/P2 O5 ratio is not critical for implant applications. Ca/P ratios in the range 0.1 to 2.0 probably show satisfactory biocompatibility. Capano (1987) found that a Ca/P ratio of 0.5, which corresponds to calcium metaphosphate ("CMP"), has the best biocompatibility when implanted in small animals.
As the apatites are nearly identical in properties and chemical compositions to bone and tooth enamel, a considerable amount of synthetic effort has been done in this area. Patents in this area include: U.S. Pat. Nos. 4,046,858; 4,274,879; 4,330,514; 4,324,772; 4,048,300; 4,097,935; 4,207,306; and U.S. Pat. No. 3,379,541.
Several patents describe methods for treating apatite materials to render implantable shapes. These methods of heating and compaction under pressure in molds produce solid porous articles in various shapes. These patents include: U.S. Pat. Nos. 4,673,355; 4,308,064; 4,113,500; 4,222,128; 4,135,935; 4,149,893; and U.S. Pat. No. 3,913,229.
Several patents speak to the use of laser radiation to bond apatite materials to tooth and other surfaces, for example, U.S. Pat. No. 4,673,355 and U.S. Pat. No. 4,224,072.
Other patents describe the use of particulate or compacted apatite in conjunction with various compounds, filler, and cements, for example, U.S. Pat. Nos. 4,673,355; 4,230,455; 4,223,412; and U.S. Pat. No. 4,131,597.
The above discussion indicates that calcium phosphates or compounds, such as CHA that are substantially TCP (Monsanto, for example, markets CHA as TCP), are useful for a variety of bioceramic applications because they are biocompatible and can be fabricated into shapes that have a desirable combination of strength, porosity, and longevity for particular sorbable and non-sorbable needs.
Virtually any calcium and phosphate source can be used to prepare materials of interest. An important issue is the ratio of Ca to P or, as it is usually expressed, CaO to P2 O5, molar ratio in the reactant mixture. For example, one can prepare monocalcium orthophosphate monohydrate from the reaction of CaO with orthophosphoric acid, H3 PO4, as shown in equation 1: ##STR1##
One could also react CHA with H3 PO4 to achieve the same product, as shown in equation 2: ##STR2##
Heating the orthophosphate hydrate can lead to a variety of known products, depending on the firing temperature used, as shown in equations 3-8: ##STR3##
The α-, β-, and δ-forms of calcium metaphosphate are different crystal structures of the same chemical compound that happen to be stable at different temperatures. Tricalcium phosphates can be easily obtained from CHA by simply lowering the Ca/P ratio, as shown in equation 9: ##STR4##
According to Mcintosh et al. (1956), the orthophosphate hydrate can be converted to two crystalline forms by heating, as shown in equations 10-11: ##STR5##
Similar reaction schemes can be written for producing di-calcium and tetra-calcium phosphates from CHA or any other calcium source by reacting with orthophosphoric acid or any other P2 O5 source. The chemical and crystalline forms of the final product are simply set by the Ca/P or CaO/P2 O5 molar ratio and the final temperature.
Five calcium phosphates which exhibit different x-ray diffraction patterns are known to be precipitated from aqueous solution at normal pressure (Van Wazer, 1958). These are Ca(H2 PO4)2, Ca(H2 PO4)2.H2 O, CaHPO4, CaHPO4.2H2 O, and crystalline precipitate of variable composition of hydroxyapatite with the base formula Ca5 (OH)(PO4)3. Various forms of calcium phosphate compounds, Ca/P ratio range from 0.5 to 1, are prepared from the reaction of calcium hydroxyapatite with phosphoric acid.
Thermally dehydrated calcium phosphates are known to form a CaO and P2 O5 binary system. For the CaO and P2 O5 binary system, the chain phosphates appear between the orthophosphate (mole ratio of CaO/P2 O5 of about 3) and metaphosphate (mole ratio of CaO/P2 O5 of about 1) or ultraphosphate (mole ratio of CaO/P2 O5 of less than 1). The metaphosphates, in particular, generally exhibit very high degrees of polymerization and good mechanical properties. In this binary system, with a mole ratio of CaO/P2 O5 less than 55/45, a glass-like structure forms from the melt which has mechanical properties similar to those of natural teeth (Yoshihiro, 1975).
Many studies and methods, from powder compaction sintering to hot isostatic pressing, have been reported for the fabrication of CHA implants. However, sintered CHA materials by conventional techniques are generally as weak as sea coral even at high compacting pressure, because CHA decomposes at temperatures lower than the required temperature for sintering.
Some more recent advances are the development of hydroxyapatite (CHA) and calcium phosphate powders that can be processed to yield porous resorbable bone facsimiles (U.S. Pat. No. 4,673,355); the development of the SLS™ process for directly shaping complex porous structures from thermally fusible polymer/ceramic powders without molds (U.S. Pat. No. 5,076,869); the development of low temperature infiltration and cementing techniques to prepare and replace the polymer binder with ceramic binder (U.S. Pat. No. 5,284,695); and the development of techniques for converting computed tomographic ("CT") information into three-dimensional mathematical files that can automatically guide the SLS™ process (Levy et al., 1992; Levy et al., 1994).
More recent work has been directed at expanding the utility of the SLS™ apparatus by preparing polymer-coated ceramic powders from spray dried mixtures of water, inorganic particulate, and a custom-synthesized, emulsified, nanometer-sized, polymer binder (Barlow, 1992; Vail et al., 1992). Ceramic composites made by this approach are relatively large, 10-50 microns, agglomerates of polymer-coated inorganic particles. These agglomerate powders may spread easily into uniform layers and fuse readily in the SLS™ machine to yield porous "green" parts that have relative densities near 50%, excellent connected internal porosity, and sufficient strengths to be easily handled and shipped. Interconnected pores in bioceramics are often difficult to achieve and are very important in fostering bone growth and for preparing metal matrix/ceramic parts, artificial hips.
Polymethyl methacrylate (PMMA) has also been used to form green composites with alumina and with silica/zircon (U.S. Pat. No. 5,284,695). In this process, an appropriate ceramic silicate colloid is used to infiltrate the connected pores of the polymer-bound green part, the colloid is solidified below the fusion temperature of the binder to maintain part geometry, the binder is then thermally removed and the part fired at typically 1000° C. to form porous, all ceramic parts that are suitable for use as cores and molds for metal castings. Such parts typically have only a 1% linear shrinkage, relative to the green state. Their strengths and porosities can be adjusted by additional infiltration and firing treatments.
Lagow and co-workers have recently described the chemical synthesis of high strength CHA (U.S. Pat. No. 4,673,355) and long-chain calcium polyphosphate bioceramic powders ("CPB") (Capano, 1987; Nelson et al., 1993). CPB powder is a pure calcium phosphate material with condensed phosphate chains (as shown below) with degrees of polymerization often greater than 120. ##STR6##
These materials produce sintered materials that have compressive strengths greater than 200,000 psi and flexural strengths in excess of 20,000 psi. These strengths are about twice that of porcelain used to make dental crowns. Using the Lagow CHA material, Lagow and Friedman have recently completed the first successful, year duration, mandible implant in a canine. Work with CPB implants has demonstrated by electron microscopy backscattering that new bone growth occupied nearly 55% of the volume of a CPB implant in the alveolar (tooth bearing) ridge of a dog, after only four months (Nelson et al., 1993). This rate of resorption and replacement by living bone in CPB is about twice as fast as that in CHA.
The lack of suitable bone replacement is a general problem that can be potentially solved by the development of synthetic bones and bone templates that are converted to bone by the body. Bone banks currently provide gamma radiation-treated cadaver bones for various orthopedic and reconstructive purposes in a world-wide business. Appropriate geometries are not always available from these sources, and there is some concern about the transmission of HIV and other diseases. For example, in connection with spinal fusions, there is a substantial need for wedge materials that can provide support and promote the deposition of additional bone. These needs could be rapidly multiplied, provided viable materials and processes could be developed to readily provide bone materials that are shaped to the needs of each individual patient.
Facial and cranial reconstructive surgery is an area where the need for individual implant geometries is especially critical. At present, such reconstructions tend to be very difficult surgical procedures, typically involving highly skilled grafting with allogenic bone. The method and system of the present invention can be utilized to accurately construct a complete facsimile bone structure, suitable for implantation, employing geometric information that is obtained from either CT data or a Computer Aided Design ("CAD") software package.
SUMMARY OF THE INVENTION
The present invention addresses the foregoing and other problems experienced in the art by providing processes for automatically shaping bone implants from various calcium phosphate powders. This invention employs polymeric binder compositions particularly adapted for the formulation of free flowing calcium phosphate/binder composite powders. The powders are suitable for production of bioceramic computer-modeled geometrical implants. Green parts produced in this manner may be post processed to be substantially free of the binder. This invention also allows bioceramic parts to be produced by the low power lasers used in the laser sintering process. The processes may utilize a process called Selective Laser Sintering™ in which complex three-dimensional objects can be built automatically by selectively fusing successive thin layers of powdered material.
One embodiment of the present invention provides a method for making an implant by forming a mixture of a calcium phosphate and a polymer binder, and selectively fusing the polymer binder to form an implant. These steps can be repeated to prepare a multiple-layered implant by successively forming layers of the calcium phosphate and polymer binder mixture, and selectively fusing the polymer binder in that layer and to other adjacent layers to form a plurality of connected layers.
As used herein the term "implant" refers to a device that is fabricated for the purpose of embedding, or placing, within a body. The types of implants encompassed by the present invention include implants suitable for the replacement, repair, or modification of bones, teeth, and the like. However, under certain circumstances it may be conceivable that implants of the present invention may serve other useful purposes.
As used herein the term "selectively fusing" refers to the process of selectively coalescing, or combining, particles such that the formed structure has sufficient strength to be handled and further processed, as desired. The term "selectively" is used to denote the controlled and discriminating fashion with which the fusing process occurs. In this aspect of the present invention, "fusing" refers to the viscous sintering of polymer binder particles that are coating, or otherwise associating with, calcium phosphate particles. This results in a linking of the calcium phosphate particles into a part, which can be further processed by thermally decomposing and removing the polymer binder or by infiltration and subsequent thermal dehydration and the like. This fusing can generally be accomplished selectively by controlling the spatial arrangement of the interconnected particles, for example, with laser sintering processes and the like. Alternatively, the selective fusing could be accomplished using a thermal mask system or by the selective spraying of liquid binders and solvents.
The thickness of the layers formed in this method is preferably from about 3 to about 12 thousandths of an inch. In cases where CT data is employed to shape the implant, the thickness of the layers may be determined by the CT data.
The calcium phosphate is preferably prepared by reacting a mixture of hydroxyapatite and phosphoric acid, although other calcium phosphates can be used. Preferred calcium phosphates include calcium metaphosphate, calcium pyrophosphate, calcium phosphate with from about 25 to about 45 percent by weight calcium oxide, and calcium phosphate with from about 0.5 to about 2 percent by weight sodium oxide, with calcium metaphosphate being particularly preferred.
The calcium phosphate preferably has a mean particle size of from about 5 to 100 microns, with the range of from about 30 to 50 microns being most preferred. Smaller particles tend to produce weaker green parts whereas larger particles can affect the layer thickness and forming.
Certain embodiments of this invention involve coating the calcium phosphate particles with polymeric binders to provide free-flowing powders with advantageous properties for processing into shapes by sintering with a laser beam. The polymeric binder compositions may be employed to mix with, or to coat, ceramic particles to produce free-flowing powders with flow characteristics substantially independent of relative humidity.
The polymer binder may be selectively fused to replicate or form a desired geometrical shape, such as a bone or an enhancement of a bone feature. This desired geometrical shape may be obtained from CT data or CAD software data and communicated to a laser beam by a computer.
The calcium phosphate powder may be mixed with water and a polymer-emulsion binder to form a slurry. In a preferred embodiment, this slurry is rapidly dried by momentarily suspending drops of it in a stream of hot air at a temperature above the fusion temperature of the binder, such as exists in a spray drier or fluidized bed coater. The binder and powder preferably agglomerate and adhere together to form a free flowing composite powder with preferred dimensions in the range of 5-75 μm.
Although it is preferable that the mixture be in the form of agglomerated polymer-coated calcium phosphate particles, mixtures of uncoated calcium phosphate powder and spray dried polymer binder can also be used. Coating the calcium phosphate with the binder is preferred as the polymer binder is used more efficiently in this embodiment, and the coating reduces segregation by density during storing or transporting.
As used herein the term "agglomerated polymer-coated calcium phosphate particles" refers to an indiscriminately formed cluster of particles consisting of calcium phosphate powders that have been coated with a polymer binder. These clusters may be free-flowing substantially independent of the relative humidity.
The implant may be thermally sintered. This can effectively remove the polymer binder, and sinter, or fuse, the calcium phosphate powder.
As used in this aspect of the invention, the terms "sinter" and "sintering" refer to the forming of a coherent bonded mass by heating without melting. In the case of post-processing, the calcium phosphate particles may be combined into a coherent mass with heating, whereas in sintering by laser the polymer binders may be selectively fused by the low energy of the laser beam employed.
Alternatively or in addition to thermal sintering, the implant may be infiltrated with a calcium phosphate solution or the like. This may decrease shrinkage in the implant and also modify the relative density, porosity, and other properties of the implant.
As used herein the term "infiltrating" refers to a process in which a porous implant is placed in an aqueous solution of an inorganic material. This allows the solution to fill the interconnected pores of the implant, and thus upon drying deposit the inorganic material inside the implant. A further thermal sintering step may be undertaken to fuse or coalesce the calcium phosphate.
Preferred polymeric binders include those formed from 1,1-disubstituted vinyl monomers such as esters and amides of methacrylic acid and its derivatives. Examples of 1,1-disubstituted vinyl monomers include methacrylic acid, dimethylamino ethylmethacrylate and methacrylamide, methyl methacrylate and butyl methacrylate. The polymers formed from these monomers are particularly preferred because the major thermal decomposition route is depolymerization to gaseous products in both oxidizing and reducing atmospheres, largely eliminating problems with residual ash.
As used herein the phrase "homopolymer, copolymer, or terpolymer of methyl methacrylate" refers to polymers that are formed by polymerizing methyl methacrylate. These polymers may be formed by the homopolymerization of methyl methacrylate or by polymerizing methyl methacrylate with one or more other monomers.
Another embodiment of the present invention encompasses the implants produced by the previously described methods. These implants preferably have a mean pore size of from about 50 to about 300 microns and a percent relative density of from about 50 to about 80%. As used herein the term "percent relative density" refers to the ratio of the implant density to the calcium phosphate density multiplied by one hundred. As defined, the percent relative density can be used to obtain the percent porosity by subtracting the percent relative density from one hundred.
Another embodiment of the present invention provides a system for making an implant, comprising a mixture of a calcium phosphate and a polymer binder, and means for selectively fusing the polymer binder to form an implant. The fusing means may comprise a laser sintering machine. The system may additionally comprise means for controlling the fusing means in order to form an implant having a desired geometrical shape. This controlling means may be a computer that obtains information about the desired geometrical shape from patient computed tomographic data or Computer Aided Design software.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a diagram showing a typical apparatus used in the Selective Laser Sintering™ process employed by certain embodiments of this invention. H is a computer control for a laser source A, focused by mirrors B. Heating is provided by a radiant heater C. D is a leveling mechanism for a powder bed F. G is a new layer being added to the part E being produced.
FIG. 2 is a scanning electron micrograph of calcium hydroxyapatite at 1000 times magnification.
FIG. 3A is an x-ray diffraction pattern for calcium phosphate with 35% by weight of calcium oxide powder. This pattern closely matches that of tromelite, Ca4 P6 O19 (upper small box).
FIG. 3B is an x-ray diffraction pattern for CMP powder (1) as directly prepared and (2) as prepared from a fired 35CaP part that was infiltrated with a calcium phosphate solution and fired again.
FIG. 4 is a photograph of an SLS™ processed craniofacial implant fabricated from CMP powder.
FIG. 5 is a graph demonstrating the effect of the density of a fired and a infiltrated part on the modulus of rupture (three point bending strength).
FIG. 6A is a scanning electron micrograph of a porous surface after firing, shown at 200 times magnification.
FIG. 6B is a scanning electron micrograph of a porous surface after firing and infiltration, shown at 200 times magnification.
FIG. 7 is a scanning electron micrograph of calcium hydroxyapatite which has been reacted with orthophosphoric acid, shown at 1000 times magnification.
FIG. 8 is a scanning electron micrograph of a polymer coated powder, shown at 800 times magnification.
FIG. 9 is a scanning electron micrograph of a sintered surface at 800 times magnification.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
Certain embodiments of the present invention provide processes capable of fabricating complex three-dimensional implants made of calcium phosphates. A preferred source of calcium phosphate is from the reaction of hydroxyapatite and orthophosphoric acid. CHA powders are generally very cohesive and consist of very porous agglomerates with mean particle size of 1 to 2 μm and bulk density of less than 0.4 g/cm3 (Hattori et al., 1990). The surface area of such powders determined by Mercury intrusion analysis is about 60 m2 /g, suggesting very small particles. Stoichiometric CHA contains constitutional water in the form of OH- ions. This water can be driven off at 1200° C. In addition, CHA is somewhat hygroscopic and will adsorb water from the atmosphere. This physically bound water forms steam when the powder is heated above 100° C. This interferes with the SLS™ process. FIG. 2 shows the microstructure of finely divided CHA powders.
These powders generally require high sintering temperatures, and therefore typically are not suitable substrates for SLS™ processing. However, coating these powders with polymer binders that can fuse under much milder conditions may alleviate this problem. Such coated particles are shown in FIG. 8 as compared to non-coated particles of CHA which are shown in FIG. 7. As used in this invention, these coated particles may provide excellent substrates for producing bioceramic implants in laser sintering processes. The binder coated calcium phosphate powders may be readily handled, conveniently shipped and may be stored for long periods of time without the separation of components sometimes encountered when using mixed powders. In addition, one may readily produce green parts that can be post-processed to be free of polymer binder.
It is preferred that the polymer be distributed so as to cover as much of the surface of the particulate as possible. In principle, this could be accomplished by dissolving the polymer in a suitable organic solvent to achieve a low concentration of the polymer, depositing the solution on the surface of the particulate, then evaporating the solvent. However, this process has the disadvantage of solvent recovery costs as well as potential environmental harm associated with use of organic solvents. To address this problem, the amorphous polymeric binders preferably are prepared by emulsion polymerization as described in the literature (U.S. patent application Ser. No. 08/279,235 filed on Jul. 22, 1994, which is commonly owned with this application; Vail et al., 1994).
Many polymers can be made by emulsion polymerization. In this technique, liquid monomers are emulsified in water with the aid of an appropriate emulsifying agent. Water-borne, ionic initiators are incorporated to polymerize the monomer, thereby forming the desired emulsified polymer. Emulsion particles are typically quite small, about 100 nm (4×10-6 in) in diameter, so that the polymer is well distributed throughout the water vehicle with concentrations in the range of 2-5×1014 particles per cubic centimeter (Bovey et al., 1955). In general, such emulsions are mechanically stable to the effects of gravity. Emulsion polymerization is generally known to produce high molecular weight products at high polymerization rates and is the method of choice for preparing the polymer binder commonly used in water-based acrylic paint systems.
To be effective in green part production and subsequent binder removal, the polymer binder should soften and flow at temperatures between 40° C. and 100° C. Additionally, the polymer coating should be rigid and non-tacky at room temperature. This reduces "blocking" or premature fusing of the polymer-coated powder during storage and provides some structural permanence (low creep rates and low flexibility at ambient temperature) to composite parts made from this powder.
The polymer's fusion temperature is a function of its molecular constituents. This temperature is characterized by the polymer's glass transition temperature, Tg, if the polymer is amorphous, or by its melting temperature, Tm, if it is semi-crystalline. The compositions employed in the present invention may be prepared from water based emulsions. This places a limit on the number of molecular constituents that are useful to give an amorphous polymer with a Tg in the desired range. An upper limit of 100° C. for the softening temperature is set by the normal boiling point of the water vehicle in the emulsion. Regardless of the process used for coating the calcium phosphate particles with polymer binder, the surface temperature of the particle will be limited to 100° C. as long as a water film is present. The lower limit of the softening temperature may be set to about 40° C. to prevent blocking and creeping at ambient temperatures.
To prevent "fines" that can cause powder spreading problems in the laser sintering processes, it is desirable for polymer flow, film formation, and wetting of the inorganic surface to occur simultaneously with water evaporation. This generally cannot occur if the binder softening temperature greatly exceeds the normal boiling point of water.
Regardless of the polymer or copolymer composition used for the binder, the green strength and agglomerate morphology are related to the binder's ability to rapidly wet the inorganic particle during the coating process. These polymeric binders can be synthesized in emulsion form at controlled viscosity (Vail et al., 1994). The viscosity and the related melt flow index are held in the desired range by the addition of chain transfer agents to the polymerization reactions. The lower viscosity material will have an increased melt flow index, near 30 g/10 min at 200° C. and 75 psi, to optimize the coating characteristics of the polymer binder and the subsequent strength of the green part.
FIG. 1 illustrates an apparatus employed in Selective Laser Sintering™ apparatus. The apparatus includes laser source A, mirrors B, radiant heater C, leveling mechanism D, green part being produced E, powder bed F, new layer G of polymer coated powder, and computer control H. The polymer binder in part E is selectively fused by the action of a low power, rastered, modulated, infrared laser beam A. The preferred type of laser used is dependent on many factors, and in particular the type of powder that is to be sintered. A 25 wattage CO2 laser, typically used to sinter waxes and plastics, generally may be used to sinter the powders of the present invention. The laser beam output of the laser A has a wavelength of 10.60 microns, which is near infrared. In the continuous mode, the laser A can be modulated on or off to selectively produce a laser beam which travels along a specified path. In this manner, the directed laser beam A selectively sinters the powder in the target area to produce the desired sintered layer with the defined boundaries of the desired cross sectional region. This process is repeated layer-by-layer with the individual layers G sintered together to form the green part as shown. It is important to note that in connection with this embodiment the laser beam A fuses only the binder and does not substantially alter or fuse the bioceramic E.
In the illustrated embodiment, the selective fusing is governed by geometric information that is generated by a compatible device at computer control H, such as the CT converter program disclosed with this invention or CAD software. The use of CT scan information permits faithful geometric replication of complex bones to be rapidly and easily prepared by this additive process. In this way, naturally complex bone geometries can be prepared from biocompatible materials that could not be prepared by conventional molding or other fabrication processes. It is also possible to design bones or to modify data from CT scans as might be useful for plastic surgery.
The polymer-bound "green" part E may be post-processed to thermally remove the polymer binder and to sinter and fuse the calcium phosphate powder to prepare bone replicas with a controlled, interconnected porosity. The polymer binder is preferably designed to provide adequate strength to permit handling of the green part, and to debond cleanly without residue. Debonding and sintering can be carried out in a conventional oven that has sufficient capacity to reach the high temperatures required for sintering the ceramic components. Porosity in the final part is a function of SLS™ processing conditions, of oven sintering times and temperatures, and of the original polymer and calcium phosphate type and content in the composite powder.
Post-processing may also encompass infiltrating the implant and then thermally dehydrating the implant. In some current methods of producing prototype parts, water-borne ceramic cementing agents are infiltrated into a polymer bound part previously shaped by laser sintering. The cementing agent is dried and set and the polymer burned out to produce an all-calcium phosphate part. This method of post SLS™ processing has been used to produce other ceramic parts and is described in U.S. Pat. No. 5,284,695. This is generally accomplished at much lower temperatures than post-processing without infiltration. Infiltration can generally accomplished with any inorganic compound or cement generally useful for this purpose. However, where biocompatible implants are desired, it is preferable to infiltrate with calcium phosphate.
Under various circumstances it may also be desirable to sinter the implant thermally and then to infiltrate and thermally dehydrate it. However, infiltration prior to sintering generally results in less shrinkage of the implant.
The polymer binder materials used in the present invention have been developed as thermoplastic binders for ceramic particles, as described in U.S. patent application Ser. No. 08/279,235. The polymeric binders are readily removed from the calcium phosphate compositions by thermal decomposition in oxidizing atmospheres to produce parts that contain only ceramic. In general, the binders are amorphous and polymeric. They are polymers, copolymers or terpolymers having glass transition temperatures above 40° C., and having a melt flow index between about 1 to about 50 g/10 min. at 200° C. and 75 psi extrusion pressure, using the instrument geometry and testing protocols described in ASTM #D1238. Preferred polymer binder compositions include methyl methacrylate and butyl methacrylate. The copolymer of methyl methacrylate and n-butyl methacrylate is particularly preferred as a polymeric binder.
The binders employed in this embodiment of the present invention are different from water soluble binders and slip aids used in conventional ceramics processes in which the binder coated powder is compressed to a shape prior to furnace treatment to remove the polymer and thermally consolidate the ceramic (German, 1990). Such compression is not used in Selective Laser Sintering™ processing; therefore, it is important that coated powders for SLS™ and similar type processing be free flowing at processing conditions.
Additionally, and in a practical sense, water immiscibility of the polymer binder is important. If the binder is too hygroscopic, excess water may create steam during the SLS™ process. This may interfere with or prevent fusion of the binder and substrate into a useful green part. Furthermore, water insoluble polymer binders may permit retention of green shape when infiltrating with water-borne inorganic materials.
Certain binder and binder coating systems may produce a coated particulate that is optimal in size for best performance in the SLS™ process. Particles with diameters from 5 μm to 25 μm have been found to spread, level, and sinter well. Depending on the thickness of the powder layer employed, particles as large as 200 μm (and perhaps larger) can be processed. Lowered bed densities and powder spreading and shear problems may result when particles with diameters smaller than 2 μm are attempted.
The disclosed emulsion polymer binders (typically containing 40% by weight of polymer solids in water) are mixed with calcium phosphate particles to produce a slurry that contains 5-40 vol % polymer when dried. A small amount, typically <1%, of the emulsion of high molecular weight, water-soluble polymer may be added as a suspension aid to help suspend the inorganic particles that are typically 2-150 μm. Typical viscosity of the slurry is kept low, approximately 10-100 poise at room temperature, to facilitate spraying of the slurry.
In one example of a preferred coating technique, the slurry of polymer binder emulsion and particulate is spray-dried in a standard NIRO spray drier equipped with a centrifugal atomizer wheel (Vail et al., 1991). The wheel is usually operated at 35,000 rpm causing a fine mist of the slurry mixture to be slung out into a hot air stream. The water in the mist rapidly evaporates to produce solid particles. Particle size in the range of about 25-50 μm in diameter is preferred. However, by varying the conditions of the spray drying, for example, temperature, feed compositions and atomizer wheel speeds, one can adjust the particle size in either direction (Lefebvre, 1989). The particles obtained are agglomerates of polymer and particulate, as can be seen in FIG. 8. An improperly processed slurry, e.g., where the exit air temperature of the dryer is too low relative to the polymer fusion temperature or where the binder viscosity is too high at the processing temperature employed, may produce a large quantity of smaller, non-agglomerated particles. Such particles do not spread and level as well as the larger agglomerates in the laser sintering processes. For this reason, the Tg or Tm of the polymer binder should be at least 10° C., preferably 15° C. or more, below the exit air temperature of the dryer. Many dryers are operated so that the exit air temperature is near 100°-110° C., and for such dryers and drying operations a Tg or Tm below 80°-90° C. is preferred.
Another preferred coating technique utilizes a fluidized bed dryer that coats the particulate by fluidizing it in a heated gas stream, then spraying the polymer emulsion into the fluidized bed of particles. This coating technique also works well with the disclosed emulsion polymer binders to give uniformly coated particles. Generally, the disclosed binder system may be used in a variety of coating applications so long as such applications incorporate evaporation of the water vehicle near the normal boiling point of water.
Decomposition of the polymeric binder material may be important because in processes used to produce implants, it is desirable to remove the binder material so all-calcium phosphate parts are obtained. Generally, most organic polymeric binders may be oxidized to carbon dioxide and water in the high temperature furnaces normally used to "fire" or sinter ceramics.
Small amounts of other substances may be added to the binder compositions. For example, chemically similar compounds that do not have the requisite structure for depolymerization may be included to enhance adhesion and other desirable properties. Preferably these monomers make up less than about 10 mole percent of the copolymer composition. Typically, this will amount to only a few percent, e.g., 3-5%, depending on the particular polymer and the desired purpose.
EXAMPLES Example 1 General Materials and Operating Methods
CHA was obtained as TCP from Monsanto Inc. and phosphoric acid was purchased from Fischer Scientific in 85% concentration. Poly(methyl methacrylate-co-n-butyl methacrylate) copolymer with a Melt Index of 30.9 g/10 min at 75 psi and 200° C. was synthesized as described in the literature (Vail et al., 1994), and used as a polymer binder in Example 2. UCAR 430 Acrylic Polymer Latex (obtained from Union Carbide Corporation) and PMMA emulsion copolymer (Vail et al., 1994) were investigated as polymer binders in Example 3. Inorganic ceramic cement, Cerama Bind™ 542 was obtained from Aremco Products Inc. This inorganic cement, employed in Example 3, is an alumino-phosphate material that can react to form phosphate bonded CHA material.
The calcium phosphate powders were ground by a Szegvary attritor system, type 1HSA, prior to being mixed with polymer for SLS™ processing. Acceptable ranges in particle size were from 20 to 100 microns in diameter with 30 to 50 microns being preferred.
The mercury porosimeter, Poresizer 9320 from Micromeretics was used to determine the surface area of the powder. The powder samples were heated to expel the absorbed moisture and then stored in a desiccator until analyzed. The sample in a penetrometer was initially evacuated to 25 μHg. Mercury was then admitted and pressure was increased up to 30,000 psi which is capable of measuring pore size of 0.006 μm. A contact angle of 130° was assumed in the calculation of pore size. The particle size distributions of powders were measured by a Coulter Multisizer.
Samples of polymer coated substrates were prepared by spray drying a slurry of emulsion copolymer and calcium phosphate powder according to the following equations that determine the amount of each ingredient: ##EQU1## where mE is the required amount of emulsion, ms the amount of powder to be coated, mw the amount of water to be added, xp is the mass fraction of polymer in the resulting sample, xE the solids mass fraction of the emulsion polymer, xs the total solids mass fraction of the final slurry, φp is the mass fraction of the copolymer, ρp is the density of the polymer, and ρs is the substrate density.
Polymer binders were deposited on the calcium phosphate powders by spray drying a slurry of the calcium phosphate powder and the polymer emulsion employing either a bench scale Pulvis Mini Spray Dryer or a pilot plant scale NIRO Spray Dryer, equipped with a centrifugal atomic wheel. Operating conditions for the NIRO Spray Dryer were 30,000 rpm and an exit gas temperature of 110° C. Alternatively, mixtures were formed by physically mixing polymer binders, which had been spray dried, with the dried calcium phosphate powder.
SLS™ Processing
The SLS™ machine used for this work was a Model #125 (DTM Corp., Austin, Tex.). Polymer coated powders produced by the spray coating method were processed by SLS™ to fabricate the desired green shapes according to the following method. The free-flowing polymer coated powder was loaded into the SLS™ machine for processing. The operating environment temperature was biased to heat the powder bed to just below the glass transition temperature, Tg, of the binder, ˜90° C. This corresponds to a setting of 104° C. on the temperature controller. This controller operated on a temperature feedback signal supplied by an infrared sensor (emissivity=0.90). The sensor indicated the temperature at the powder surface. Overbiasing of the environment temperature was prevented by a thermocouple located just below the surface of the radiant heater. At equilibrium conditions this thermocouple indicated a temperature of ˜119° C. These readings were machine dependent as well as material dependent. The powder bed temperature and the operating environment were allowed to equilibrate for at least 1 hr. The environmental atmosphere was maintained semi-inert (O2 <8%) by N2 purge.
Sintering of the polymer coated powder was accomplished using a modulated, CO2 laser beam using scanning conditions prescribed in the actual experiments. The parameters, except the layer thickness, can be combined to give the applied energy density defined as: ##EQU2## where AN is the applied energy density, P the laser output power, BS the beam scan speed, and SCSP the scan line spacing. When expressed in the given units this number had values generally less than 10.0 cal/cm2. Parts exhibiting acceptable green strengths were produced with AN >0.5 cal/cm2. This lower limit appeared to be constant for most material systems. Typically, parts were produced with AN values of about 2 to 2.5.
Processing CT Scan Data for SLS™
The CT data image of human temporal bones was received from a GE 9800 CT scanner as a series of slices, nominally 1.5 mm thick. Each slice consisted of a raster image of the temporal bone; the resolution of each image was 256×256 volume elements, or voxels. Each voxel was 2.5 mm2 and was represented as a floating point number indicating the average density of the tissue at that voxel location. The density is measured in Hounsfeld units, representing the ratio of the tissue density to the density of water. Density values ranged from -1000 to 3095. The SLS™ process required boundary information rather than interior density data; therefore, a conversion process was necessary.
A computer program was written to convert the raster images to contour images of the temporal bone slice in each plane by specifying a minimum threshold density below which the data could be ignored. A source code listing of this program is appended at the end of this specification. The threshold value was selected manually by a CT technician and provided as input. The program then scanned each row in the raster image to locate changes in density that crossed the threshold value provided. These changes represent the bone contour outline. Each voxel at which the threshold crossing is detected is converted to a laser toggle point location by simple translation and scaling transformations. The parameters for this conversion are based on the known size of the sample. The toggle point information was then written in a file in the correct format for direct processing by the SLS™ machine.
In cases where the thickness did not coincide with the thickness required for the SLS™ process (typically 0.005 to 0.01 inches), the SLS™ control compensated for this by either skipping layers (for thinner layers) or replicating layers (for thicker layers).
The thresholding software was implemented in the C programming language on a Sun Microsystems SparcStation 2 workstation with the UNIX operating system. The implementation is independent of the hardware and could be ported to other stations.
Example 2 Bioceramics from CHA Derived Powders
This experiment illustrates the fabrication of complex and delicate bone shape parts from CT data using a Selective Laser Sintering™ process. In order to make denser porous implants, calcium metaphosphate powder that has been mixed with polymer binder and SLS™ processed was either heated at high temperatures for long periods of time, a procedure that increased shrinkage and geometric inaccuracies, or heated at lower temperatures for shorter periods of time to lightly sinter the part followed by infiltration with a calcium phosphate solution, drying, and refiring at a lower temperature to produce a calcium ultraphosphate glass-bound calcium metaphosphate structure. Alternatively, a part made from a calcium phosphate powder that contained a higher Ca/P ratio than CMP, e.g., tromelite (referred to herein as "35CAP"), was infiltrated with a calcium phosphate solution and fired to produce a calcium metaphosphate-bound structure that had better physical properties, low shrinkage and higher density. It is also possible to infiltrate with a calcium phosphate solution prior to the first heating to remove polymer and sinter the part.
Complex bone shapes, such as that shown in FIG. 4, required green strengths near 150 psi to permit ordinary handling. This craniofacial image, composed of 27 different layers, was created from CT scans of a human temporal bone (Levy, 1992). This part was approximately four inches long and one and half inch thick with well defined cavities.
Powder Preparation
(1) Calcium metaphosphate ({Ca(PO3)2 }n, "CMP")
CHA (251 g) was reacted with a solution of 85% phosphoric acid (403 g) in water (150 g) at room temperature, pursuant to equation 14. The prepared paste was dried at room temperature and then heated to 150°-200° C., pursuant to equation 15. ##STR7##
The reaction product was confirmed by the x-ray diffraction analysis. Powder that was heated to 150° C. exhibited the x-ray diffraction pattern of a mixture of Ca(H2 PO4)2 and Ca(H2 PO4)2.H2 O. This powder was further dehydrated to β-calcium metaphosphate (CMP), pursuant to equation 16, which is theoretically composed of 28 wt % of CaO and 72% of P2 O5 and reported to have an average chain length of 10,000 (Corbridge, 1990). The x-ray diffraction pattern of CMP made by the described method is compared to the standard pattern in FIG. 3B. ##STR8## (2) Calcium pyrophosphate (Ca2 P2 O7, "CPP")
CPP was prepared from reacting CHA (251 g) with 85% phosphoric acid (196 g) in a manner analogous to that described for the preparation of CMP. ##STR9## (3) Calcium phosphate with 35 wt % of CaO ("35CaP")
CHA (251 g) was reacted with 85% phosphoric acid (251 g). X-ray diffraction pattern of this powder, as shown in FIG. 3A, was identified by JADE x-ray peak identifying program as mixture of major phase of 4CaO.3P2 O5 and minor phase of CPP, "tromelite".
(4) CPP with 1 wt. % of Na2 O ("1NaCPP")
The prepared CPP powder was mixed with 1 weight percent of Na2 O (by addition of 1.7% by weight of Na2CO3) to depress the melting temperature in order to study the influence of surface area of the powder on green strength. 1NaCPP was thermally coalesced at 1020° C. and then ground in the attritor. The ball milling time was controlled to have different particle size and consequently surface area. Three samples of pore surface area, 1.8, 1.4, and 1.1 m2 /g, were measured by mercury porosity.
In the powder preparation step, a firing temperature of 900° C. was sufficient to coalesce CMP, melting point of 985° C. However, for 35CaP powder, which had a higher melting temperature 900° C. was not high enough to coalesce the powder. The resulting powder had a very high surface area but the green parts had only 40 psi strength with 15% by weight of polymer binder. This reasoning was verified when CPP powder, fired at 1300° C. for 2 hours, then ground in the attritor and classified to a mean diameter of 30 μm, showed good green strength, whereas the powder fired at 900° C., ground to a mean diameter of 2 μm, showed barely any green strength. Also, 1NaCPP powder with a surface area of 1.8 m2 /g exhibited poor green strength, while the powder with a surface area of 1.4 m2 /g showed very good strength. Both powders were mixed with 15% polymer binder by weight.
SLS™ Processing
The appropriate powder was physically mixed with 15% by weight (30% by volume) of spray dried polymer, poly(methyl methacrylate-co-n-butyl methacrylate) copolymer, and SLS™ processed with the conditions shown in Table 1.
              TABLE 1                                                     
______________________________________                                    
SLS Parameters                                                            
Power Scan Space                                                          
                Beam Speed Layer thickness                                
                                     Bed Temp.                            
(W)   (mil)     (ips)      (mil)     (°C.)                         
______________________________________                                    
7.5   5         25         5         90                                   
______________________________________                                    
The SLS™ processed CMP green parts had a density of about 0.91±0.03 g/cm3, 33% of the theoretical density, with the fracture strength of 130±20 psi. This was sufficient to permit rough handling of complex bone shapes, such as that shown in FIG. 4.
However, 35CaP green parts had a density of 0.83 g/cm3 with a fracture strength of 40±10 psi. This relatively low strength of the latter parts was attributed to smaller particle size and, consequently, higher surface area of this powder than that of the CMP powder.
Post processing
Three methods to process the implants after they have been formed by laser sintering are: (1) thermal sintering, (2) thermal sintering to set implant and then infiltration/dehydration/sintering, and (3) no thermal sintering prior to infiltration/dehydration/sintering. The first method involved firing the implant for several hours at sintering temperatures, roughly 800°-1600° C., depending on the calcium phosphate composition used. This approach produced the highest strength materials. However, the firing step caused the part to shrink, which may not be desirable for construction of an accurate facsimile bone structure from geometric information obtained from patient CT data. Furthermore, the shrinkage was not isotropic. Linear shrinkage in thickness was much larger than that in width or length, due to the nature of layer-wise construction of parts in SLS™ process.
The second approach was accomplished either by sintering the implant for a reduced period of time, and then infiltrating and dehydrating the implant and heating to the melting point of the infiltrant to sinter the part. This approach allowed the implant's density and strength to be increased relative to an implant with the same sintering conditions but no infiltrant. The implant also shrank much less than in the direct thermal sintering approach. However, the implant exhibited less green strength as a function of density, as shown in FIG. 5.
The third approach to reduce shrinkage is to infiltrate the implant and then thermally dehydrate and sinter it without a previous firing step (U.S. Pat. No. 5,284,695). This may decrease the amount of shrinkage and green strength even more.
Another issue that affects the choice of post-processing method is the resorbability of implant desired. The resorbability is a function of the density. Therefore, by adjusting density, perhaps by filling the pores with calcium phosphate, the resorbability of the implant can also be adjusted.
Due to the severe restriction imposed on the selection of a cement for biomedical applications, a calcium phosphate solution was chosen as the infiltrant in this experiment. For effective penetration through the pore, the calcium phosphate should to be dissolved completely in a biologically acceptable media.
(1) Thermal Sintering Method
The green parts were fired up to sintering temperature to remove the polymer and subsequently sinter the calcium phosphate. The temperature was raised at an average rate of 16° C./min up to 500° C. and then raised slowly to 880° C. The parts were held at 880° C. for 2 hours and cooled down slowly. During the firing, the parts were kept in lightly packed CHA powder to help maintain the shape and provide even heat distribution to reduce curling. CHA was chosen as the packing material due to its low bulk density, less than 0.5 g/cm3, and high melting temperature.
CMP green parts were fired at 880° C. for 2 hours. The fired CMP parts showed a 3 point bending strength of about 400 psi and a density of about 0.97 g/cm3, corresponding to a 17% volume shrinkage. A strength of about 2700 psi was obtained by firing a CMP part at 940° C. for 1 hour with a density of about 1.4 g/cm3.
(2) Infiltration/Dehydration/Sintering after Thermal Sintering Method
Parts were sintered as described above, and then infiltrated with a calcium phosphate solution. Calcium phosphate paste was prepared by mixing CHA and phosphoric acid which was then diluted with water to form a slurry. The prepared slurry was dissolved in boiling water. It was found that 15g of CHA with 60g of 85% phosphoric acid was a good composition when dissolved in boiling water to make about 120 ml of solution.
Infiltration was performed mainly by capillary action by placing the implant in the solution. After the pores were saturated with infiltrant, the parts were taken out of the solution and allowed to dry at 50° C. and then fired at the appropriate temperature according to the expected final Ca/P ratio. It was found that when the pores were saturated upon infiltration, the resulting weight gain was inversely proportional to the initial density.
The polymer free parts with a density of about 0.97 g/cm3 were infiltrated as described earlier. For the CMP parts, a first infiltration resulted in 31±2% weight gain after firing 725° C. and strength of 1100 psi and subsequent infiltration increased the density about 50% and strength about 1500 psi. Strength vs. density data are shown in FIG. 5. Further infiltration caused the parts to melt and deform inhomogeneously at 725° C., which could indicate existence of a Ca/P concentration gradient through the part. This also lowered the strength of the part. The fractured surface of this part showed randomly distributed vitrified parts. It is believed that infiltrant filled up the pore and formed a phosphate glass.
The formation of phosphate glass was verified in a separate experiment. In this experiment, the calcium phosphate solution was heated to 600° C. where it formed a nonporous transparent glass that contained 15.7% CaO. As additional proof, the infiltrated part was ground to a powder for x-ray diffraction analysis. There was no significant difference in x-ray patterns before and after infiltration. This indicates that no new crystalline phase had been formed.
A 35CaP green part was fired for 2.5 hours at 880° C. to achieve a lightly sintered structure. The structure showed a 40% weight gain upon first infiltration with a calcium phosphate solution due to its lower density. This part was dried and then heated to 725° for longer than 6 hours. Further infiltration increased the strength to about 4200 psi and a relative density of 57%, density of 1.6 g/cm3.
X-ray diffraction analysis indicated that the initial powder, which was a mixture of major phase of 4CaO.3P2 O5 and minor phase of CPP, was converted to calcium metaphosphate after post processing. FIG. 3B shows this phase transformation. The morphology of the fired and infiltrated fracture surface are shown in FIGS. 6A and 6B. Infiltration caused more necking between the grains. The pores were well interconnected and the pore size was approximately larger than 50 μm.
Example 3 Implant Fabrication with Hydroxyapatite
This experiment details preliminary efforts to fabricate implants from calcium hydroxyapatite reacted with orthophosphoric acid. The strengths of the sintered materials in this example were found to be very low.
The failure of this experiment has been ascribed to the lower temperatures of the reaction of the CHA and orthophosphoric acid. In this case, the calcium phosphates were not converted to the more stable meta- and pyro-phosphates but were instead hydroxyapatite hydrates. When these compositions were processed with laser sintering, they were converted to the meta- and pyro-phosphates with the concomitant production of steam. This water was very detrimental to the formation of the implants. Therefore, implants with acceptable green strengths, densities and porosities were not produced.
This example demonstrates that the calcium phosphates of the present invention must be prepared at high enough temperatures prior to SLS™ processing to not decompose during such processing to produce water.
Experimental
To determine the required amount of polymer binder, the coated powder was heated in air to 150° C. to fuse the polymer. Afterwards, the powder was cooled and qualitatively examined. More than 20% (45 vol. %) of UCAR 430 was required to produce a cake that barely permitted handling. While polymethyl methacrylate copolymer coated materials showed better properties at 20% coating, cakes were still easily crumbled. These problems were attributed to the high surface area of the finely divided CHA powder.
In an attempt to modify surface area, CHA (50 g) was reacted with orthophosphoric acid (H3 PO4) (100 ml, 5M), and heated to 150° C. to form a cake. The cake was then ground back to a finely divided powder. The morphology of the reacted CHA powder is shown in FIG. 7. The powder was spray dried with 14% by weight (30% by volume) of polymethyl methacrylate polymer and examined. The oven sintered cake showed significantly improved strengths, enough to permit rough handling.
Based on the oven tests, the coating of the CHA powders with the 14% of PMMA copolymer was scaled up by using an Anhydro Laboratory Spray Dryer (Vail et al., 1991). The operating conditions were as follows:
______________________________________                                    
Slurry solids content:                                                    
                      45 wt. %                                            
Inlet temperature:    175° C.                                      
Outlet temperature:   110° C.                                      
Atomizer speed:       30,000 rpm                                          
______________________________________                                    
FIG. 8 shows the scanning electron micrograph of a polymer coated powder. Spray dried powders were SLS™ processed employing the operating conditions presented in Table 2.
              TABLE 2                                                     
______________________________________                                    
Operating conditions of SLS ™ machine.                                 
Power Bed Temp. Layer Thickness                                           
                             Scan Space                                   
                                     Scan Speed                           
(W)   (°C.)                                                        
                (mil)        (mil)   (inch\sec)                 
______________________________________                                    
5     120       8            5       15                                   
______________________________________                                    
SLS™ processed parts were infiltrated with a phosphoric acid based inorganic cement. High surface tension was observed upon infiltration which prevented effective penetration by the cement, Cerama Bind™. Methanol and Witcolate D51-51 surfactant (Witco Corporation) were used to reduce the surface tension. Infiltrated green parts were dried for 5 days under ambient conditions. Upon drying, the parts were cured in the oven, at 200° C., raised from ambient temperatures at a rate of 50° C./hr. As a final step, green parts were fired up to 700° C. in the furnace for 2 hours to burn off the polymer.
Results and Conclusions
Oven tests showed that parts made with polymer coated non-reacted CHA could not achieve acceptable green strengths. Low bulk density, due to very large specific surface area caused by very small particle sizes and large porosity, is believed to be the reason for this behavior, although the hygroscopic nature of the CHA could be a contributing factor.
While CHA in its pure form has a bulk density of less than 0.4 g/cm3, CHA reacted with 5M phosphoric acid shows increased density to over 0.7 g/cm3. SLS™ processed parts made of reacted CHA had sufficient strengths for rough handling as oven tests of the sintered cakes predicted. The strengths of post-processed bioceramic parts were even higher. FIG. 9 shows a fractured surface of a part that was post processed and fired.
While the compositions and methods of this invention have been described in terms of preferred embodiments, it will be apparent to those of skill in the art that variations may be applied to the systems, compositions, methods and in the steps or in the sequence of steps of the methods described herein without departing from the concept, spirit and scope of the invention. For example, it will be apparent that certain agents which are chemically, compositionally and functionally related may be substituted for the agents described herein where the same or similar results may be achieved. All such similar substitutes and modifications apparent to those skilled in the art are considered to be within the spirit, scope and concept of the invention as defined by the appended claims.
BIBLIOGRAPHY
U.S. Pat. No. 3,379,541 to Tuvell (1968).
U.S. Pat. No. 3,913,229 to Driskell et al. (1975).
U.S. Pat. No. 4,046,858 to Barsa et al. (1977).
U.S. Pat. No. 4,048,300 to Tomlinson et al. (1977).
U.S. Pat. No. 4,097,935 to Jarcho (1978).
U.S. Pat. No. 4,113,500 to Ebihara et al. (1978).
U.S. Pat. No. 4,131,597 to Bluethgen, et al. (1978).
U.S. Pat. No. 4,135,935 to Pfeil et al. (1979).
U.S. Pat. No. 4,149,893 to Aoki et al. (1979).
U.S. Pat. No. 4,207,306 to Jarcho (1980).
U.S. Pat. No. 4,222,128 to Tomonaga et al. (1980).
U.S. Pat. No. 4,223,412 to Aoyagi et al. (1980).
U.S. Pat. No. 4,224,072 to Steward (1980).
U.S. Pat. No. 4,230,455 to Hidaka et al. (1980).
U.S. Pat. No. 4,274,879 to Irvine (1981).
U.S. Pat. No. 4,308,064 to Takami et al. (1981).
U.S. Pat. No. 4,324,772 to Conn et al. (1982).
U.S. Pat. No. 4,330,514 to Nagai et al. (1982).
U.S. Pat. No. 4,673,355 to Farris et al. (1987).
U.S. Pat. No. 5,076,869 to Bourell et al. (1991).
U.S. Pat. No. 5,284,695 to Vail and Barlow (1994).
U.S. patent application Ser. No. 08/279,235 filed Jul. 22, 1994 by Barlow et al.
Albee et al. Ann. Surg., 71:32-39, (1920).
Barlow 3rd International Conference on Rapid Prototyping, pp. 73-79, (1992).
Bhashar et al. Oral Surg., 31:282-289, (1971).
Bovey et al. Emulsion Polymerization, Interscience Publishers, Inc. , 1, (1955).
Cameron et al. J. Biomed. Materials Res., 11:179-186, (1977).
Capano The chemical synthesis and biomedical and dental applications of the first truly successful in vivo replacements for bones, teeth, and similar materials, Ph. D. Thesis, University of Texas at Austin, (1987).
Corbridge Phosphorous: an outline of its chemistry, biochemistry and technology, Elsevier, 224, (1990).
Cutright et al. Oral Surg., 33:850-856, (1972).
deGroot J. Biomaterials, 1:47-50, (1980).
Ferraro et al. J. Dent. Res., 58-A:410, (1979).
German Powder Injection Molding, Metal Powder Industrial Federation, (1990).
Hattori et al. J. Am. Ceram. Soc., 73(6) :1803, (1990).
Hill et al. Amer. J. Sci. 242:457-477, 542-562, (1944).
Holmes Plast. Rec. Surg., 63: 626-633, (1979).
Hulbert et al. "History of Bioceramics", in Ceramics in Surgery, Vincenzini, ed., Elsevier: Amsterdam, 3-27, (1983).
Jarcho et al. J. Materials Science, 11:2027-2035, (1976).
Jarcho et al. J. Bioeng., 1:79-92, (1977).
Koster et al. Langenbeck's Arch. Chir., 343:172-181, (1977).
Koster et al. Langenbeck's Arch. Chir., 341:77-86, (1976).
Lefebvre Atomization and Sprays, Hemisphere Publishing, (1989).
Levy et al. Am. J. of Neuroradiology, 15:473-477, (1994).
Levy et al. Solid Freeform Fabrication Symposium Proceedings, 3:161-173, (1992).
Mcintosh et al. Anal. Chem., 28(9):1424-1427, (1956).
Nelson et al. J. Oral & Maxillofacial Surg., 51:1363-1371, (1993).
Nielson, A.; Acta Chir. Scandanav., 91:17-27, (1944).
Peltier et al. Ann. Surg., 146:61-64, (1957).
Vail et al. J. Appl. Polym. Sci., 52:789-812, (1994).
Vail et al. Solid Freeform Fabrication Symposium Proceedings, 3:124-130, (1992).
Vail et al. Solid Freeform Fabrication Symposium Proceedings, 2:195-205, (1991).
Van Wazer Phosphorous and Its Compounds, Interscience Publisher, 1:517-522, (1958).
Yoshihiro Shika Rikogaku Zasshi, 16:196-202, (1975).
______________________________________                                    
/***********************************************************              
#     Section Name :newimage.c    *                                       
#     Resp. Engineers                                                     
                   :Suman Day and Sashidhar Guduri                        
#     Description  :Program to convert CT scan data to                    
#                  toggle point format                                    
************************************************************              
#     Included Functions                                                  
************************************************************              
#     Current SCCS Version:1      *                                       
************************************************************              
#     Revision History                                                    
#     1.1 on 5/2/1992                                                     
*********************************************************** /             
#include <stdio.h>                                                        
#define TRUE 1                                                            
#define FALSE 0                                                           
main(argc,argv)               main                                        
int argc;                                                                 
char *argv[];                                                             
unsigned short inbuf[512];                                                
unsigned short outbuf[1024];                                              
FILE *infp;                                                               
int i;          /* pixel count */                                         
int j;          /* scanline count */                                      
int k;                                                                    
int flag;                                                                 
unsigned short eol = Oxfffe;                                              
flag = FALSE;                                                             
if (argo = 2)                                                             
{                                                                         
if((infp = fopen(argv[1],"rb")) == NULL)                                  
        {                                                                 
        fputs("open failed",stdout);                                      
        exit(0);                                                          
        }                                                                 
for(j=0;j<512;j++)                                                        
        {                                                                 
        k = 0;                                                            
        fread(inbuf,sizeof(unsigned short),512,infp);                     
        for(i=0;i<512;i++)                                                
          }                                                               
if(inbuf[i] > 1224)                                                       
            {                                                             
            if(flag == FALSE)                                             
              {                                                           
              outbuf[k] = j;                                              
              outbuf[k+1] = i;                                            
              k = k + 2;                                                  
            flag = TRUE;                                                  
            }                                                             
          else                                                            
            {                                                             
            if(flag == TRUE)                                              
              {                                                           
              outbuf[k] = j;                                              
              outbuf[k+1] = i;                                            
              k = k + 2;                                                  
              }                                                           
              flag = FALSE;                                               
            }                                                             
          }                                                               
        fwrite (outbut, sizeof (unsigned short), k, stdout);              
}                                                                         
fwrite (&eol, sizeof (unsigned short), 1, stdout);                        
fclose(infp);                                                             
}                                                                         
}                                                                         
______________________________________                                    

Claims (25)

What is claimed is:
1. A method for making an implant green part, comprising the steps of:
(a) forming a mixture of a calcium phosphate composition and a polymer binder, wherein the calcium phosphate composition is calcium metaphosphate, calcium pyrophosphate, or mixtures thereof; and
(b) selectively fusing the polymer binder with a laser beam to form the implant green part.
2. The method of claim 1, wherein the mixture comprises a plurality of agglomerated polymer-coated calcium phosphate particles.
3. The method of claim 2, wherein the polymer-coated particles are formed by spray drying an aqueous mixture of the calcium phosphate and the polymer binder.
4. The method of claim 1, further comprising the steps of infiltrating and thermally sintering the implant green part.
5. The method of claim 4, wherein the implant green part is infiltrated with a calcium phosphate solution.
6. The method of claim 1, further comprising the step of thermally sintering the implant green part.
7. The method of claim 6, further comprising the steps of infiltrating and again thermally sintering the implant green part.
8. The method of claim 7, wherein the implant green part is infiltrated with a calcium phosphate solution.
9. The method of claim 1, wherein the polymer binder is selectively fused to replicate a desired geometrical shape.
10. The method of claim 1, wherein the polymer binder is selectively fused to form a desired geometrical shape.
11. The method of claim 9 or claim 10, wherein the desired geometrical shape is communicated to the laser beam by a computer.
12. The method of claim 11, wherein the desired geometrical shape is obtained from computed tomographic data.
13. The method of claim 11, wherein the desired geometrical shape is obtained from computer aided design software data.
14. The method of claim 1, wherein the calcium phosphate composition is prepared by reacting aqueous solutions of hydroxyapatite and phosphoric acid.
15. The method of claim 1, wherein the calcium phosphate composition contains:
from about 25 to about 45 percent by weight calcium oxide, or from about 0.5 to about 2 percent by weight sodium oxide.
16. The method of claim 1, wherein the calcium phosphate comprises calcium metaphosphate.
17. The method of claim 1, wherein the calcium phosphate has a mean particle size of from about 5 to about 100 microns.
18. The method of claim 1, wherein the calcium phosphate has a mean particle size of from about 30 to about 50 microns.
19. The method of claim 1, wherein the polymer binder has the following properties:
(a) a Tg of between about 40° C. and about 100° C.; and
(b) a melt flow index of between about 1 and about 50 g/10 minutes at 200° C. and 75 psi extrusion pressure.
20. The method of claim 19, wherein the polymer binder comprises a homopolymer, copolymer, or terpolymer of methyl methacrylate.
21. The method of claim 20, wherein the polymer binder comprises a poly(methyl methacrylate-co-n-butyl methacrylate) copolymer.
22. A method for making an implant green part, comprising the steps of:
(a) forming a mixture of a calcium phosphate composition and a polymer binder, wherein the calcium phosphate composition is calcium metaphosphate, calcium pyrophosphate, or mixtures thereof;
(b) forming a layer of the mixture;
(c) selectively fusing the polymer binder with a laser beam; and
(d) repeating steps (b) and (c) a desired number of times to form a plurality of layers, wherein each layer is fused to adjacent layers to form the implant green part.
23. The method of claim 22, wherein the thickness of each layer is from about 3 to about 12 thousandths of an inch.
24. The method of claim 22, wherein the implant green part has a mean pore size of from about 100 to about 300 microns.
25. The method of claim 22, wherein the implant green part has a relative density of from about 50 to about 80%.
US08/288,120 1994-08-08 1994-08-08 Method for fabricating artificial bone implant green parts Expired - Lifetime US5639402A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US08/288,120 US5639402A (en) 1994-08-08 1994-08-08 Method for fabricating artificial bone implant green parts
AU33614/95A AU702229B2 (en) 1994-08-08 1995-08-08 Method and system for fabricating artificial bone implants
JP8507436A JPH10508324A (en) 1994-08-08 1995-08-08 Methods and systems for making artificial bone implants
PCT/US1995/010017 WO1996005038A1 (en) 1994-08-08 1995-08-08 Method and system for fabricating artificial bone implants
EP95930121A EP0775046A4 (en) 1994-08-08 1995-08-08 Method and system for fabricating artificial bone implants
US08/832,882 US6183515B1 (en) 1994-08-08 1997-04-04 Artificial bone implants
US09/765,801 US6540784B2 (en) 1994-08-08 2001-01-19 Artificial bone implants
US10/255,336 US20030069638A1 (en) 1994-08-08 2002-09-26 Method and system for fabricating artificial bone implants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/288,120 US5639402A (en) 1994-08-08 1994-08-08 Method for fabricating artificial bone implant green parts

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US08/832,882 Continuation US6183515B1 (en) 1994-08-08 1997-04-04 Artificial bone implants

Publications (1)

Publication Number Publication Date
US5639402A true US5639402A (en) 1997-06-17

Family

ID=23105822

Family Applications (4)

Application Number Title Priority Date Filing Date
US08/288,120 Expired - Lifetime US5639402A (en) 1994-08-08 1994-08-08 Method for fabricating artificial bone implant green parts
US08/832,882 Expired - Lifetime US6183515B1 (en) 1994-08-08 1997-04-04 Artificial bone implants
US09/765,801 Expired - Fee Related US6540784B2 (en) 1994-08-08 2001-01-19 Artificial bone implants
US10/255,336 Abandoned US20030069638A1 (en) 1994-08-08 2002-09-26 Method and system for fabricating artificial bone implants

Family Applications After (3)

Application Number Title Priority Date Filing Date
US08/832,882 Expired - Lifetime US6183515B1 (en) 1994-08-08 1997-04-04 Artificial bone implants
US09/765,801 Expired - Fee Related US6540784B2 (en) 1994-08-08 2001-01-19 Artificial bone implants
US10/255,336 Abandoned US20030069638A1 (en) 1994-08-08 2002-09-26 Method and system for fabricating artificial bone implants

Country Status (5)

Country Link
US (4) US5639402A (en)
EP (1) EP0775046A4 (en)
JP (1) JPH10508324A (en)
AU (1) AU702229B2 (en)
WO (1) WO1996005038A1 (en)

Cited By (124)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999001268A2 (en) * 1997-07-01 1999-01-14 University Of Utah Research Foundation Improved rapid prototyping method
US5872159A (en) * 1994-07-22 1999-02-16 Julie Cougoulic Method for preparing a material for medical or veterinary use, resulting material, and uses thereof
US5888067A (en) * 1997-08-15 1999-03-30 Gibbs; David Dental implant
US5902441A (en) * 1996-09-04 1999-05-11 Z Corporation Method of three dimensional printing
US6022509A (en) * 1998-09-18 2000-02-08 Johnson & Johnson Professional, Inc. Precision powder injection molded implant with preferentially leached texture surface and method of manufacture
US6077989A (en) * 1996-05-28 2000-06-20 Kandel; Rita Resorbable implant biomaterial made of condensed calcium phosphate particles
US6093450A (en) * 1996-12-20 2000-07-25 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method for manufacturing a fiber-reinforced bioactive ceramic implant
US6183515B1 (en) 1994-08-08 2001-02-06 Board Of Regents, The University Of Texas System Artificial bone implants
US6248392B1 (en) 1996-12-20 2001-06-19 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Ondersoek Tno Method for manufacturing a fiber-reinforced bioactive ceramic implant
US6270347B1 (en) * 1999-06-10 2001-08-07 Rensselaer Polytechnic Institute Nanostructured ceramics and composite materials for orthopaedic-dental implants
US20020169066A1 (en) * 2001-04-16 2002-11-14 Cerabio, L.L.C. Dense porous structures for use as bone substitutes
US20030042641A1 (en) * 2001-08-30 2003-03-06 Asahi Kogaku Kogyo Kabushiki Kaisha Implant forming method
US20030065400A1 (en) * 2001-04-12 2003-04-03 Beam Heather Ann Method and apparatus for engineered regenrative biostructures such as hydroxyapatite substrates for bone healing applications
US20030074096A1 (en) * 2001-10-15 2003-04-17 Suman Das Solid freeform fabrication of structurally engineered multifunctional devices
US20040026418A1 (en) * 2000-09-26 2004-02-12 Ingo Ederer Interchangeable container
US20040025905A1 (en) * 2000-10-04 2004-02-12 Ingo Ederer Method for unpacking shaped bodies embedded inside unbound particle material
US20040035542A1 (en) * 2000-09-26 2004-02-26 Ingo Ederer Device for manufacturing models layer by layer
US20040056378A1 (en) * 2002-09-25 2004-03-25 Bredt James F. Three dimensional printing material system and method
US20040170765A1 (en) * 2001-04-10 2004-09-02 Ingo Ederer Method and device for applying fluids
US6822194B2 (en) * 2002-05-29 2004-11-23 The Boeing Company Thermocouple control system for selective laser sintering part bed temperature control
US20050017394A1 (en) * 2003-06-16 2005-01-27 Voxeljet Gmbh Methods and systems for the manufacture of layered three-dimensional forms
US20050053510A1 (en) * 2000-12-19 2005-03-10 Honda Giken Kogyo Kabushiki Kaisha Method of producing composite material
US20050059757A1 (en) * 2003-08-29 2005-03-17 Z Corporation Absorbent fillers for three-dimensional printing
US20050085922A1 (en) * 2003-10-17 2005-04-21 Shappley Ben R. Shaped filler for implantation into a bone void and methods of manufacture and use thereof
US20050124720A1 (en) * 2002-04-03 2005-06-09 Mathys Medizinaltechnik Ag Kneadable and pliable bone replacement material
US20050167872A1 (en) * 2002-06-05 2005-08-04 Tatsuo Tsubaki Method for constructing patterns in a layered manner
US20050177237A1 (en) * 2001-04-12 2005-08-11 Ben Shappley Spinal cage insert, filler piece and method of manufacturing
US20050197431A1 (en) * 2000-04-14 2005-09-08 Z Corporation Compositions for three-dimensional printing of solid objects
US20050230870A1 (en) * 2003-06-24 2005-10-20 Christopher Oriakhi Cement system including a binder for use in freeform fabrication
US6977095B1 (en) 1997-10-01 2005-12-20 Wright Medical Technology Inc. Process for producing rigid reticulated articles
US20060008504A1 (en) * 2004-06-10 2006-01-12 Sean Kerr Flexible bone composite
US20060088601A1 (en) * 2004-10-22 2006-04-27 Wright Medical Technology, Inc. Synthetic bone substitute material
US20060105102A1 (en) * 2002-04-11 2006-05-18 Rainer Hochsmann Method and device for applying fluids
US20060141002A1 (en) * 2003-06-04 2006-06-29 Jiankai Liu Coated implants and methods of coating
US20060166159A1 (en) * 2005-01-25 2006-07-27 Norbert Abels Laser shaping of green metal body used in manufacturing an orthodontic bracket
US20060163774A1 (en) * 2005-01-25 2006-07-27 Norbert Abels Methods for shaping green bodies and articles made by such methods
US20060237159A1 (en) * 2003-06-17 2006-10-26 Voxelet Gmbh Method for the layered construction of models
US20060246150A1 (en) * 2000-12-22 2006-11-02 Thorne Kevin J Composition and Process for Bone Growth and Repair
US7147666B1 (en) * 1997-11-26 2006-12-12 Bernard Francis Grisoni Monolithic implants with openings
US20070009606A1 (en) * 2004-05-12 2007-01-11 Serdy James G Manufacturing process, such as three dimensional printing, including binding of water-soluble material followed by softening and flowing and forming films of organic-solvent-soluble material
US20070110890A1 (en) * 2005-11-14 2007-05-17 Berckmans Bruce Iii Deposition of discrete nanoparticles on an implant surface
US20070231364A1 (en) * 2004-04-30 2007-10-04 Kunio Nishimoto Biocompatible Membrane and Process for Producing the Same
US20080233302A1 (en) * 2004-05-24 2008-09-25 Technische Universität Berlin Method and Device for Production of a Three-Dimensional Article
US20090157181A1 (en) * 2007-12-13 2009-06-18 Osman Said G Biologic Artificial Bone
US20090191507A1 (en) * 2008-01-28 2009-07-30 Biomet 3I, Llc Implant surface with increased hydrophilicity
US20100028191A1 (en) * 1999-01-19 2010-02-04 Bego Bremer Goldschlagerei Wilh. Herbst Gmbh & Co. Kg Method for Producing Tooth Replacements and Auxiliary Dental Parts
US20100133106A1 (en) * 2007-08-03 2010-06-03 Ramberg Charles E Porous Bodies and Methods
US7736578B2 (en) 2006-06-30 2010-06-15 Ingo Ederer Method for the construction of a laminated compound
US7754246B2 (en) 2005-09-09 2010-07-13 Wright Medical Technology, Inc. Composite bone graft substitute cement and articles produced therefrom
US20100212584A1 (en) * 2007-10-23 2010-08-26 Voxeljet Technology Gmbh Device for the layer-wise production of patterns
US7795349B2 (en) 1999-11-05 2010-09-14 Z Corporation Material systems and methods of three-dimensional printing
US20100244301A1 (en) * 2007-10-11 2010-09-30 Voxeljet Technology Gmbh Material system and method for changing properties of a plastic component
US20100272519A1 (en) * 2007-10-21 2010-10-28 Voxeljet Technology Gmbh Method and device for conveying particulate material during the layer-wise production of patterns
US20100291314A1 (en) * 2006-08-20 2010-11-18 Voxeljet Technology Self-hardening material and process for layerwise formation of models
US20110024028A1 (en) * 2009-07-31 2011-02-03 United States Gypsum Company Method for preparing three-dimensional plaster objects
US7905951B2 (en) 2006-12-08 2011-03-15 Z Corporation Three dimensional printing material system and method using peroxide cure
US7968626B2 (en) 2007-02-22 2011-06-28 Z Corporation Three dimensional printing material system and method using plasticizer-assisted sintering
WO2011082152A1 (en) * 2009-12-30 2011-07-07 Synthes Usa, Llc Intergrated multi-material implants and methods of manufacture
US20110223437A1 (en) * 2008-11-20 2011-09-15 Voxeljet Technology Gmbh Method for the layered construction of plastic models
US8025903B2 (en) 2005-09-09 2011-09-27 Wright Medical Technology, Inc. Composite bone graft substitute cement and articles produced therefrom
WO2011060312A3 (en) * 2009-11-12 2011-09-29 Smith & Nephew, Inc. Controlled randomized porous structures and methods for making same
US8096262B2 (en) 2004-02-19 2012-01-17 Ingo Ederer Method and device for applying fluids
US8167999B2 (en) 2007-01-10 2012-05-01 3D Systems, Inc. Three-dimensional printing material system with improved color, article performance, and ease of use
US8277743B1 (en) 2009-04-08 2012-10-02 Errcive, Inc. Substrate fabrication
US8359829B1 (en) 2009-06-25 2013-01-29 Ramberg Charles E Powertrain controls
US8475946B1 (en) 2007-03-20 2013-07-02 Bowling Green State University Ceramic article and method of manufacture
US8568649B1 (en) * 2007-03-20 2013-10-29 Bowling Green State University Three-dimensional printer, ceramic article and method of manufacture
US8613938B2 (en) 2010-11-15 2013-12-24 Zimmer Orthobiologics, Inc. Bone void fillers
US8641418B2 (en) 2010-03-29 2014-02-04 Biomet 3I, Llc Titanium nano-scale etching on an implant surface
US8741194B1 (en) 2000-09-25 2014-06-03 Voxeljet Ag Method for producing a part using a depostion technique
US8742072B2 (en) 2006-12-21 2014-06-03 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
US8843229B2 (en) * 2012-07-20 2014-09-23 Biomet Manufacturing, Llc Metallic structures having porous regions from imaged bone at pre-defined anatomic locations
US8911226B2 (en) 2010-04-14 2014-12-16 Voxeljet Ag Device for producing three-dimensional models
US8956144B2 (en) 2010-02-04 2015-02-17 Voxeijet AG Device for producing three-demensional models
US8956140B2 (en) 2010-07-13 2015-02-17 Voxeljet Ag Apparatus for producing three-dimensional models by means of a layer build up technique
US20150118650A1 (en) * 2012-04-06 2015-04-30 Limacorporate Spa Prosthetic Element for Bone Extremities Such as Fingers or Toes, or for Teeth, and Corresponding Production Method
WO2015106113A1 (en) * 2014-01-09 2015-07-16 United Technologies Corporation Material and processes for additively manufacturing one or more parts
US9131995B2 (en) 2012-03-20 2015-09-15 Biomet 3I, Llc Surface treatment for an implant surface
US9174392B2 (en) 2009-06-22 2015-11-03 Voxeljet Ag Method and device for switching a particulate material flow in the construction of models in layers
US9174391B2 (en) 2010-03-31 2015-11-03 Voxeljet Ag Device for producing three-dimensional models
US9205276B2 (en) * 2005-03-31 2015-12-08 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Light as a replacement for mitogenic factors on progenitor cells
US9242413B2 (en) 2011-01-05 2016-01-26 Voxeljet Ag Device and method for constructing a laminar body comprising at least one position adjustable body defining the working area
US9333709B2 (en) 2010-03-31 2016-05-10 Voxeljet Ag Device and method for producing three-dimensional models
US9446170B2 (en) 2013-12-13 2016-09-20 Agnovos Healthcare, Llc Multiphasic bone graft substitute material
US9505176B2 (en) 2007-07-18 2016-11-29 Voxeljet Ag Method for producing three-dimensional components
US9668863B2 (en) 2009-08-19 2017-06-06 Smith & Nephew, Inc. Porous implant structures
US20170266879A1 (en) * 2015-06-12 2017-09-21 Ashok Chand Mathur Method And Apparatus Of Very Much Faster 3D Printer
US9770867B2 (en) 2010-12-29 2017-09-26 Voxeljet Ag Method and material system for building models in layers
US9833932B1 (en) 2010-06-30 2017-12-05 Charles E. Ramberg Layered structures
US9914169B2 (en) 2010-04-17 2018-03-13 Voxeljet Ag Method and device for producing three-dimensional models
US9943981B2 (en) 2013-12-11 2018-04-17 Voxeljet Ag 3D infiltration method
US10052682B2 (en) 2012-10-12 2018-08-21 Voxeljet Ag 3D multi-stage method
US10059062B2 (en) 2012-05-25 2018-08-28 Voxeljet Ag Device for producing three-dimensional models with special building platforms and drive systems
US10059058B2 (en) 2012-06-22 2018-08-28 Voxeljet Ag Device for building a multilayer structure with storage container or filling container movable along the dispensing container
US10213831B2 (en) 2012-11-25 2019-02-26 Voxeljet Ag Construction of a 3D printing device for producing components
US10220568B2 (en) 2013-12-02 2019-03-05 Voxeljet Ag Interchangeable container with moveable side walls
US10220567B2 (en) 2012-03-06 2019-03-05 Voxeljet Ag Method and device for producing three-dimensional models
US10226919B2 (en) 2007-07-18 2019-03-12 Voxeljet Ag Articles and structures prepared by three-dimensional printing method
US10343301B2 (en) 2013-02-28 2019-07-09 Voxeljet Ag Process for producing a moulding using a water-soluble casting mould and material system for the production thereof
US10442170B2 (en) 2013-12-20 2019-10-15 Voxeljet Ag Device, special paper, and method for producing shaped articles
US10449692B2 (en) 2014-12-08 2019-10-22 Tethon Corporation Three-dimensional (3D) printing
US10682809B2 (en) 2014-12-22 2020-06-16 Voxeljet Ag Method and device for producing 3D moulded parts by means of a layer construction technique
EP1021997B2 (en) 1999-01-19 2020-07-01 BEGO Bremer Goldschlägerei Wilh.-Herbst GmbH & Co KG Method of manufacture of dental prostheses and auxiliary elements
US10786945B2 (en) 2013-10-30 2020-09-29 Voxeljet Ag Method and device for producing three-dimensional models using a binding agent system
US10843404B2 (en) 2015-05-20 2020-11-24 Voxeljet Ag Phenolic resin method
US20200367477A1 (en) * 2019-05-24 2020-11-26 Alexander SCHOFIELD Artificial coral articles and preparation methods thereof
US10882110B2 (en) 2015-09-09 2021-01-05 Voxeljet Ag Method and device for applying fluids
US10913204B2 (en) 2011-08-31 2021-02-09 Voxeljet Ag Device for constructing models in layers and methods thereof
US10913207B2 (en) 2014-05-26 2021-02-09 Voxeljet Ag 3D reverse printing method and device
US10946556B2 (en) 2014-08-02 2021-03-16 Voxeljet Ag Method and casting mold, in particular for use in cold casting methods
US11077611B2 (en) 2015-03-17 2021-08-03 Voxeljet Ag Method and device for producing 3D shaped articles with a double recoater
US11097469B2 (en) 2012-10-15 2021-08-24 Voxeljet Ag Method and device for producing three-dimensional models with a temperature-controllable print head
US11097471B2 (en) 2014-03-31 2021-08-24 Voxeljet Ag Method and device for 3D printing using temperature-controlled processing
US11235518B2 (en) 2015-12-01 2022-02-01 Voxeljet Ag Method and device for producing three-dimensional components with the aid of an overfeed sensor
US11253633B2 (en) * 2014-10-27 2022-02-22 I.Ceram Porous composition filled with an active ingredient
US11273605B2 (en) 2016-11-15 2022-03-15 Voxeljet Ag Integrated print head maintenance station for powder bed-based 3D printing
US11279087B2 (en) 2017-07-21 2022-03-22 Voxeljet Ag Process and apparatus for producing 3D moldings comprising a spectrum converter
US11419726B2 (en) 2012-01-20 2022-08-23 Conformis, Inc. Systems and methods for manufacturing, preparation and use of blanks in orthopedic implants
US11504879B2 (en) 2020-04-17 2022-11-22 Beehive Industries, LLC Powder spreading apparatus and system
US11718030B2 (en) * 2016-12-29 2023-08-08 3D Systems, Inc Spatial light modulation of powder-based additive manufacturing with temperature control including by sensor feedback
US11820076B2 (en) 2019-11-01 2023-11-21 Voxeljet Ag 3D printing process and molding produced by this process using lignosulfate
US11826958B2 (en) 2019-02-05 2023-11-28 Voxeljet Ag Exchangeable process unit
US11890810B2 (en) 2015-09-16 2024-02-06 Voxeljet Ag Device and method for producing three-dimensional shaped parts
US11890320B2 (en) 2015-04-20 2024-02-06 The Board Of Regents Of The University Of Texas System CLEC11A is a bone growth agent

Families Citing this family (196)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2324470A (en) * 1997-04-24 1998-10-28 Customflex Limited Prosthetic implants
US6736849B2 (en) * 1998-03-11 2004-05-18 Depuy Products, Inc. Surface-mineralized spinal implants
US20030114936A1 (en) * 1998-10-12 2003-06-19 Therics, Inc. Complex three-dimensional composite scaffold resistant to delimination
EP1053214B1 (en) * 1998-12-10 2008-03-05 Robert Bosch Gmbh Polymer compound, the production and use thereof, and sintered compacts produced therefrom
US8133421B2 (en) * 1999-02-23 2012-03-13 Warsaw Orthopedic, Inc. Methods of making shaped load-bearing osteoimplant
US20070233272A1 (en) * 1999-02-23 2007-10-04 Boyce Todd M Shaped load-bearing osteoimplant and methods of making same
US6520996B1 (en) 1999-06-04 2003-02-18 Depuy Acromed, Incorporated Orthopedic implant
EP2275152A1 (en) 1999-07-08 2011-01-19 CAP Biotechnology, Inc. Calcium-containing structures and methods of making and using the same
US6592625B2 (en) * 1999-10-20 2003-07-15 Anulex Technologies, Inc. Spinal disc annulus reconstruction method and spinal disc annulus stent
US6630153B2 (en) * 2001-02-23 2003-10-07 Smith & Nephew, Inc. Manufacture of bone graft substitutes
WO2001093785A2 (en) * 2000-06-05 2001-12-13 Laser Fare Orthopedic implant and method of making metal articles
US6899713B2 (en) 2000-06-23 2005-05-31 Vertelink Corporation Formable orthopedic fixation system
AU2001225881A1 (en) * 2000-06-23 2002-01-08 University Of Southern California Percutaneous vertebral fusion system
US6875212B2 (en) 2000-06-23 2005-04-05 Vertelink Corporation Curable media for implantable medical device
US6964667B2 (en) * 2000-06-23 2005-11-15 Sdgi Holdings, Inc. Formed in place fixation system with thermal acceleration
US8545786B2 (en) * 2000-09-22 2013-10-01 Colorado School Of Mines Manufacture of porous net-shaped materials comprising alpha or beta tricalcium phosphate or mixtures thereof
DE10057616B4 (en) * 2000-11-21 2006-09-14 Stryker Trauma Gmbh Method for mixing and applying flowable bone cement and bone cement mixing device
US6949251B2 (en) * 2001-03-02 2005-09-27 Stryker Corporation Porous β-tricalcium phosphate granules for regeneration of bone tissue
JP2003052804A (en) * 2001-08-09 2003-02-25 Ichiro Ono Manufacturing method for implant and implant
US8801720B2 (en) 2002-05-15 2014-08-12 Otismed Corporation Total joint arthroplasty system
DE60300277T2 (en) 2002-11-08 2006-01-12 Howmedica Osteonics Corp. Laser generated porous surface
US20060147332A1 (en) 2004-12-30 2006-07-06 Howmedica Osteonics Corp. Laser-produced porous structure
JP3927487B2 (en) * 2002-12-02 2007-06-06 株式会社大野興業 Manufacturing method of artificial bone model
PT1624904E (en) * 2003-05-22 2007-04-30 Artoss Gmbh Inorganic resorbable bone substitute material
US7252686B2 (en) * 2003-08-13 2007-08-07 Boston Scientific Scimed Methods for reducing bone compression fractures using wedges
US20050046067A1 (en) * 2003-08-27 2005-03-03 Christopher Oriakhi Inorganic phosphate cement compositions for solid freeform fabrication
US7348075B2 (en) * 2003-10-28 2008-03-25 Hewlett-Packard Development Company, L.P. System and method for fabricating three-dimensional objects using solid free-form fabrication
US7455805B2 (en) * 2003-10-28 2008-11-25 Hewlett-Packard Development Company, L.P. Resin-modified inorganic phosphate cement for solid freeform fabrication
JP4199653B2 (en) * 2003-12-09 2008-12-17 松崎 浩巳 Bone filling material
US7357887B2 (en) * 2004-04-08 2008-04-15 Hewlett-Packard Development Company, L.P. Identifiable structures and systems and methods for forming the same in a solid freeform fabrication system
US7758896B2 (en) * 2004-04-16 2010-07-20 University Of Massachusetts Porous calcium phosphate networks for synthetic bone material
US9168328B2 (en) * 2005-02-25 2015-10-27 Drexel University Layered manufacturing utilizing foam as a support and multifunctional material for the creation of parts and for tissue engineering
EP1712343A1 (en) * 2005-04-12 2006-10-18 Stichting Dutch Polymer Institute Method of producing a composite article by Solid Freefrom manufacturing
JP4975741B2 (en) * 2005-05-26 2012-07-11 ジマー デンタル, インコーポレイテッド Artificial dental prosthesis
US8814567B2 (en) * 2005-05-26 2014-08-26 Zimmer Dental, Inc. Dental implant prosthetic device with improved osseointegration and esthetic features
US20060269687A1 (en) * 2005-05-31 2006-11-30 Federal-Mogul World Wide, Inc. Selective area fusing of a slurry coating using a laser
EP2921131B1 (en) 2005-06-30 2020-11-04 Biomet 3i, LLC Method for manufacturing dental implant components
US8562346B2 (en) 2005-08-30 2013-10-22 Zimmer Dental, Inc. Dental implant for a jaw with reduced bone volume and improved osseointegration features
US8075312B2 (en) 2005-08-30 2011-12-13 Zimmer Dental, Inc. Dental implant with improved osseointegration features
US8936805B2 (en) 2005-09-09 2015-01-20 Board Of Trustees Of The University Of Arkansas Bone regeneration using biodegradable polymeric nanocomposite materials and applications of the same
EP1931401A2 (en) * 2005-09-09 2008-06-18 University of Arkansas at Little Rock System and method for tissue generation and bone regeneration
US9763788B2 (en) 2005-09-09 2017-09-19 Board Of Trustees Of The University Of Arkansas Bone regeneration using biodegradable polymeric nanocomposite materials and applications of the same
ITMI20051717A1 (en) * 2005-09-16 2007-03-17 Leader Italia S R L DENTAL ENDOSSEO PLANT STRUCTURE WITH DEFAULT GEOMETRY SURFACE
US8257083B2 (en) 2005-10-24 2012-09-04 Biomet 3I, Llc Methods for placing an implant analog in a physical model of the patient's mouth
US11219511B2 (en) 2005-10-24 2022-01-11 Biomet 3I, Llc Methods for placing an implant analog in a physical model of the patient's mouth
EP3175819A1 (en) * 2005-10-24 2017-06-07 Biomet 3I, LLC Methods for manufacturing a rapid prototype overmold for locating a dental implant analog
US8728387B2 (en) 2005-12-06 2014-05-20 Howmedica Osteonics Corp. Laser-produced porous surface
CA2572095C (en) * 2005-12-30 2009-12-08 Howmedica Osteonics Corp. Laser-produced implants
US10130561B2 (en) * 2006-01-31 2018-11-20 Robert L. Karlinsey Functionalized calcium phosphate hybrid systems for confectionery and foodstuff applications
CA2576637A1 (en) * 2006-02-01 2007-08-01 Sidney Omelon Polyphoshate ceramic and method of making same
US9808262B2 (en) 2006-02-15 2017-11-07 Howmedica Osteonics Corporation Arthroplasty devices and related methods
WO2007097853A2 (en) 2006-02-15 2007-08-30 Otismed Corp Arthroplasty jigs and related methods
US8591516B2 (en) 2006-02-27 2013-11-26 Biomet Manufacturing, Llc Patient-specific orthopedic instruments
US8603180B2 (en) 2006-02-27 2013-12-10 Biomet Manufacturing, Llc Patient-specific acetabular alignment guides
US9339278B2 (en) 2006-02-27 2016-05-17 Biomet Manufacturing, Llc Patient-specific acetabular guides and associated instruments
US8070752B2 (en) 2006-02-27 2011-12-06 Biomet Manufacturing Corp. Patient specific alignment guide and inter-operative adjustment
US8858561B2 (en) 2006-06-09 2014-10-14 Blomet Manufacturing, LLC Patient-specific alignment guide
US8568487B2 (en) 2006-02-27 2013-10-29 Biomet Manufacturing, Llc Patient-specific hip joint devices
US10278711B2 (en) 2006-02-27 2019-05-07 Biomet Manufacturing, Llc Patient-specific femoral guide
US9918740B2 (en) 2006-02-27 2018-03-20 Biomet Manufacturing, Llc Backup surgical instrument system and method
US20150335438A1 (en) 2006-02-27 2015-11-26 Biomet Manufacturing, Llc. Patient-specific augments
US9907659B2 (en) 2007-04-17 2018-03-06 Biomet Manufacturing, Llc Method and apparatus for manufacturing an implant
US8241293B2 (en) 2006-02-27 2012-08-14 Biomet Manufacturing Corp. Patient specific high tibia osteotomy
US8608748B2 (en) 2006-02-27 2013-12-17 Biomet Manufacturing, Llc Patient specific guides
US9113971B2 (en) 2006-02-27 2015-08-25 Biomet Manufacturing, Llc Femoral acetabular impingement guide
US8608749B2 (en) 2006-02-27 2013-12-17 Biomet Manufacturing, Llc Patient-specific acetabular guides and associated instruments
US8298237B2 (en) 2006-06-09 2012-10-30 Biomet Manufacturing Corp. Patient-specific alignment guide for multiple incisions
US8282646B2 (en) 2006-02-27 2012-10-09 Biomet Manufacturing Corp. Patient specific knee alignment guide and associated method
US7967868B2 (en) 2007-04-17 2011-06-28 Biomet Manufacturing Corp. Patient-modified implant and associated method
US8133234B2 (en) 2006-02-27 2012-03-13 Biomet Manufacturing Corp. Patient specific acetabular guide and method
US8407067B2 (en) 2007-04-17 2013-03-26 Biomet Manufacturing Corp. Method and apparatus for manufacturing an implant
US9173661B2 (en) 2006-02-27 2015-11-03 Biomet Manufacturing, Llc Patient specific alignment guide with cutting surface and laser indicator
US8092465B2 (en) 2006-06-09 2012-01-10 Biomet Manufacturing Corp. Patient specific knee alignment guide and associated method
US8864769B2 (en) 2006-02-27 2014-10-21 Biomet Manufacturing, Llc Alignment guides with patient-specific anchoring elements
US8535387B2 (en) 2006-02-27 2013-09-17 Biomet Manufacturing, Llc Patient-specific tools and implants
US9345548B2 (en) 2006-02-27 2016-05-24 Biomet Manufacturing, Llc Patient-specific pre-operative planning
US8377066B2 (en) 2006-02-27 2013-02-19 Biomet Manufacturing Corp. Patient-specific elbow guides and associated methods
US8473305B2 (en) 2007-04-17 2013-06-25 Biomet Manufacturing Corp. Method and apparatus for manufacturing an implant
US9289253B2 (en) 2006-02-27 2016-03-22 Biomet Manufacturing, Llc Patient-specific shoulder guide
US9795399B2 (en) 2006-06-09 2017-10-24 Biomet Manufacturing, Llc Patient-specific knee alignment guide and associated method
JP5422205B2 (en) * 2006-06-16 2014-02-19 株式会社マンダム Oral stain remover and oral composition
US20080033522A1 (en) * 2006-08-03 2008-02-07 Med Institute, Inc. Implantable Medical Device with Particulate Coating
US8147861B2 (en) 2006-08-15 2012-04-03 Howmedica Osteonics Corp. Antimicrobial implant
US8460302B2 (en) * 2006-12-18 2013-06-11 Otismed Corporation Arthroplasty devices and related methods
US8663328B2 (en) * 2006-12-21 2014-03-04 Warsaw Orthopedic, Inc. Methods for positioning a load-bearing component of an orthopedic implant device by inserting a malleable device that hardens in vivo
US7771476B2 (en) 2006-12-21 2010-08-10 Warsaw Orthopedic Inc. Curable orthopedic implant devices configured to harden after placement in vivo by application of a cure-initiating energy before insertion
US8758407B2 (en) * 2006-12-21 2014-06-24 Warsaw Orthopedic, Inc. Methods for positioning a load-bearing orthopedic implant device in vivo
US8480718B2 (en) * 2006-12-21 2013-07-09 Warsaw Orthopedic, Inc. Curable orthopedic implant devices configured to be hardened after placement in vivo
US9205036B2 (en) 2007-01-31 2015-12-08 Robert Karlinsey Dental composition
US9023373B2 (en) * 2007-01-31 2015-05-05 Indiana Nanotech Functionalized calcium phosphate hybrid systems for the remineralization of teeth and a method for producing the same
BRPI0807003A2 (en) * 2007-02-06 2014-04-15 Indiana Nanotech Division Of Therametric Technologies Inc HYBRID ORGANIC / INORGANIC CHEMICAL SYSTEMS, INCLUDING FUNCTIONAL HYBRID CALCIUM PHOSPHATE SYSTEMS, AND A SOLID METHOD TO PRODUCE THE SAME
US8206153B2 (en) 2007-05-18 2012-06-26 Biomet 3I, Inc. Method for selecting implant components
US8142886B2 (en) * 2007-07-24 2012-03-27 Howmedica Osteonics Corp. Porous laser sintered articles
US9149345B2 (en) * 2007-08-30 2015-10-06 Zimmer Dental, Inc. Multiple root implant
US9775882B2 (en) 2007-09-20 2017-10-03 Medtronic, Inc. Medical devices and methods including polymers having biologically active agents therein
US8265949B2 (en) 2007-09-27 2012-09-11 Depuy Products, Inc. Customized patient surgical plan
US8361076B2 (en) 2007-09-30 2013-01-29 Depuy Products, Inc. Patient-customizable device and system for performing an orthopaedic surgical procedure
US8357111B2 (en) 2007-09-30 2013-01-22 Depuy Products, Inc. Method and system for designing patient-specific orthopaedic surgical instruments
USD642263S1 (en) 2007-10-25 2011-07-26 Otismed Corporation Arthroplasty jig blank
US8460303B2 (en) * 2007-10-25 2013-06-11 Otismed Corporation Arthroplasty systems and devices, and related methods
US8777612B2 (en) 2007-11-16 2014-07-15 Biomet 3I, Llc Components for use with a surgical guide for dental implant placement
US10582934B2 (en) * 2007-11-27 2020-03-10 Howmedica Osteonics Corporation Generating MRI images usable for the creation of 3D bone models employed to make customized arthroplasty jigs
US20100251774A1 (en) * 2007-11-29 2010-10-07 Corning Incorporated Creep resistant multiple layer refractory used in a glass manufacturing system
US8545509B2 (en) 2007-12-18 2013-10-01 Otismed Corporation Arthroplasty system and related methods
US8311306B2 (en) 2008-04-30 2012-11-13 Otismed Corporation System and method for image segmentation in generating computer models of a joint to undergo arthroplasty
US8715291B2 (en) * 2007-12-18 2014-05-06 Otismed Corporation Arthroplasty system and related methods
US8221430B2 (en) 2007-12-18 2012-07-17 Otismed Corporation System and method for manufacturing arthroplasty jigs
US8777875B2 (en) * 2008-07-23 2014-07-15 Otismed Corporation System and method for manufacturing arthroplasty jigs having improved mating accuracy
US8737700B2 (en) 2007-12-18 2014-05-27 Otismed Corporation Preoperatively planning an arthroplasty procedure and generating a corresponding patient specific arthroplasty resection guide
US8617171B2 (en) * 2007-12-18 2013-12-31 Otismed Corporation Preoperatively planning an arthroplasty procedure and generating a corresponding patient specific arthroplasty resection guide
US8480679B2 (en) 2008-04-29 2013-07-09 Otismed Corporation Generation of a computerized bone model representative of a pre-degenerated state and useable in the design and manufacture of arthroplasty devices
US8160345B2 (en) 2008-04-30 2012-04-17 Otismed Corporation System and method for image segmentation in generating computer models of a joint to undergo arthroplasty
US9408618B2 (en) 2008-02-29 2016-08-09 Howmedica Osteonics Corporation Total hip replacement surgical guide tool
US8651858B2 (en) 2008-04-15 2014-02-18 Biomet 3I, Llc Method of creating an accurate bone and soft-tissue digital dental model
EP3000430B1 (en) 2008-04-16 2017-11-15 Biomet 3i, LLC Method of virtually developing a surgical guide for dental implant
WO2009152172A2 (en) * 2008-06-09 2009-12-17 Alcoa Inc. Defluoridation of water
US8899982B2 (en) 2008-07-02 2014-12-02 Zimmer Dental, Inc. Implant with structure for securing a porous portion
US9095396B2 (en) 2008-07-02 2015-08-04 Zimmer Dental, Inc. Porous implant with non-porous threads
US8231387B2 (en) 2008-07-02 2012-07-31 Zimmer, Inc. Porous implant with non-porous threads
US8562348B2 (en) 2008-07-02 2013-10-22 Zimmer Dental, Inc. Modular implant with secured porous portion
US8617175B2 (en) * 2008-12-16 2013-12-31 Otismed Corporation Unicompartmental customized arthroplasty cutting jigs and methods of making the same
US20100047434A1 (en) * 2008-08-21 2010-02-25 Biomet Manufacturing Corp. Fabrication of monolithic zones on porous scaffold
US8603441B2 (en) * 2008-09-12 2013-12-10 Indiana Nanotech Llc Functionalized calcium phosphate hybrid systems for confectionery and foodstuff applications
US20100114314A1 (en) 2008-11-06 2010-05-06 Matthew Lomicka Expandable bone implant
US8170641B2 (en) 2009-02-20 2012-05-01 Biomet Manufacturing Corp. Method of imaging an extremity of a patient
US9707058B2 (en) 2009-07-10 2017-07-18 Zimmer Dental, Inc. Patient-specific implants with improved osseointegration
DE102009028503B4 (en) 2009-08-13 2013-11-14 Biomet Manufacturing Corp. Resection template for the resection of bones, method for producing such a resection template and operation set for performing knee joint surgery
TWI421062B (en) * 2009-10-21 2014-01-01 Univ Lunghwa Sci & Technology Method and equipment of forming porous bio-ceramic bone scaffold
US8602782B2 (en) 2009-11-24 2013-12-10 Zimmer Dental, Inc. Porous implant device with improved core
US8632547B2 (en) 2010-02-26 2014-01-21 Biomet Sports Medicine, Llc Patient-specific osteotomy devices and methods
US9066727B2 (en) 2010-03-04 2015-06-30 Materialise Nv Patient-specific computed tomography guides
CA3048850A1 (en) 2010-05-11 2011-11-17 Howmedica Osteonics Corp. Organophosphorous, multivalent metal compounds, & polymer adhesive interpenetrating network compositions & methods
US9271744B2 (en) 2010-09-29 2016-03-01 Biomet Manufacturing, Llc Patient-specific guide for partial acetabular socket replacement
US9968376B2 (en) 2010-11-29 2018-05-15 Biomet Manufacturing, Llc Patient-specific orthopedic instruments
EP2462893B8 (en) 2010-12-07 2014-12-10 Biomet 3i, LLC Universal scanning member for use on dental implant and dental implant analogs
US9241745B2 (en) 2011-03-07 2016-01-26 Biomet Manufacturing, Llc Patient-specific femoral version guide
US8715289B2 (en) 2011-04-15 2014-05-06 Biomet Manufacturing, Llc Patient-specific numerically controlled instrument
US9675400B2 (en) 2011-04-19 2017-06-13 Biomet Manufacturing, Llc Patient-specific fracture fixation instrumentation and method
US8956364B2 (en) 2011-04-29 2015-02-17 Biomet Manufacturing, Llc Patient-specific partial knee guides and other instruments
US8668700B2 (en) 2011-04-29 2014-03-11 Biomet Manufacturing, Llc Patient-specific convertible guides
WO2012158527A2 (en) 2011-05-13 2012-11-22 Howmedica Osteonics Organophosphorous & multivalent metal compound compositions & methods
US8944816B2 (en) 2011-05-16 2015-02-03 Biomet 3I, Llc Temporary abutment with combination of scanning features and provisionalization features
US8532807B2 (en) 2011-06-06 2013-09-10 Biomet Manufacturing, Llc Pre-operative planning and manufacturing method for orthopedic procedure
US9084618B2 (en) 2011-06-13 2015-07-21 Biomet Manufacturing, Llc Drill guides for confirming alignment of patient-specific alignment guides
US20130001121A1 (en) 2011-07-01 2013-01-03 Biomet Manufacturing Corp. Backup kit for a patient-specific arthroplasty kit assembly
US8764760B2 (en) 2011-07-01 2014-07-01 Biomet Manufacturing, Llc Patient-specific bone-cutting guidance instruments and methods
US8597365B2 (en) 2011-08-04 2013-12-03 Biomet Manufacturing, Llc Patient-specific pelvic implants for acetabular reconstruction
US9295497B2 (en) 2011-08-31 2016-03-29 Biomet Manufacturing, Llc Patient-specific sacroiliac and pedicle guides
US9066734B2 (en) 2011-08-31 2015-06-30 Biomet Manufacturing, Llc Patient-specific sacroiliac guides and associated methods
US9386993B2 (en) 2011-09-29 2016-07-12 Biomet Manufacturing, Llc Patient-specific femoroacetabular impingement instruments and methods
US9301812B2 (en) 2011-10-27 2016-04-05 Biomet Manufacturing, Llc Methods for patient-specific shoulder arthroplasty
US9451973B2 (en) 2011-10-27 2016-09-27 Biomet Manufacturing, Llc Patient specific glenoid guide
EP2770918B1 (en) 2011-10-27 2017-07-19 Biomet Manufacturing, LLC Patient-specific glenoid guides
KR20130046337A (en) 2011-10-27 2013-05-07 삼성전자주식회사 Multi-view device and contol method thereof, display apparatus and contol method thereof, and display system
US9554910B2 (en) 2011-10-27 2017-01-31 Biomet Manufacturing, Llc Patient-specific glenoid guide and implants
US9452032B2 (en) 2012-01-23 2016-09-27 Biomet 3I, Llc Soft tissue preservation temporary (shell) immediate-implant abutment with biological active surface
US9089382B2 (en) 2012-01-23 2015-07-28 Biomet 3I, Llc Method and apparatus for recording spatial gingival soft tissue relationship to implant placement within alveolar bone for immediate-implant placement
US9237950B2 (en) 2012-02-02 2016-01-19 Biomet Manufacturing, Llc Implant with patient-specific porous structure
US9364896B2 (en) 2012-02-07 2016-06-14 Medical Modeling Inc. Fabrication of hybrid solid-porous medical implantable devices with electron beam melting technology
US9135374B2 (en) 2012-04-06 2015-09-15 Howmedica Osteonics Corp. Surface modified unit cell lattice structures for optimized secure freeform fabrication
US9180010B2 (en) 2012-04-06 2015-11-10 Howmedica Osteonics Corp. Surface modified unit cell lattice structures for optimized secure freeform fabrication
US20140080092A1 (en) 2012-09-14 2014-03-20 Biomet 3I, Llc Temporary dental prosthesis for use in developing final dental prosthesis
US9402637B2 (en) 2012-10-11 2016-08-02 Howmedica Osteonics Corporation Customized arthroplasty cutting guides and surgical methods using the same
US9060788B2 (en) 2012-12-11 2015-06-23 Biomet Manufacturing, Llc Patient-specific acetabular guide for anterior approach
US9204977B2 (en) 2012-12-11 2015-12-08 Biomet Manufacturing, Llc Patient-specific acetabular guide for anterior approach
RU2531377C2 (en) * 2012-12-14 2014-10-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Method for preparing calcium pyrophosphate porous ceramics
US8926328B2 (en) 2012-12-27 2015-01-06 Biomet 3I, Llc Jigs for placing dental implant analogs in models and methods of doing the same
US9839438B2 (en) 2013-03-11 2017-12-12 Biomet Manufacturing, Llc Patient-specific glenoid guide with a reusable guide holder
US9579107B2 (en) 2013-03-12 2017-02-28 Biomet Manufacturing, Llc Multi-point fit for patient specific guide
US9498233B2 (en) 2013-03-13 2016-11-22 Biomet Manufacturing, Llc. Universal acetabular guide and associated hardware
US9826981B2 (en) 2013-03-13 2017-11-28 Biomet Manufacturing, Llc Tangential fit of patient-specific guides
US9517145B2 (en) 2013-03-15 2016-12-13 Biomet Manufacturing, Llc Guide alignment system and method
EP2784045A1 (en) * 2013-03-29 2014-10-01 Osseomatrix Selective laser sintering/melting process
US10118827B2 (en) 2013-05-10 2018-11-06 Reed A. Ayers Combustion synthesis of calcium phosphate constructs and powders doped with atoms, molecules, ions, or compounds
DE102013017193A1 (en) 2013-10-16 2015-04-16 Schunk Ingenieurkeramik Gmbh Process for the production of moldings from reaction-bonded, silicon-infiltrated silicon carbide and / or boron carbide and moldings produced in this way
US20150112349A1 (en) 2013-10-21 2015-04-23 Biomet Manufacturing, Llc Ligament Guide Registration
EP3094283A4 (en) 2013-12-20 2018-01-24 Biomet 3i, LLC Dental system for developing custom prostheses through scanning of coded members
US10282488B2 (en) 2014-04-25 2019-05-07 Biomet Manufacturing, Llc HTO guide with optional guided ACL/PCL tunnels
US9408616B2 (en) 2014-05-12 2016-08-09 Biomet Manufacturing, Llc Humeral cut guide
US9839436B2 (en) 2014-06-03 2017-12-12 Biomet Manufacturing, Llc Patient-specific glenoid depth control
US9561040B2 (en) 2014-06-03 2017-02-07 Biomet Manufacturing, Llc Patient-specific glenoid depth control
US9700390B2 (en) 2014-08-22 2017-07-11 Biomet 3I, Llc Soft-tissue preservation arrangement and method
US9826994B2 (en) 2014-09-29 2017-11-28 Biomet Manufacturing, Llc Adjustable glenoid pin insertion guide
US9833245B2 (en) 2014-09-29 2017-12-05 Biomet Sports Medicine, Llc Tibial tubercule osteotomy
EP3267936A4 (en) 2015-03-09 2018-12-26 Stephen J. Chu Gingival ovate pontic and methods of using the same
US9820868B2 (en) 2015-03-30 2017-11-21 Biomet Manufacturing, Llc Method and apparatus for a pin apparatus
US10226262B2 (en) 2015-06-25 2019-03-12 Biomet Manufacturing, Llc Patient-specific humeral guide designs
US10568647B2 (en) 2015-06-25 2020-02-25 Biomet Manufacturing, Llc Patient-specific humeral guide designs
RU2606041C2 (en) * 2015-10-16 2017-01-10 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский радиологический центр" Министерства здравоохранения Российской Федерации (ФГБУ "НМИРЦ" Минздрава России) Method of producing composite 3d frame for replacement of bone-cartilage defects
CN106925770A (en) * 2015-12-30 2017-07-07 西门子公司 3D printing powder and 3D printing method
US10722310B2 (en) 2017-03-13 2020-07-28 Zimmer Biomet CMF and Thoracic, LLC Virtual surgery planning system and method
DE102017004180A1 (en) * 2017-04-28 2018-10-31 Emery Oleochemicals Gmbh Process for the preparation of a thermoplastic molding material powder
AU2018203479A1 (en) 2017-05-18 2018-12-06 Howmedica Osteonics Corp. High fatigue strength porous structure
US11051829B2 (en) 2018-06-26 2021-07-06 DePuy Synthes Products, Inc. Customized patient-specific orthopaedic surgical instrument
IT201800009553A1 (en) 2018-10-17 2020-04-17 Andrea Brovelli METHOD FOR MAKING SCREWS FOR INTRA-BONE FIXATIONS AND SCREWS OBTAINED BY THIS METHOD
US20220274330A1 (en) * 2019-10-23 2022-09-01 Hewlett-Packard Development Company, L.P. Three-dimensional printing with redox-active inorganic salts

Citations (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3379541A (en) * 1964-02-18 1968-04-23 Monsanto Co Alkaline earth metal hydroxylapatites, processes for preparing the same and compositions containing the same
US3913229A (en) * 1974-02-25 1975-10-21 Miter Inc Dental treatments
US4046858A (en) * 1974-07-24 1977-09-06 Barsa John J Synthesis for crystalline hydroxyapatite
US4048300A (en) * 1973-01-11 1977-09-13 Colgate-Palmolive Company Dental preparation containing materials having calcium and phosphate components
US4097935A (en) * 1976-07-21 1978-07-04 Sterling Drug Inc. Hydroxylapatite ceramic
US4113500A (en) * 1976-06-02 1978-09-12 Asahi Kogaku Kogyo Kabushiki Kaisha Sintered apatite body
US4131597A (en) * 1975-01-17 1978-12-26 Ernst Leitz Gmbh Bioactive composite material process of producing and method of using same
US4135935A (en) * 1973-09-17 1979-01-23 Ernst Leitz Wetzlar Gmbh Sintered composite material, a process of making same, and a method of using same
US4149893A (en) * 1975-11-21 1979-04-17 Tokyo Medical And Dental University Orthopedic and dental implant ceramic composition and process for preparing same
US4207306A (en) * 1974-08-02 1980-06-10 Sterling Drug Inc. Process for producing polycrystalline ceramic oxides
US4222128A (en) * 1977-05-20 1980-09-16 Kureha Kagaku Kogyo Kabushiki Kaisha Composite implant materials and process for preparing same
US4223412A (en) * 1976-12-16 1980-09-23 Sumitomo Chemical Company, Limited Implants for bones, joints or tooth roots
US4224072A (en) * 1978-09-11 1980-09-23 University Of Utah Pit and fissure sealant for teeth
US4230455A (en) * 1976-06-07 1980-10-28 Asahi Kogaku Kogyo Kabushiki Kaisha Prosthetic teeth and bones
US4274879A (en) * 1979-03-05 1981-06-23 Tate & Lyle Limited Synthetic bone ash
US4308064A (en) * 1978-10-19 1981-12-29 Ngk Spark Plugs Co., Ltd. Phosphate of calcium ceramics
US4324772A (en) * 1980-11-19 1982-04-13 Monsanto Company Process for producing hydroxyapatite
US4330514A (en) * 1979-09-25 1982-05-18 Kureha Kagaku Kogyo Kabushiki Kaisha Hydroxyapatite, ceramic material and process for preparing thereof
US4673355A (en) * 1982-10-25 1987-06-16 Farris Edward T Solid calcium phosphate materials
US4693986A (en) * 1985-06-25 1987-09-15 Orthomatrix, Inc. Ceramic process and products
US4699742A (en) * 1984-08-24 1987-10-13 Kuraray Co., Ltd. Process for forming calcium phosphate ceramic articles
US5076869A (en) * 1986-10-17 1991-12-31 Board Of Regents, The University Of Texas System Multiple material systems for selective beam sintering
US5132143A (en) * 1986-10-17 1992-07-21 Board Of Regents, The University Of Texas System Method for producing parts
US5134009A (en) * 1988-09-15 1992-07-28 Asahi Kogaku Kogyo K.K. Shaped article of oriented calcium phosphate type compounds, sinter thereof and processes for producing same
US5152791A (en) * 1989-12-07 1992-10-06 Olympus Optical Co., Ltd. Prosthetic artificial bone having ceramic layers of different porosity
US5182170A (en) * 1989-09-05 1993-01-26 Board Of Regents, The University Of Texas System Method of producing parts by selective beam interaction of powder with gas phase reactant
US5284695A (en) * 1989-09-05 1994-02-08 Board Of Regents, The University Of Texas System Method of producing high-temperature parts by way of low-temperature sintering
WO1996005038A1 (en) * 1994-08-08 1996-02-22 Board Of Regents, The University Of Texas System Method and system for fabricating artificial bone implants

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3859421A (en) 1969-12-05 1975-01-07 Edward E Hucke Methods of producing carbonaceous bodies and the products thereof
US3905047A (en) * 1973-06-27 1975-09-16 Posta Jr John J Implantable ceramic bone prosthesis
US4761272A (en) * 1981-09-25 1988-08-02 Union Oil Company Densified carbonaceous bodies with improved surface finishes
US4436684A (en) 1982-06-03 1984-03-13 Contour Med Partners, Ltd. Method of forming implantable prostheses for reconstructive surgery
US4721615A (en) 1986-05-05 1988-01-26 Monsanto Company Calcium phosphates
US5155324A (en) * 1986-10-17 1992-10-13 Deckard Carl R Method for selective laser sintering with layerwise cross-scanning
US4737411A (en) * 1986-11-25 1988-04-12 University Of Dayton Controlled pore size ceramics particularly for orthopaedic and dental applications
US4861733A (en) 1987-02-13 1989-08-29 Interpore International Calcium phosphate bone substitute materials
GB8803573D0 (en) 1988-02-16 1988-03-16 Topline Leisure Ltd Vending & gaming machine
US4976736A (en) 1989-04-28 1990-12-11 Interpore International Coated biomaterials and methods for making same
US5510066A (en) 1992-08-14 1996-04-23 Guild Associates, Inc. Method for free-formation of a free-standing, three-dimensional body
US5370692A (en) 1992-08-14 1994-12-06 Guild Associates, Inc. Rapid, customized bone prosthesis
US6048954A (en) 1994-07-22 2000-04-11 The University Of Texas System Board Of Regents Binder compositions for laser sintering processes
US5783217A (en) 1995-11-07 1998-07-21 Etex Corporation Low temperature calcium phosphate apatite and a method of its manufacture

Patent Citations (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3379541A (en) * 1964-02-18 1968-04-23 Monsanto Co Alkaline earth metal hydroxylapatites, processes for preparing the same and compositions containing the same
US4048300A (en) * 1973-01-11 1977-09-13 Colgate-Palmolive Company Dental preparation containing materials having calcium and phosphate components
US4135935A (en) * 1973-09-17 1979-01-23 Ernst Leitz Wetzlar Gmbh Sintered composite material, a process of making same, and a method of using same
US3913229A (en) * 1974-02-25 1975-10-21 Miter Inc Dental treatments
US4046858A (en) * 1974-07-24 1977-09-06 Barsa John J Synthesis for crystalline hydroxyapatite
US4207306A (en) * 1974-08-02 1980-06-10 Sterling Drug Inc. Process for producing polycrystalline ceramic oxides
US4131597A (en) * 1975-01-17 1978-12-26 Ernst Leitz Gmbh Bioactive composite material process of producing and method of using same
US4149893A (en) * 1975-11-21 1979-04-17 Tokyo Medical And Dental University Orthopedic and dental implant ceramic composition and process for preparing same
US4113500A (en) * 1976-06-02 1978-09-12 Asahi Kogaku Kogyo Kabushiki Kaisha Sintered apatite body
US4230455A (en) * 1976-06-07 1980-10-28 Asahi Kogaku Kogyo Kabushiki Kaisha Prosthetic teeth and bones
US4097935A (en) * 1976-07-21 1978-07-04 Sterling Drug Inc. Hydroxylapatite ceramic
US4223412A (en) * 1976-12-16 1980-09-23 Sumitomo Chemical Company, Limited Implants for bones, joints or tooth roots
US4222128A (en) * 1977-05-20 1980-09-16 Kureha Kagaku Kogyo Kabushiki Kaisha Composite implant materials and process for preparing same
US4224072A (en) * 1978-09-11 1980-09-23 University Of Utah Pit and fissure sealant for teeth
US4308064A (en) * 1978-10-19 1981-12-29 Ngk Spark Plugs Co., Ltd. Phosphate of calcium ceramics
US4274879A (en) * 1979-03-05 1981-06-23 Tate & Lyle Limited Synthetic bone ash
US4330514A (en) * 1979-09-25 1982-05-18 Kureha Kagaku Kogyo Kabushiki Kaisha Hydroxyapatite, ceramic material and process for preparing thereof
US4324772A (en) * 1980-11-19 1982-04-13 Monsanto Company Process for producing hydroxyapatite
US4673355A (en) * 1982-10-25 1987-06-16 Farris Edward T Solid calcium phosphate materials
US4699742A (en) * 1984-08-24 1987-10-13 Kuraray Co., Ltd. Process for forming calcium phosphate ceramic articles
US4693986A (en) * 1985-06-25 1987-09-15 Orthomatrix, Inc. Ceramic process and products
US5076869A (en) * 1986-10-17 1991-12-31 Board Of Regents, The University Of Texas System Multiple material systems for selective beam sintering
US5132143A (en) * 1986-10-17 1992-07-21 Board Of Regents, The University Of Texas System Method for producing parts
US5134009A (en) * 1988-09-15 1992-07-28 Asahi Kogaku Kogyo K.K. Shaped article of oriented calcium phosphate type compounds, sinter thereof and processes for producing same
US5182170A (en) * 1989-09-05 1993-01-26 Board Of Regents, The University Of Texas System Method of producing parts by selective beam interaction of powder with gas phase reactant
US5284695A (en) * 1989-09-05 1994-02-08 Board Of Regents, The University Of Texas System Method of producing high-temperature parts by way of low-temperature sintering
US5152791A (en) * 1989-12-07 1992-10-06 Olympus Optical Co., Ltd. Prosthetic artificial bone having ceramic layers of different porosity
WO1996005038A1 (en) * 1994-08-08 1996-02-22 Board Of Regents, The University Of Texas System Method and system for fabricating artificial bone implants

Non-Patent Citations (64)

* Cited by examiner, † Cited by third party
Title
Albee, et al., Ann. Surg ., 71:32 39, 1920. *
Albee, et al., Ann. Surg., 71:32-39, 1920.
Barlow, 3rd International Conference on Rapid Prototyping , 73 79, 1992. *
Barlow, 3rd International Conference on Rapid Prototyping, 73-79, 1992.
Bhashar, et al., Oral Surg ., 31:282 289, 1971. *
Bhashar, et al., Oral Surg., 31:282-289, 1971.
Bovey, et al., Emulsion Polymerization , Interscience Publishers, Inc., 1, 1955. *
Bovey, et al., Emulsion Polymerization, Interscience Publishers, Inc., 1, 1955.
Cameron, et al., J. Biomed. Materials Res ., 11:179 186, 1977. *
Cameron, et al., J. Biomed. Materials Res., 11:179-186, 1977.
Corbridge, Phosphorous: an outline of its chemistry, biochemistry and technology, Elsevier, 224, 1990. *
Cutright, et al., Oral Surg ., 33:850 856, 1972. *
Cutright, et al., Oral Surg., 33:850-856, 1972.
deGroot, J. Biomaterials , 1:47 50, 1980. *
deGroot, J. Biomaterials, 1:47-50, 1980.
Ferraro, et al., J. Dent. Res ., 58 A:410, 1979. *
Ferraro, et al., J. Dent. Res., 58-A:410, 1979.
German, Powder Injection Molding , Metal Powder Industrial Federation, 1990. *
German, Powder Injection Molding, Metal Powder Industrial Federation, 1990.
Hattori, et al., J. Am. Ceram. Soc ., 73(6):1803, 1990. *
Hattori, et al., J. Am. Ceram. Soc., 73(6):1803, 1990.
Hill, et al., Amer. J. Sci ., 242:457 477, 542 562, 1944. *
Hill, et al., Amer. J. Sci., 242:457-477, 542-562, 1944.
Holmes, Plast. Rec. Surg ., 63:626 633, 1979. *
Holmes, Plast. Rec. Surg., 63:626-633, 1979.
Hulbert et al., "History of Bioceramics," Ceramics in Surgery, 3-27, 1983.
Hulbert et al., History of Bioceramics, Ceramics in Surgery , 3 27, 1983. *
Jarcho, et al., J. Bioeng ., 1:79 92, 1977. *
Jarcho, et al., J. Bioeng., 1:79-92, 1977.
Jarcho, et al., J. Materials Science , 11:2027 2035, 1976. *
Jarcho, et al., J. Materials Science, 11:2027-2035, 1976.
Koster, et al., Langenbeck s Arch. Chir ., 341:77 86, 1976. *
Koster, et al., Langenbeck s Arch. Chir ., 343:172 181, 1977. *
Koster, et al., Langenbeck's Arch. Chir., 341:77-86, 1976.
Koster, et al., Langenbeck's Arch. Chir., 343:172-181, 1977.
Lee, et al., "Selective Laser Sintering of Bioceramic Materials for Implants," Solid Freeform Fabrication Proceedings, 376-380, 1993.
Lee, et al., Selective Laser Sintering of Bioceramic Materials for Implants, Solid Freeform Fabrication Proceedings , 376 380, 1993. *
Lefebvre, Atomization and Sprays , Hemisphere Publishing, 1989. *
Lefebvre, Atomization and Sprays, Hemisphere Publishing, 1989.
Levy, et al., Am J. Of Neuroradiology , 15:473 477, 1994. *
Levy, et al., Am J. Of Neuroradiology, 15:473-477, 1994.
Levy, et al., Solid Freeform Fabrication Symposium Proceedings , 3:161 173, 1992. *
Levy, et al., Solid Freeform Fabrication Symposium Proceedings, 3:161-173, 1992.
McIntosh, et al., Anal. Chem ., 28(9):1424 1427, 1956. *
McIntosh, et al., Anal. Chem., 28(9):1424-1427, 1956.
Nelson, et al., J. Oral & Maxillofacial Surg ., 51:1363 1371, 1993. *
Nelson, et al., J. Oral & Maxillofacial Surg., 51:1363-1371, 1993.
Nielson, Acta Chir. Scandanav ., 91:17 27, 1944. *
Nielson, Acta Chir. Scandanav., 91:17-27, 1944.
PCT Search Report US95/10017 issued Dec. 20, 1995.
Peltier, et al., Ann. Surg ., 146:61 64, 1957. *
Peltier, et al., Ann. Surg., 146:61-64, 1957.
Vail, et al., "Development of a Poly(Methyl Methacrylate-co-n-Butyl Methacrylate) Copolymer Binder System," J. Appl. Polym. Sci., 52:789-812, 1994.
Vail, et al., "Silicon Carbide Preforms for Metal Infiltration by Selective Laser Sintering™ of Polymer Encapsulated Powders," Solid Freeform Fabrication Proceeding, 204-214, 1993.
Vail, et al., Development of a Poly(Methyl Methacrylate co n Butyl Methacrylate) Copolymer Binder System, J. Appl. Polym. Sci ., 52:789 812, 1994. *
Vail, et al., Silicon Carbide Preforms for Metal Infiltration by Selective Laser Sintering of Polymer Encapsulated Powders, Solid Freeform Fabrication Proceeding , 204 214, 1993. *
Vail, et al., Solid Freeform Fabrication Symposium Proceedings , 2:195 205, 1991. *
Vail, et al., Solid Freeform Fabrication Symposium Proceedings , 3:124 130, 1992. *
Vail, et al., Solid Freeform Fabrication Symposium Proceedings, 2:195-205, 1991.
Vail, et al., Solid Freeform Fabrication Symposium Proceedings, 3:124-130, 1992.
Van Wazer, "Phosphorous and Its Compounds," Interscience Publisher, 1, 517-522, 1958.
Van Wazer, Phosphorous and Its Compounds , Interscience Publisher, 1, 517 522, 1958. *
Yoshihiro, Shika Rikogaku Zasshi , 16:196 202, 1975. *
Yoshihiro, Shika Rikogaku Zasshi, 16:196-202, 1975.

Cited By (264)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5872159A (en) * 1994-07-22 1999-02-16 Julie Cougoulic Method for preparing a material for medical or veterinary use, resulting material, and uses thereof
US6540784B2 (en) 1994-08-08 2003-04-01 Board Of Regents, The University Of Texas System Artificial bone implants
US6183515B1 (en) 1994-08-08 2001-02-06 Board Of Regents, The University Of Texas System Artificial bone implants
US6077989A (en) * 1996-05-28 2000-06-20 Kandel; Rita Resorbable implant biomaterial made of condensed calcium phosphate particles
US6416850B1 (en) 1996-09-04 2002-07-09 Z Corporation Three dimensional printing materials system
US5902441A (en) * 1996-09-04 1999-05-11 Z Corporation Method of three dimensional printing
US6610429B2 (en) 1996-09-04 2003-08-26 Z Corporation Three dimensional printing material system and method
US6248392B1 (en) 1996-12-20 2001-06-19 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Ondersoek Tno Method for manufacturing a fiber-reinforced bioactive ceramic implant
US6093450A (en) * 1996-12-20 2000-07-25 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method for manufacturing a fiber-reinforced bioactive ceramic implant
US6231802B1 (en) * 1997-07-01 2001-05-15 University Of Utah Research Foundation Rapid prototyping method
WO1999001268A2 (en) * 1997-07-01 1999-01-14 University Of Utah Research Foundation Improved rapid prototyping method
WO1999001268A3 (en) * 1997-07-01 1999-03-25 Univ Utah Res Found Improved rapid prototyping method
US6250923B1 (en) 1997-08-15 2001-06-26 David Gibbs Resorbable implant
US5888067A (en) * 1997-08-15 1999-03-30 Gibbs; David Dental implant
US6977095B1 (en) 1997-10-01 2005-12-20 Wright Medical Technology Inc. Process for producing rigid reticulated articles
US20060093729A1 (en) * 1997-10-01 2006-05-04 Marx Jeffrey G Process for producing rigid reticulated articles
US7740897B2 (en) 1997-10-01 2010-06-22 Wright Medical Technology, Inc. Process for producing rigid reticulated articles
US7147666B1 (en) * 1997-11-26 2006-12-12 Bernard Francis Grisoni Monolithic implants with openings
US6022509A (en) * 1998-09-18 2000-02-08 Johnson & Johnson Professional, Inc. Precision powder injection molded implant with preferentially leached texture surface and method of manufacture
US20100028191A1 (en) * 1999-01-19 2010-02-04 Bego Bremer Goldschlagerei Wilh. Herbst Gmbh & Co. Kg Method for Producing Tooth Replacements and Auxiliary Dental Parts
EP1021997B2 (en) 1999-01-19 2020-07-01 BEGO Bremer Goldschlägerei Wilh.-Herbst GmbH & Co KG Method of manufacture of dental prostheses and auxiliary elements
US6270347B1 (en) * 1999-06-10 2001-08-07 Rensselaer Polytechnic Institute Nanostructured ceramics and composite materials for orthopaedic-dental implants
US7795349B2 (en) 1999-11-05 2010-09-14 Z Corporation Material systems and methods of three-dimensional printing
US20050197431A1 (en) * 2000-04-14 2005-09-08 Z Corporation Compositions for three-dimensional printing of solid objects
US9403324B2 (en) 2000-09-25 2016-08-02 Voxeljet Ag Method for producing a part using a deposition technique
US10213938B2 (en) 2000-09-25 2019-02-26 Voxeljet Ag Method for producing a part using a deposition technique
US8741194B1 (en) 2000-09-25 2014-06-03 Voxeljet Ag Method for producing a part using a depostion technique
US7204684B2 (en) 2000-09-26 2007-04-17 Ingo Ederer Interchangeable container
US20060108090A1 (en) * 2000-09-26 2006-05-25 Ingo Ederer Device for pattern building in layers
US20040035542A1 (en) * 2000-09-26 2004-02-26 Ingo Ederer Device for manufacturing models layer by layer
US7137431B2 (en) 2000-09-26 2006-11-21 Ingo Ederer Device for pattern building in layers
US20040026418A1 (en) * 2000-09-26 2004-02-12 Ingo Ederer Interchangeable container
US7004222B2 (en) 2000-09-26 2006-02-28 Ingo Ederer Device for manufacturing models layer by layer
US20040025905A1 (en) * 2000-10-04 2004-02-12 Ingo Ederer Method for unpacking shaped bodies embedded inside unbound particle material
US20050053510A1 (en) * 2000-12-19 2005-03-10 Honda Giken Kogyo Kabushiki Kaisha Method of producing composite material
US7635448B2 (en) * 2000-12-19 2009-12-22 Honda Giken Kogyo Kabushiki Kaisha Method of producing composite material
US8690874B2 (en) 2000-12-22 2014-04-08 Zimmer Orthobiologics, Inc. Composition and process for bone growth and repair
US20060246150A1 (en) * 2000-12-22 2006-11-02 Thorne Kevin J Composition and Process for Bone Growth and Repair
US20040170765A1 (en) * 2001-04-10 2004-09-02 Ingo Ederer Method and device for applying fluids
US7879393B2 (en) 2001-04-10 2011-02-01 Ingo Ederer Method and device for applying fluids
US20030065400A1 (en) * 2001-04-12 2003-04-03 Beam Heather Ann Method and apparatus for engineered regenrative biostructures such as hydroxyapatite substrates for bone healing applications
US20050177237A1 (en) * 2001-04-12 2005-08-11 Ben Shappley Spinal cage insert, filler piece and method of manufacturing
US7122057B2 (en) 2001-04-12 2006-10-17 Therics, Llc Method and apparatus for engineered regenerative biostructures such as hydroxyapatite substrates for bone healing applications
US20020169066A1 (en) * 2001-04-16 2002-11-14 Cerabio, L.L.C. Dense porous structures for use as bone substitutes
US7113841B2 (en) * 2001-08-30 2006-09-26 Pentax Corporation Implant forming method
US20030042641A1 (en) * 2001-08-30 2003-03-06 Asahi Kogaku Kogyo Kabushiki Kaisha Implant forming method
US7509240B2 (en) 2001-10-15 2009-03-24 The Regents Of The University Of Michigan Solid freeform fabrication of structurally engineered multifunctional devices
US20030074096A1 (en) * 2001-10-15 2003-04-17 Suman Das Solid freeform fabrication of structurally engineered multifunctional devices
US9050390B2 (en) 2002-04-03 2015-06-09 DePuy Synthes Products, LLC Kneadable and pliable bone replacement material
US8603184B2 (en) 2002-04-03 2013-12-10 DePuy Synthes Products, LLC Kneadable and pliable bone replacement material
US20050124720A1 (en) * 2002-04-03 2005-06-09 Mathys Medizinaltechnik Ag Kneadable and pliable bone replacement material
US20060105102A1 (en) * 2002-04-11 2006-05-18 Rainer Hochsmann Method and device for applying fluids
US7748971B2 (en) 2002-04-11 2010-07-06 Voxeljet Technology Gmbh Method and device for applying fluids
US6822194B2 (en) * 2002-05-29 2004-11-23 The Boeing Company Thermocouple control system for selective laser sintering part bed temperature control
US7531117B2 (en) 2002-06-05 2009-05-12 Ingo Ederer Method for constructing patterns in a layered manner
US7955537B2 (en) 2002-06-05 2011-06-07 Ingo Ederer Method for constructing patterns in a layered manner
US20050167872A1 (en) * 2002-06-05 2005-08-04 Tatsuo Tsubaki Method for constructing patterns in a layered manner
US20040056378A1 (en) * 2002-09-25 2004-03-25 Bredt James F. Three dimensional printing material system and method
US7087109B2 (en) 2002-09-25 2006-08-08 Z Corporation Three dimensional printing material system and method
US7341756B2 (en) 2003-06-04 2008-03-11 Chemat Technology, Inc. Coated implants and methods of coating
US20080152785A1 (en) * 2003-06-04 2008-06-26 Jiankai Liu Coated implants and methods of coating
US7648726B2 (en) 2003-06-04 2010-01-19 Chemat Technology, Inc. Coated implants and methods of coating
US20060141002A1 (en) * 2003-06-04 2006-06-29 Jiankai Liu Coated implants and methods of coating
US7807077B2 (en) 2003-06-16 2010-10-05 Voxeljet Technology Gmbh Methods and systems for the manufacture of layered three-dimensional forms
US20080237933A1 (en) * 2003-06-16 2008-10-02 Rainer Hochsmann Methods and systems for manufacturing the manufacture of layered three-dimensional forms
US20050017394A1 (en) * 2003-06-16 2005-01-27 Voxeljet Gmbh Methods and systems for the manufacture of layered three-dimensional forms
US8506870B2 (en) 2003-06-16 2013-08-13 Voxeljet Technology Gmbh Methods of manufacturing layered three-dimensional forms
US20060237159A1 (en) * 2003-06-17 2006-10-26 Voxelet Gmbh Method for the layered construction of models
US8020604B2 (en) 2003-06-17 2011-09-20 Hoechsmann Rainer Method for the layered construction of models
US8122939B2 (en) 2003-06-17 2012-02-28 Rainer Hochsmann Method for the layered construction of models
US20050230870A1 (en) * 2003-06-24 2005-10-20 Christopher Oriakhi Cement system including a binder for use in freeform fabrication
US7435367B2 (en) 2003-06-24 2008-10-14 Hewlett-Packard Development Company, L.P. Cement system including a binder for use in freeform fabrication
EP1491517A3 (en) * 2003-06-24 2007-11-21 Hewlett-Packard Development Company, L.P. A cement system including a binder for use in freeform fabrication
US20050059757A1 (en) * 2003-08-29 2005-03-17 Z Corporation Absorbent fillers for three-dimensional printing
US20050085922A1 (en) * 2003-10-17 2005-04-21 Shappley Ben R. Shaped filler for implantation into a bone void and methods of manufacture and use thereof
US9463488B2 (en) 2004-02-19 2016-10-11 Voxeljet Ag Method for applying particle material including a metering system and leveling element
US8096262B2 (en) 2004-02-19 2012-01-17 Ingo Ederer Method and device for applying fluids
US20070231364A1 (en) * 2004-04-30 2007-10-04 Kunio Nishimoto Biocompatible Membrane and Process for Producing the Same
US7815826B2 (en) 2004-05-12 2010-10-19 Massachusetts Institute Of Technology Manufacturing process, such as three-dimensional printing, including solvent vapor filming and the like
US20080032083A1 (en) * 2004-05-12 2008-02-07 Massachusetts Institute Of Technology Manufacturing Process, Such as Three-Dimensional Printing, Including Solvent Vapor Filming and the Like
US20070009606A1 (en) * 2004-05-12 2007-01-11 Serdy James G Manufacturing process, such as three dimensional printing, including binding of water-soluble material followed by softening and flowing and forming films of organic-solvent-soluble material
US20080233302A1 (en) * 2004-05-24 2008-09-25 Technische Universität Berlin Method and Device for Production of a Three-Dimensional Article
US7767130B2 (en) 2004-05-24 2010-08-03 Voxeljet Technology Gmbh Method and device for production of a three-dimensional article
US8012501B2 (en) * 2004-06-10 2011-09-06 Synthes Usa, Llc Flexible bone composite
US20120269873A1 (en) * 2004-06-10 2012-10-25 Synthes Usa, Llc Flexible Bone Composite
US20060008504A1 (en) * 2004-06-10 2006-01-12 Sean Kerr Flexible bone composite
US8420108B2 (en) * 2004-06-10 2013-04-16 Synthes Usa, Llc Flexible bone composite
US8771721B2 (en) 2004-06-10 2014-07-08 DePuy Synthes Products, LLC Flexible bone composite
US7766972B2 (en) 2004-10-22 2010-08-03 Wright Medical Technology, Inc. Synthetic, malleable bone graft substitute material
US20060088601A1 (en) * 2004-10-22 2006-04-27 Wright Medical Technology, Inc. Synthetic bone substitute material
US20080014242A1 (en) * 2004-10-22 2008-01-17 Wright Medical Technology, Inc. Synthetic Bone Substitute Material
US7250550B2 (en) 2004-10-22 2007-07-31 Wright Medical Technology, Inc. Synthetic bone substitute material
US20060166159A1 (en) * 2005-01-25 2006-07-27 Norbert Abels Laser shaping of green metal body used in manufacturing an orthodontic bracket
US10058400B2 (en) 2005-01-25 2018-08-28 Ormco Corporation Method of manufacturing an orthodontic bracket having a laser shaped green body
US20090169841A1 (en) * 2005-01-25 2009-07-02 Ormco Corporation Methods for shaping green bodies and articles made by such methods
US8479393B2 (en) 2005-01-25 2013-07-09 Ormco Corporation Method of manufacturing an orthodontic bracket having a laser shaped green body
US20160157963A1 (en) * 2005-01-25 2016-06-09 Ormco Corporation Methods for shaping green bodies and articles made by such methods
US9107725B2 (en) 2005-01-25 2015-08-18 Ormco Corporation Method of manufacturing an orthodontic bracket having a laser shaped green body
US9877805B2 (en) * 2005-01-25 2018-01-30 Ormco Corporation Methods for shaping green bodies and articles made by such methods
US8871132B2 (en) 2005-01-25 2014-10-28 Ormco Corporation Methods for shaping green bodies and articles made by such methods
US20150137400A1 (en) * 2005-01-25 2015-05-21 Ormco Corporation Methods for shaping green bodies and articles made by such methods
US9539064B2 (en) * 2005-01-25 2017-01-10 Ormco Corporation Methods for shaping green bodies and articles made by such methods
US20060163774A1 (en) * 2005-01-25 2006-07-27 Norbert Abels Methods for shaping green bodies and articles made by such methods
US20110047799A1 (en) * 2005-01-25 2011-03-03 Ormco Corporation Laser shaped green metal body and orthodontic bracket
US8931171B2 (en) 2005-01-25 2015-01-13 Ormco Corporation Method of manufacturing an orthodontic bracket having a laser shaped green body
US9205276B2 (en) * 2005-03-31 2015-12-08 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Light as a replacement for mitogenic factors on progenitor cells
US9180224B2 (en) 2005-09-09 2015-11-10 Agnovos Healthcare, Llc Composite bone graft substitute cement and articles produced therefrom
US8025903B2 (en) 2005-09-09 2011-09-27 Wright Medical Technology, Inc. Composite bone graft substitute cement and articles produced therefrom
US8685464B2 (en) 2005-09-09 2014-04-01 Agnovos Healthcare, Llc Composite bone graft substitute cement and articles produced therefrom
US7754246B2 (en) 2005-09-09 2010-07-13 Wright Medical Technology, Inc. Composite bone graft substitute cement and articles produced therefrom
US8685465B2 (en) 2005-09-09 2014-04-01 Agnovos Healthcare, Llc Composite bone graft substitute cement and articles produced therefrom
US20070112353A1 (en) * 2005-11-14 2007-05-17 Berckmans Bruce Iii Deposition of discrete nanoparticles on an implant surface
US7771774B2 (en) 2005-11-14 2010-08-10 Biomet 3l, LLC Deposition of discrete nanoparticles on an implant surface
US8486483B2 (en) 2005-11-14 2013-07-16 Biomet 3I, Llc Deposition of discrete nanoparticles on an implant surface
US20070110890A1 (en) * 2005-11-14 2007-05-17 Berckmans Bruce Iii Deposition of discrete nanoparticles on an implant surface
US9763751B2 (en) 2005-11-14 2017-09-19 Biomet 3I, Llc Deposition of discrete nanoparticles on an implant surface
US20100243123A1 (en) * 2006-06-30 2010-09-30 Voxeljet Technology Gmbh Method for the construction of a laminated compound
US7736578B2 (en) 2006-06-30 2010-06-15 Ingo Ederer Method for the construction of a laminated compound
US7927539B2 (en) 2006-06-30 2011-04-19 Ingo Ederer Method for the construction of a laminated compound
US9676143B2 (en) 2006-08-10 2017-06-13 Voxeljet Ag Self-hardening material and process for layerwise formation of models
US9643360B2 (en) 2006-08-20 2017-05-09 Voxeljet Ag Self-hardening material and process for layerwise formation of models
US20100291314A1 (en) * 2006-08-20 2010-11-18 Voxeljet Technology Self-hardening material and process for layerwise formation of models
US7905951B2 (en) 2006-12-08 2011-03-15 Z Corporation Three dimensional printing material system and method using peroxide cure
US8157908B2 (en) 2006-12-08 2012-04-17 3D Systems, Inc. Three dimensional printing material system and method using peroxide cure
US8742072B2 (en) 2006-12-21 2014-06-03 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
US8167999B2 (en) 2007-01-10 2012-05-01 3D Systems, Inc. Three-dimensional printing material system with improved color, article performance, and ease of use
US8506862B2 (en) 2007-02-22 2013-08-13 3D Systems, Inc. Three dimensional printing material system and method using plasticizer-assisted sintering
US7968626B2 (en) 2007-02-22 2011-06-28 Z Corporation Three dimensional printing material system and method using plasticizer-assisted sintering
US8845953B1 (en) * 2007-03-20 2014-09-30 Tethon Corporation Three-dimensional printer, ceramic article and method of manufacture
US8568649B1 (en) * 2007-03-20 2013-10-29 Bowling Green State University Three-dimensional printer, ceramic article and method of manufacture
US8475946B1 (en) 2007-03-20 2013-07-02 Bowling Green State University Ceramic article and method of manufacture
US9505176B2 (en) 2007-07-18 2016-11-29 Voxeljet Ag Method for producing three-dimensional components
US10226919B2 (en) 2007-07-18 2019-03-12 Voxeljet Ag Articles and structures prepared by three-dimensional printing method
US10960655B2 (en) 2007-07-18 2021-03-30 Voxeljet Ag Articles and structures prepared by three-dimensional printing method
US7981375B2 (en) 2007-08-03 2011-07-19 Errcive, Inc. Porous bodies and methods
US8551216B2 (en) 2007-08-03 2013-10-08 Errcive, Inc. Porous bodies and methods
US8092753B2 (en) 2007-08-03 2012-01-10 Errcive, Inc. Porous bodies and methods
US8361406B2 (en) 2007-08-03 2013-01-29 Errcive, Inc. Porous bodies and methods
US8097220B2 (en) 2007-08-03 2012-01-17 Errcive, Inc. Porous bodies and methods
US8221694B2 (en) 2007-08-03 2012-07-17 Errcive, Inc. Porous bodies and methods
US8361420B2 (en) 2007-08-03 2013-01-29 Errcive, Inc. Porous bodies and methods
US20100133106A1 (en) * 2007-08-03 2010-06-03 Ramberg Charles E Porous Bodies and Methods
US8821803B2 (en) 2007-08-03 2014-09-02 Errcive, Inc. Porous bodies and methods
US8623287B2 (en) 2007-08-03 2014-01-07 Errcive, Inc. Porous bodies and methods
US20100244301A1 (en) * 2007-10-11 2010-09-30 Voxeljet Technology Gmbh Material system and method for changing properties of a plastic component
US8349233B2 (en) 2007-10-11 2013-01-08 Voxeljet Gmbh Material system and method for changing properties of a plastic component
US9469074B2 (en) 2007-10-21 2016-10-18 Voxeljet Ag Method and device for conveying particulate material during the layer-wise production of patterns
US10099426B2 (en) 2007-10-21 2018-10-16 Voxeljet Ag Method and device for layer-wise production of patterns
US8727672B2 (en) 2007-10-21 2014-05-20 Voxeljet Ag Method and device for conveying particulate material during the layer-wise production of patterns
US20100272519A1 (en) * 2007-10-21 2010-10-28 Voxeljet Technology Gmbh Method and device for conveying particulate material during the layer-wise production of patterns
US20100212584A1 (en) * 2007-10-23 2010-08-26 Voxeljet Technology Gmbh Device for the layer-wise production of patterns
US8992205B2 (en) 2007-10-23 2015-03-31 Voxeijet AG Device for the layer-wise production of patterns
US9757831B2 (en) 2007-10-23 2017-09-12 Voxeljet Ag Methods for assembling a device for the layer-wise production of patterns
US10799989B2 (en) 2007-10-23 2020-10-13 Voxeljet Ag Pre-assembled module for a device for the layer-wise production of patterns
US8663326B2 (en) 2007-12-13 2014-03-04 Said G. Osman Biologic artificial bone
US9326860B2 (en) 2007-12-13 2016-05-03 Amendia, Inc. Biologic artificial bone
US20090157181A1 (en) * 2007-12-13 2009-06-18 Osman Said G Biologic Artificial Bone
US8852672B2 (en) 2008-01-28 2014-10-07 Biomet 3I, Llc Implant surface with increased hydrophilicity
US8309162B2 (en) 2008-01-28 2012-11-13 Biomet 3I, Llc Implant surface with increased hydrophilicity
US20090191507A1 (en) * 2008-01-28 2009-07-30 Biomet 3I, Llc Implant surface with increased hydrophilicity
US9198742B2 (en) 2008-01-28 2015-12-01 Biomet 3I, Llc Implant surface with increased hydrophilicity
US20110223437A1 (en) * 2008-11-20 2011-09-15 Voxeljet Technology Gmbh Method for the layered construction of plastic models
US8715832B2 (en) 2008-11-20 2014-05-06 Voxeljet Ag Method for the layered construction of plastic models
US8679418B2 (en) 2009-04-08 2014-03-25 Errcive, Inc. Substrate fabrication
US9511345B1 (en) 2009-04-08 2016-12-06 Errcive, Inc. Substrate fabrication
US8277743B1 (en) 2009-04-08 2012-10-02 Errcive, Inc. Substrate fabrication
US9174392B2 (en) 2009-06-22 2015-11-03 Voxeljet Ag Method and device for switching a particulate material flow in the construction of models in layers
US9931762B2 (en) 2009-06-22 2018-04-03 Voxeljet Ag Method and device for switching a particulate material flow in the construction of models in layers
US8359829B1 (en) 2009-06-25 2013-01-29 Ramberg Charles E Powertrain controls
US20110024028A1 (en) * 2009-07-31 2011-02-03 United States Gypsum Company Method for preparing three-dimensional plaster objects
US8323429B2 (en) 2009-07-31 2012-12-04 United States Gypsum Company Method for preparing three-dimensional plaster objects
US9668863B2 (en) 2009-08-19 2017-06-06 Smith & Nephew, Inc. Porous implant structures
US10945847B2 (en) 2009-08-19 2021-03-16 Smith & Nephew, Inc. Porous implant structures
US10588749B2 (en) 2009-08-19 2020-03-17 Smith & Nephew, Inc. Porous implant structures
US11793645B2 (en) 2009-08-19 2023-10-24 Smith & Nephew, Inc. Porous implant structures
US11529235B2 (en) 2009-08-19 2022-12-20 Smith & Nephew, Inc. Porous implant structures
AU2010319306B2 (en) * 2009-11-12 2015-08-27 Smith & Nephew, Inc. Controlled randomized porous structures and methods for making same
WO2011060312A3 (en) * 2009-11-12 2011-09-29 Smith & Nephew, Inc. Controlled randomized porous structures and methods for making same
US10166316B2 (en) 2009-11-12 2019-01-01 Smith & Nephew, Inc. Controlled randomized porous structures and methods for making same
US9944020B2 (en) 2009-12-30 2018-04-17 DePuy Synthes Products, Inc. Method of fabricating a bone joining implant
WO2011082152A1 (en) * 2009-12-30 2011-07-07 Synthes Usa, Llc Intergrated multi-material implants and methods of manufacture
US20110190904A1 (en) * 2009-12-30 2011-08-04 Beat Lechmann Integrated multi-material implants and methods of manufacture
US9174390B2 (en) 2009-12-30 2015-11-03 DePuy Synthes Products, Inc. Integrated multi-material implants and methods of manufacture
US9925721B2 (en) 2010-02-04 2018-03-27 Voxeljet Ag Device for producing three-dimensional models
US8956144B2 (en) 2010-02-04 2015-02-17 Voxeijet AG Device for producing three-demensional models
US10182887B2 (en) 2010-03-29 2019-01-22 Biomet 3I, Llc Titanium nano-scale etching on an implant surface
US9283056B2 (en) 2010-03-29 2016-03-15 Biomet 3I, Llc Titanium nano-scale etching on an implant surface
US8641418B2 (en) 2010-03-29 2014-02-04 Biomet 3I, Llc Titanium nano-scale etching on an implant surface
US10765494B2 (en) 2010-03-29 2020-09-08 Biomet 3I, Llc Titanium nano-scale etching on an implant surface
US9757212B2 (en) 2010-03-29 2017-09-12 Biomet 3I, Llc Titanium nano-scale etching on an implant surface
US9034201B2 (en) 2010-03-29 2015-05-19 Biomet 3I, Llc Titanium nano-scale etching on an implant surface
US9656423B2 (en) 2010-03-31 2017-05-23 Voxeljet Ag Device and method for producing three-dimensional models
US9174391B2 (en) 2010-03-31 2015-11-03 Voxeljet Ag Device for producing three-dimensional models
US9815243B2 (en) 2010-03-31 2017-11-14 Voxeljet Ag Device for producing three-dimensional models
US9993975B2 (en) 2010-03-31 2018-06-12 Voxeljet Ag Device for producing three-dimensional models
US9333709B2 (en) 2010-03-31 2016-05-10 Voxeljet Ag Device and method for producing three-dimensional models
US9962885B2 (en) 2010-04-14 2018-05-08 Voxeljet Ag Device for producing three-dimensional models
US8911226B2 (en) 2010-04-14 2014-12-16 Voxeljet Ag Device for producing three-dimensional models
US9914169B2 (en) 2010-04-17 2018-03-13 Voxeljet Ag Method and device for producing three-dimensional models
US10179365B2 (en) 2010-04-17 2019-01-15 Voxeljet Ag Method and device for producing three-dimensional models
US10639715B2 (en) 2010-04-17 2020-05-05 Voxeljet Ag Method and device for producing three-dimensional models
US9833932B1 (en) 2010-06-30 2017-12-05 Charles E. Ramberg Layered structures
US8956140B2 (en) 2010-07-13 2015-02-17 Voxeljet Ag Apparatus for producing three-dimensional models by means of a layer build up technique
US9149987B2 (en) 2010-07-13 2015-10-06 Voxeljet Ag Device for producing three-dimensional models by a layering technique
US8613938B2 (en) 2010-11-15 2013-12-24 Zimmer Orthobiologics, Inc. Bone void fillers
US9770867B2 (en) 2010-12-29 2017-09-26 Voxeljet Ag Method and material system for building models in layers
US10946636B2 (en) 2011-01-05 2021-03-16 Voxeljet Ag Device and method for constructing a layer body
US9649812B2 (en) 2011-01-05 2017-05-16 Voxeljet Ag Device and method for constructing a laminar body comprising at least one position-adjustable body defining the working area
US11407216B2 (en) 2011-01-05 2022-08-09 Voxeljet Ag Device and method for constructing a layer body
US10513105B2 (en) 2011-01-05 2019-12-24 Voxeljet Ag Device and method for constructing a layer body
US9242413B2 (en) 2011-01-05 2016-01-26 Voxeljet Ag Device and method for constructing a laminar body comprising at least one position adjustable body defining the working area
US10913204B2 (en) 2011-08-31 2021-02-09 Voxeljet Ag Device for constructing models in layers and methods thereof
US11419726B2 (en) 2012-01-20 2022-08-23 Conformis, Inc. Systems and methods for manufacturing, preparation and use of blanks in orthopedic implants
US10220567B2 (en) 2012-03-06 2019-03-05 Voxeljet Ag Method and device for producing three-dimensional models
US10589460B2 (en) 2012-03-06 2020-03-17 Voxeljet Ag Method and device for producing three-dimensional models
US9131995B2 (en) 2012-03-20 2015-09-15 Biomet 3I, Llc Surface treatment for an implant surface
US9949834B2 (en) * 2012-04-06 2018-04-24 Limacorporate Spa Prosthetic element for bone extremities such as fingers or toes, or for teeth, and corresponding production method
US20150118650A1 (en) * 2012-04-06 2015-04-30 Limacorporate Spa Prosthetic Element for Bone Extremities Such as Fingers or Toes, or for Teeth, and Corresponding Production Method
US11225029B2 (en) 2012-05-25 2022-01-18 Voxeljet Ag Device for producing three-dimensional models and methods thereof
US10059062B2 (en) 2012-05-25 2018-08-28 Voxeljet Ag Device for producing three-dimensional models with special building platforms and drive systems
US10059058B2 (en) 2012-06-22 2018-08-28 Voxeljet Ag Device for building a multilayer structure with storage container or filling container movable along the dispensing container
US9993341B2 (en) 2012-07-20 2018-06-12 Biomet Manufacturing, Llc Metallic structures having porous regions from imaged bone at pre-defined anatomic locations
US8843229B2 (en) * 2012-07-20 2014-09-23 Biomet Manufacturing, Llc Metallic structures having porous regions from imaged bone at pre-defined anatomic locations
US10052682B2 (en) 2012-10-12 2018-08-21 Voxeljet Ag 3D multi-stage method
US11097469B2 (en) 2012-10-15 2021-08-24 Voxeljet Ag Method and device for producing three-dimensional models with a temperature-controllable print head
US10213831B2 (en) 2012-11-25 2019-02-26 Voxeljet Ag Construction of a 3D printing device for producing components
US11130290B2 (en) 2012-11-25 2021-09-28 Voxeljet Ag Construction of a 3D printing device for producing components
US10343301B2 (en) 2013-02-28 2019-07-09 Voxeljet Ag Process for producing a moulding using a water-soluble casting mould and material system for the production thereof
US11072090B2 (en) 2013-02-28 2021-07-27 Voxeljet Ag Material system for producing a molded part using a water-soluble casting mold
US11541596B2 (en) 2013-10-30 2023-01-03 Voxeljet Ag Method and device for producing three-dimensional models using a binding agent system
US10786945B2 (en) 2013-10-30 2020-09-29 Voxeljet Ag Method and device for producing three-dimensional models using a binding agent system
US11292188B2 (en) 2013-12-02 2022-04-05 Voxeljet Ag Interchangeable container with moveable side walls
US11850796B2 (en) 2013-12-02 2023-12-26 Voxeljet Ag Interchangeable container with moveable side walls
US10220568B2 (en) 2013-12-02 2019-03-05 Voxeljet Ag Interchangeable container with moveable side walls
US9943981B2 (en) 2013-12-11 2018-04-17 Voxeljet Ag 3D infiltration method
US10973949B2 (en) 2013-12-13 2021-04-13 Agnovos Healthcare, Llc Multiphasic bone graft substitute material
US9446170B2 (en) 2013-12-13 2016-09-20 Agnovos Healthcare, Llc Multiphasic bone graft substitute material
US10889055B2 (en) 2013-12-20 2021-01-12 Voxeljet Ag Device, special paper, and method for producing shaped articles
US10442170B2 (en) 2013-12-20 2019-10-15 Voxeljet Ag Device, special paper, and method for producing shaped articles
WO2015106113A1 (en) * 2014-01-09 2015-07-16 United Technologies Corporation Material and processes for additively manufacturing one or more parts
US11033961B2 (en) 2014-01-09 2021-06-15 Raytheon Technologies Corporation Material and processes for additively manufacturing one or more parts
US11097471B2 (en) 2014-03-31 2021-08-24 Voxeljet Ag Method and device for 3D printing using temperature-controlled processing
US10913207B2 (en) 2014-05-26 2021-02-09 Voxeljet Ag 3D reverse printing method and device
US10946556B2 (en) 2014-08-02 2021-03-16 Voxeljet Ag Method and casting mold, in particular for use in cold casting methods
US11253633B2 (en) * 2014-10-27 2022-02-22 I.Ceram Porous composition filled with an active ingredient
US10449692B2 (en) 2014-12-08 2019-10-22 Tethon Corporation Three-dimensional (3D) printing
US10682809B2 (en) 2014-12-22 2020-06-16 Voxeljet Ag Method and device for producing 3D moulded parts by means of a layer construction technique
US11077611B2 (en) 2015-03-17 2021-08-03 Voxeljet Ag Method and device for producing 3D shaped articles with a double recoater
US11890320B2 (en) 2015-04-20 2024-02-06 The Board Of Regents Of The University Of Texas System CLEC11A is a bone growth agent
US10843404B2 (en) 2015-05-20 2020-11-24 Voxeljet Ag Phenolic resin method
US20170266879A1 (en) * 2015-06-12 2017-09-21 Ashok Chand Mathur Method And Apparatus Of Very Much Faster 3D Printer
US20170291261A1 (en) * 2015-06-12 2017-10-12 Ashok Chand Mathur Method And Apparatus Of Very Much Faster 3D Printer
US10882110B2 (en) 2015-09-09 2021-01-05 Voxeljet Ag Method and device for applying fluids
US11890810B2 (en) 2015-09-16 2024-02-06 Voxeljet Ag Device and method for producing three-dimensional shaped parts
US11235518B2 (en) 2015-12-01 2022-02-01 Voxeljet Ag Method and device for producing three-dimensional components with the aid of an overfeed sensor
US11273605B2 (en) 2016-11-15 2022-03-15 Voxeljet Ag Integrated print head maintenance station for powder bed-based 3D printing
US11760023B2 (en) 2016-11-15 2023-09-19 Voxeljet Ag Print head parking or maintenance unit for powder bed-based 3D printing, 3D printing systems and methods thereof
US11718030B2 (en) * 2016-12-29 2023-08-08 3D Systems, Inc Spatial light modulation of powder-based additive manufacturing with temperature control including by sensor feedback
US11279087B2 (en) 2017-07-21 2022-03-22 Voxeljet Ag Process and apparatus for producing 3D moldings comprising a spectrum converter
US11731361B2 (en) 2017-07-21 2023-08-22 Voxeljet Ag Process and apparatus for producing 3D moldings comprising a spectrum converter
US11826958B2 (en) 2019-02-05 2023-11-28 Voxeljet Ag Exchangeable process unit
US20200367477A1 (en) * 2019-05-24 2020-11-26 Alexander SCHOFIELD Artificial coral articles and preparation methods thereof
US11820076B2 (en) 2019-11-01 2023-11-21 Voxeljet Ag 3D printing process and molding produced by this process using lignosulfate
US11504879B2 (en) 2020-04-17 2022-11-22 Beehive Industries, LLC Powder spreading apparatus and system

Also Published As

Publication number Publication date
US20030069638A1 (en) 2003-04-10
US6540784B2 (en) 2003-04-01
WO1996005038A1 (en) 1996-02-22
EP0775046A1 (en) 1997-05-28
JPH10508324A (en) 1998-08-18
US6183515B1 (en) 2001-02-06
AU702229B2 (en) 1999-02-18
US20010005797A1 (en) 2001-06-28
AU3361495A (en) 1996-03-07
EP0775046A4 (en) 2000-02-02

Similar Documents

Publication Publication Date Title
US5639402A (en) Method for fabricating artificial bone implant green parts
WO1996005038A9 (en) Method and system for fabricating artificial bone implants
Babaie et al. Fabrication aspects of porous biomaterials in orthopedic applications: A review
Schumacher et al. Indirect rapid prototyping of biphasic calcium phosphate scaffolds as bone substitutes: influence of phase composition, macroporosity and pore geometry on mechanical properties
US8303976B2 (en) Inorganic shaped bodies and methods for their production and use
Tarafder et al. Microwave‐sintered 3D printed tricalcium phosphate scaffolds for bone tissue engineering
Ebrahimi et al. Fabrication and characterization of novel nano hydroxyapatite/β‐tricalcium phosphate scaffolds in three different composition ratios
JP4358374B2 (en) Method for producing biological implant material
Lee et al. Selective laser sintering of bioceramic materials for implants
JP2001224679A (en) Porous ceramic body
Mbarki et al. Hydroxyapatite bioceramic with large porosity
Safronova et al. Powder systems for calcium phosphate ceramics
JP2011042572A (en) Foamed ceramic
Emadi et al. Nanostructured forsterite coating strengthens porous hydroxyapatite for bone tissue engineering
Abdurrahim et al. Recent progress on the development of porous bioactive calcium phosphate for biomedical applications
Mallick et al. 3D bioceramic foams for bone tissue engineering
Yang et al. Fabrication of β-TCP scaffold with pre-designed internal pore architecture by rapid prototyping of mask projection stereolithography
Lagow et al. Artificial bone implants
Meininger et al. Low temperature 3D printing of drug loaded bioceramic scaffolds and implants
Çalışkan et al. Fabrication of bioactive high porous hydroxyapatite ceramics
Crawford et al. Replacement of biological parts using solid freeform fabrication technologies
Hench a Julian R. Jones
Bose et al. Controlled Porosity Ceramics for Bone Graft Applications
ZA200106061B (en) Inorganic shaped bodies and methods for their production and use.
IL144448A (en) Inorganic shaped bodies and methods for their production and use

Legal Events

Date Code Title Description
AS Assignment

Owner name: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM,

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BARLOW, JOEL W.;LEE, GOONHEE;CRAWFORD, RICHARD H.;AND OTHERS;REEL/FRAME:007173/0915

Effective date: 19941006

STCF Information on status: patent grant

Free format text: PATENTED CASE

AS Assignment

Owner name: NAVY, SECRETARY OF THE, UNITED STATES OF AMERICA,

Free format text: CONFIRMATORY INSTRUMENT;ASSIGNOR:TEXAS, UNIVERSITY OF, AT AUSTIN;REEL/FRAME:008626/0980

Effective date: 19950824

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12

AS Assignment

Owner name: CROSS ATLANTIC PARTNERS IV, K/S, AS ADMINISTRATIVE

Free format text: SECURITY AGREEMENT;ASSIGNOR:BIOMEDICAL ENTERPRISES, INC.;REEL/FRAME:022510/0127

Effective date: 20090406

AS Assignment

Owner name: CROSS ATLANTIC PARTNERS IV, K/S AS ADMINISTRATIVE

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BIOMEDICAL ENTERPRISES, INC.;REEL/FRAME:022764/0679

Effective date: 20090406

AS Assignment

Owner name: BIOMEDICAL ENTERPRISES, INC., TEXAS

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE IDENTITY OF THE ASSIGNOR AND THE ASSIGNEE. PREVIOUSLY RECORDED ON REEL 022764 FRAME 0679;ASSIGNOR:CROSS ATLANTIC PARTNERS IV, K/S;REEL/FRAME:022783/0734

Effective date: 20090602